Pesticidally active pyrazole derivatives

The present invention relates to pyrazole derivatives, to processes for preparing them, to

intermediates for preparing them, to pesticidal, in particular insecticidal, acaricidal, molluscicidal and nematicidal compositions comprising those derivatives and to methods of using them to combat and control pests such as insect, acarine, mollusc and nematode pests.

It has now surprisingly been found that certain pyrazole derivatives have highly potent insecticidal properties. Other compounds in this area are known from WO2014/122083, WO2012/107434, WO2015/067646, WO2015/067647, WO2015/067648 and WO2010/051926.

Thus, as embodiment 1 , the present invention relates to a compound of formula (I),

wherein

R is selected from H, Ci.Ce-alkyI, C ₃ .C ₆ alkenyl, C ₃ .C ₆ alkinyl, C ₃ .C ₇ cycloalkyi, C ₃ .C ₇ cycloalkyi- Ci_C ₃ - alkyl, d-C ₆ -alkylcarbonyl, Ci_C ₆ -alkoxycarbonyl, aryl(C ₀ -C ₃ )-alkyl and heteroaryl(C ₀ -C ₃ )-alkyl, wherein each of Ci_C ₆ -alkyl, C ₃ .C ₆ alkenyl, C ₃ .C ₆ alkinyl, C ₃ .C ₇ cycloalkyi, C ₃ .C ₇ cycloalkyi- Ci_C ₃ -alkyl, Ci.Ce- alkylcarbonyl, Ci-C ₆ -alkoxycarbonyl, aryl(C ₀ -C ₃ )-alkyl and heteroaryl(C ₀ -C ₃ )-alkyl is unsubstituted or substituted with 1 to 5 substituents independently selected from halogen, cyano, Ci_C ₆ -alkoxy and Ci_ C ₆ -alkoxycarbonyl;

Q is selected from H, hydroxy, HC(=0)-, Ci_C ₆ -alkyl, Ci_C ₆ -alkoxy, C ₃ .C ₆ alkenyl, C ₃ .C ₆ alkinyl, C ₃ .C ₇ cycloalkyi, C ₃ .C ₇ heterocycloalkyl ,C ₃ .C ₇ cycloalkyi- Ci_C ₃ -alkyl, Ci_C ₃ -alkyl-C ₃ .C ₇ cycloalkyi, aryl(C ₀ - C ₃ )-alkyl, heteroaryl(C ₀ -C ₃ )-alkyl, N- Ci_C ₆ -alkylamino, N- Ci_C ₆ -alkylcarbonylamino and Λ/,/V-di (Ci_C ₆ - alkyl)amino, wherein each of Ci_C ₆ -alkyl, Ci_C ₆ -alkoxy, C ₃ .C ₆ alkenyl, C ₃ .C ₆ alkinyl, C ₃ .C ₇ cycloalkyi, C ₃ . C ₇ heterocycloalkyl ,C ₃ .C ₇ cycloalkyi- Ci_C ₃ -alkyl, Ci_C ₃ -alkyl-C ₃ .C ₇ cycloalkyi, aryl(C ₀ -C ₃ )-alkyl, heteroaryl(C ₀ -C ₃ )-alkyl, N- Ci_C ₆ -alkylamino, N- Ci_C ₆ -alkylcarbonylamino and Λ/,/V-di (Ci_C ₆ - alkyl)amino is unsubstituted or substituted with 1 to 5 substituents independently selected from halogen, hydroxyl, Ci_C ₆ -haloalkyl, nitro, amino, cyano, Ci_C ₆ -alkoxy, Ci_C ₆ -alkoxycarbonyl, hydroxycarbonyl, Ci_C ₆ -alkylcarbamoyl, C ₃ .C ₆ -cycloalkylcarbamoyl, -S-NH ₂ , phenyl and pyridyl;

W is O or S;

A ¹ is CR ² or N; A ² is CR ³ or N;

A ³ is CR ⁴ or N;

A ⁴ is CR ⁵ or N;

with the proviso that no more than 3 of A ¹ , A ² , A ³ and A ⁴ are N;

R ² , R ³ , R ⁴ and R ⁵ are independently selected from H, halogen, cyano, nitro, d-C ₆ -alkyl, Ci_C ₆ -alkoxy, N- Ci-C ₆ -alkoxy-imino-Ci-C3-alkyl, Ci_C ₆ -alkylsulfanyl, Ci_C ₆ -alkylsulfinyl, Ci_C ₆ -alkylsulfonyl, A/- Ci_C ₆ - alkylamino and Λ/,/V-di- Ci_C ₆ -alkylamino, wherein each of Ci_C ₆ -alkyl, Ci_C ₆ -alkoxy, N- Ci_C ₆ -alkoxy- imino-Ci-C ₃ -alkyl, Ci_C ₆ -alkylsulfanyl, d _C ₆ -al kylsu If i nyl , Ci_C ₆ -alkylsulfonyl, N- Ci_C ₆ -alkylamino and Λ/,/V-di- Ci_C ₆ -alkylamino is unsubstituted or substituted with 1 to 5 substituents independently selected from halogen, hydroxy, nitro, amino, cyano, Ci_C ₆ -alkoxy, Ci_C ₆ -alkoxycarbonyl, hydroxycarbonyl, d. C ₆ -alkylcarbamoyl, C ₃ .C ₆ -cycloalkylcarbamoyl and phenyl;

T is a 5-membered heteroaryl of formula

D is selected from CR ^6a , N, NR ^6b , O and S;

D ² is selected from CR ^7a , N, NR ^7b , O and S;

D ³ is C or N;

D ⁴ is selected from CR ^8a , N, NR ^8b and O;

with the proviso that at least one of D , D ² , D ³ and D ⁴ is selected from N, O and S, and that no more than one of D , D ² , D ³ and D ⁴ is O or S;

R ^6a , R ^7a and R ^8a are independently selected from H, halogen, cyano, nitro, amino, Ci_C ₆ -alkyl, Ci_C ₆ - alkoxy, Ci_C ₆ -alkylcarbonyl, Ci_C ₆ -alkylsulfanyl, d _C ₆ -al ky Is u If i nyl and Ci_C ₆ -alkylsulfonyl, wherein each of Ci_C ₆ -alkyl, Ci_C ₆ -alkoxy, Ci_C ₆ -alkylcarbonyl, Ci_C ₆ -alkylsulfanyl, d _C ₆ -al kylsu If i nyl , Ci_C ₆ - alkylsulfonyl is unsubstituted or substituted with 1 to 5 halogen;

R ^6b , R ^7b and R ^8b are independently selected from H and Ci_C ₆ -alkyl, wherein each of Ci_C ₆ -alkyl is unsubstituted or substituted with 1 to 5 halogen;

Z is selected from C ₃ .C ₇ heterocycloalkyl, Ci_C ₆ -halogenalkyl, C ₃ .C ₆ -cycloalkyl and C ₃ .C ₆ - halogencycloalkyl, wherein each of Ci_C ₆ -halogenalkyl, C ₃ .C ₆ -cycloalkyl and C ₃ .C ₆ -halogencycloalkyl is unsubstituted or substituted with 1 to 5 substituents independently selected from halogen, hydroxy, nitro, amino, cyano, Ci_C ₆ -alkoxy, Ci_C ₆ -alkoxycarbonyl, hydroxycarbonyl, Ci_C ₆ -alkylcarbamoyl, C ₃ . C ₆ -cycloalkylcarbamoyl and phenyl;

Z ² is selected from H, halogen, cyano, nitro, amino, Ci_C ₆ -alkyl, Ci_C ₆ -alkylcarbonyl, wherein each of Ci-C ₆ -alkyl and Ci_C ₆ -alkylcarbonyl is unsubstituted or substituted with 1 to 5 substituents independently selected from halogen, hydroxy, nitro, amino, cyano, hydroxycarbonyl, Ci_C ₆ - alkylcarbamoyl, C ₃ .C ₆ -cycloalkylcarbamoyl and phenyl;

Z ³ is selected from d-C ₆ -alkyl, Ci_C ₆ -cycloalkyl, Ci_C ₆ -alkenyl, Ci_C ₆ -alkinyl, aryl and heteroaryl, wherein each of Ci_C ₆ -alkyl, Ci_C ₆ -cycloalkyl, Ci_C ₆ -alkenyl, Ci_C ₆ -alkinyl, aryl and heteroaryl is unsubstituted or substituted with 1 to 5 substituents independently selected from halogen, hydroxy, nitro, amino, cyano, Ci_C ₆ -alkoxy, Ci_C ₆ -alkoxycarbonyl, hydroxycarbonyl, Ci_C ₆ -alkylcarbamoyl, C ₃ . C ₆ -cycloalkylcarbamoyl and phenyl;

or an agrochemically acceptable salt or N-oxide thereof. Preferred values of A ¹ , A ² , A ³ , A ⁴ , R ¹ , R ² , R ³ , R ⁴ , R ⁵ , R ^6a , R ^6b , R ^7a , R ^7b , R ^8a , R ^8b , Q, z Z ² and Z ³ in relation to each compound of the present invention, including the intermediate compounds, are as set out below in embodiments 2 to 24.

Embodiment 2: A compound or salt according to embodiment 1 , wherein T is selected from

T1 T2 T3 T4 T5 T6

T13 T14 T15 T16 T17 T18

T25 T26 T27 T28 T29 T30



T20 T21 T22 T23 T24

T28 wherein ^ indicates the bond to the pyrazole group.

Embodiment 4: A compound or salt according to embodiment 1 , wherein T is selected from

T15 T16 wherein ^ indicates the bond to the pyrazole group.

Embodiment 4.1 : A compound or salt according to embodiment 1 , wherein T is selected from

T13 T15 wherein indicates the bond to the pyrazole group.

Embodiment 5: A compound or salt according to any one of embodiments 1 to 4, wherein

R is selected from H, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-butyl, propenyl, methoxymethyl, ethoxymethyl, propoxymethyl, methylcarbonyl, ethylcarbonyl, n-propylcarbonyl, isopropylcarbonyl, s-butylcarbonyl, t-butylcarbonyl, methoxycarbonyl, ethoxycarbonyl, n- propoxycarbonyl, isopropoxycarbonyl, s-butoxycarbonyl, t-butoxycarbonyl, cyanomethyl, 2-cyanoethyl, benzyl, 4-methoxybenzyl, pyrid-2-yl-m ethyl, pyrid-3-yl-m ethyl, pyrid-4-yl-m ethyl and 4-chlor-pyrid-3-yl- m ethyl.

Embodiment 6: A compound or salt according to any one of embodiments 1 to 4, wherein

R is selected from H, methyl, ethyl, n-propyl, n-propylcarbonyl and propenyl.

Embodiment 7: A compound or salt according to any one of embodiments 1 to 4, wherein

R is H or methyl.

Embodiment 8: A compound or salt according to any one of embodiments 1 to 7, wherein

Q is selected from H, hydroxy, HC(=0)-, Ci_C ₆ -alkyl, d-C ₆ -alkoxy, C ₃ .C ₆ alkenyl, C ₃ .C ₆ alkinyl, C ₃ .C ₇ cycloalkyi, C ₃ .C ₇ heterocycloalkyl ,C ₃ .C ₇ cycloalkyi- Ci_C ₃ -alkyl, Ci.C ₃ -alkyl-C ₃ .C ₇ cycloalkyi, aryl(C ₀ - C ₃ )-alkyl, heteroaryl(C ₀ -C ₃ )-alkyl, N- Ci_C ₆ -alkylamino, N- Ci_C ₆ -alkylcarbonylamino and Λ/,/V-di (Ci_C ₆ - alkyl)amino, wherein each of Ci_C ₆ -alkyl, Ci_C ₆ -alkoxy, C ₃ .C ₆ alkenyl, C ₃ .C ₆ alkinyl, C ₃ .C ₇ cycloalkyi, C ₃ . C ₇ heterocycloalkyl ,C ₃ .C ₇ cycloalkyi- Ci_C ₃ -alkyl, Ci_C ₃ -alkyl-C ₃ .C ₇ cycloalkyi, aryl(C ₀ -C ₃ )-alkyl, heteroaryl(C ₀ -C ₃ )-alkyl, N- Ci_C ₆ -alkylamino, N- Ci_C ₆ -alkylcarbonylamino and Λ/,/V-di (Ci_C ₆ - alkyl)amino is unsubstituted or substituted with 1 to 5 substituents independently selected from halogen, hydroxyl, nitro, amino, cyano, Ci_C ₆ -alkoxy, Ci_C ₆ -alkoxycarbonyl, hydroxycarbonyl, Ci_C ₆ - alkylcarbamoyl, C ₃ .C ₆ -cycloalkylcarbamoyl and phenyl.

Embodiment 9: A compound or salt according to any one of embodiments 1 to 7, wherein

Q is selected from H, methyl, ethyl, n-propyl, 1 -methylethyl, 1 ,1 -dimethylethyl, 1 -methylpropyl, n- butyl, 2-methylpropyl, 2-methylbutyl, hydroxyethyl, 2-hydroxypropyl, cyanomethyl, 2- cyanoethyl, 2- fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluorethyl, 1 -trifluoromethylethyl, 2,2- difluoropropyl, 3,3,3- trifluoropropyl, 2,2-dimethyl-3-fluoropropyl, cyclopropyl, 1-cyano- cyclopropyl, 1 -methoxycarbonyl- cyclopropyl, 1 -(N-methylcarbamoyl)cyclopropyl, 1 -carbamoyl- cyclopropyl, 1 -carbamothioyl- cyclopropyl, 1 -(N-cyclopropylcarbamoyl)cyclopropyl, cyclopropyl-methyl, cyclobutyl, cyclopentyl, cyclohexyl, 1 -cyclopropylethyl, bis(cyclopropyl)methyl, 2,2-dimethylcyclopropyl-methyl, 2- phenylcyclopropyl, 2,2- dichlorocyclopropyl, trans-2-chlorocyclopropyl, cis-2-chlorocyclopropyl, 2,2- difluorocyclopropyl, trans-2-fluorocyclopropyl, cis-2-fluorocyclopropyl, trans-4-hydroxycyclohexyl, 4- trifluoromethylcyclohexyl, prop-2-enyl, 2-methylprop-2-enyl, prop-2-inyl, 1 , 1 -dimethylbut-2- inyl, 3- chloro-prop-2-enyl, 3-fluoro-prop-2-enyl, 3,3-dichloro-prop-2-enyl, 3, 3 -dichloro- 1 , 1- dimethylprop-2- enyl, oxetan-3-yl, thietan-3-yl, 1-oxido-thietan-3-yl, 1 , 1-dioxido-thietan-3-yl, isoxazol-3-ylmethyl, 1 ,2,4- triazol-3-ylmethyl, 3-methyloxetan-3-ylmethyl, benzyl, 2,6- difluorophenylmethyl, 3-fluorophenylmethyl, 2-fluorophenylmethyl, 2,5-difluorophenylmethyl, 1- phenylethyl, 4-chlorophenylethyl, 2- trifluoromethylphenylethyl, 1 -pyridin-2-ylethyl, pyridin-2- ylmethyl, 5-fluoropyridin-2-ylmethyl, (6-chloro- pyridin-3-yl)methyl, pyrimidin-2-ylmethyl, methoxy, 2-ethoxyethyl, 2-methoxyethyl, 2- (methylsulfanyl)ethyl, 1-methyl-2-(ethylsulfanyl)ethyl, 2-methyl-1-(methylsulfanyl)propan-2-yl, methoxycarbonyl, methoxycarbonylmethyl, NH ₂ , N-ethylamino, N-allylamino, Ν,Ν-dimethylamino, N,N- diethylamino, 2-thienylmethyl, isopropyl, isobutyl, methylsulfonyl, methylsulfinyl, 3-(methylsulfanyl)- cyclobutyl, 2-oxo-2[(2,2,2)-trifluoroethyl)amino]ethyl, 1-(CF ₃ )cyclopropyl, 2-methylcyclopropyl, 1 ,1 , 1- trifluoropropan-2-yl, buta-2,3-dien-1-yl, 3-chloroprop-2-en-1-yl, 3-cyanothientan-3-yl, 3- (methylsulfonyl)cyclobutyl, 4-fluorophenyl, 2-[(methylsulfinyl)methyl]cyclobutyl, 3-methylbutan-2-yl, 2- (methylsulfonyl)cyclobutyl, 2-(dimethylamino)ethyl and 2-methoxyethyl; or

Q is selected from phenyl, naphthyl, pyridazine, pyrazine, pyrimidine, triazine, pyridine, pyrazole, thiazole isothiazole, oxazole, isoxazole, triazole, imidazole, furan, thiophene, pyrrole, oxadiazole, thiadiazole, tetrazole and tetrahydrofuran, each of which is unsubstituted or substituted with 1 to 4 substituents independently selected from V;

V is selected from fluoro, chloro, bromo, iodo, cyano, nitro, methyl, ethyl, difluoromethyl, hydroxyl, trichloromethyl, chlorodifluoromethyl, dichlorofluoromethyl, trifluoromethyl, 1 -fluoroethyl, 2- fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 1 ,2,2,2-tetrafluoroethyl, 1 -chloro- 1 ,2,2,2- tetrafluoroethyl, 2,2,2-trichloroethyl, 2-chloro-2,2-difluoroethyl, 1 , 1 -dilfluoroethyl, pentafluoroethyl heptafluoro-n-propyl, heptafluoro-isopropyl, nonafluoro-n-butyl, cyclopropyl, cyclobutyl, methoxy, ethoxy, n-propoxy, 1 -methylethoxy, fluormethoxy, difluormethoxy, chloro-difluormethoxy, dichloro- fluoromethoxy, trifluoromethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2,2- difluorethoxy, pentafluorethoxy, N- methoxyiminomethyl, l-(N-methoxyimino)-ethyl, methylsulfanyl, methylsulfonyl, methylsulfinyl, trifluormethylsulfonyl, trifluormethylsulfinyl, trifluormethylsulfanyl and N,N-dimethylamino.

Embodiment 10: A compound or salt according to any one of embodiments 1 to 7, wherein

Q is selected from 1 -cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl. Embodiment 1 1 : A compound or salt according to any one of embodiments 1 to 10, wherein

W is O.

Embodiment 12: A compound or salt according to any one of embodiments 1 to 1 1 , wherein

A ¹ is CR ² or N;

A ² is CR ³ or N;

A ³ is CR ⁴ or N;

A ⁴ is CR ⁵ or N;

with the proviso that no more than 3 of A ¹ , A ² , A ³ and A ⁴ are N;

R ² and R ⁵ are independently selected from H, methyl, fluoro and chloro;

R ³ and R ⁴ are independently selected from H, fluoro, chloro, bromo, iodo, cyano, nitro, methyl, ethyl, fluoromethyl, difluoromethyl, chlordifluormethyl, trifluorm ethyl, 2 ,2 ,2-tri If I uoroethy I , methoxy, ethoxy, n- propoxy, 1 -methylethoxy, fluoromethoxy, difluoromethoxy, chloro-difluoromethoxy, dichloro- fluoromethoxy, trifluoromethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2,2-difluorethoxy, pentafluoroethoxy, N- methoxyiminomethyl, 1-(N-methoxyimino)-ethyl, methylsulfanyl, trifluoromethylsulfanyl, methylsulfonyl, methylsulfinyl, trifluormethylsulfonyl and trifluormethylsulfinyl.

Embodiment 13: A compound or salt according to any one of embodiments 1 to 1 1 , wherein

A ¹ and A ⁴ are CH;

A ² is CH or CF;

A ³ is CH or CCI.

Embodiment 14: A compound or salt according to any one of embodiments 1 to 13, wherein

R ^6a , R ^7a and R ^8a are independently selected from H, halogen, cyano, nitro, amino, methyl, ethyl, propyl, 1- methylethyl, tert-butyl, trifluoromethyl, difluoromethyl, methoxy, ethoxy, trifluoromethoxy, 2,2- difluoroethoxy, 2,2,2-trifluoroethoxy, methylcarbonyl, ethylcarbonyl, trifluoromethylcarbonyl, methylsulfanyl, methylsulfinyl, methylsulfonyl, trifluoromethylsulfonyl, trifluoromethylsulfanyl and tri If I uoromethylsu If i nyl ;

R ^6b , R ^7b and R ^8b are independently selected from H or methyl.

Embodiment 15: A compound or salt according to any one of embodiments 1 to 13, wherein

R ^6a , R ^7a and R ^8a are independently selected from H, methyl and trifluoromethoxy;

R ^6b , R ^7b and R ^8b are independently selected from H and methyl. Embodiment 16: A compound or salt according to any one of embodiments 1 to 15, wherein

Z is selected from methyl, ethyl, 1 ,1-dimethylethyl, difluoromethyl, trichloromethyl,

chlorodifluoromethyl, dichlorofluoromethyl, trifluoromethyl, bromodichloromethyl, 1 -fluoroethyl, 1- fluoro-1 -methylethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 1 ,2,2,2-tetrafluoroethyl, 1- chloro- 1 ,2,2,2- tetrafluoroethyl, 2,2,2-trichloroethyl, 2-chloro-2,2-difluoroethyl, 1 ,1 -difluoroethyl, pentafluoroethyl, heptafluoro-n-propyl, heptafluoro-isopropyl and nonafluoro-n-butyl;

Z ² is selected from H, halogen, cyano, nitro, amino, methyl, ethyl, 1 ,1 -dimethylethyl, difluoromethyl, trichloromethyl, chlorodifluoromethyl, dichlorofluoromethyl, trifluoromethyl, bromodichloromethyl, 1- fluoroethyl, 1-fluoro-1 methylethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 1 ,2,2,2- tetrafluoroethyl, 1 -chloro- 1 ,2,2,2-tetrafluoroethyl, 2,2,2-trichloroethyl, 2-chloro-2,2-difluoroethyl, 1 ,1 - difluoroethyl, pentafluoroethyl heptafluoro-n-propyl, heptafluoro- isopropyl and nonafluoro-n-butyl; Z ³ is selected from H, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-butyl, ethenyl, 1- propenyl, 1-propinyl, 1 -butinyl, difluoromethyl, trichloromethyl, chlorodifluoromethyl,

dichlorofluoromethyl, trifluoromethyl, 1 -fluoroethyl, 1 fluoro- 1 -methylethyl, 2-fluoroethyl, 2,2- difluoroethyl, 2,2,2-trifluoroethyl, phenyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, 2,5- dichlorophenyl, 3,4-dichlorophenyl, 2,6-dichlorophenyl 2,6-dichloro-4-trifluoromethylphenyl, 3- chlor-5- trifluormethylpyridin-2-yl, 4-N0 ₂ -phenyl and 3-chloro-pyridin-2-yl. Embodiment 17: A compound or salt according to any one of embodiments 1 to 15, wherein

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chloro-pyridin-2-yl. Embodiment 18: A compound or salt according to embodiment 3 or 4, wherein

R is H;

Q is selected from 1 -cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ is CR ² or N;

A ² is CR ³ or N;

A ³ is CR ⁴ or N;

A ⁴ is CR ⁵ or N;

with the proviso that no more than 3 of A ¹ , A ² , A ³ and A ⁴ are N;

R ² and R ⁵ are independently selected from H, methyl, fluoro and chloro;

R ³ and R ⁴ are independently selected from H, fluoro, chloro, bromo, iodo, cyano, nitro, methyl, ethyl, fluoromethyl, difluoromethyl, chlordifluoromethyl, trifluoromethyl, 2,2,2-trilfluoroethyl, methoxy, ethoxy, n-propoxy, 1 -methylethoxy, fluoromethoxy, difluoromethoxy, chloro-difluoromethoxy, dichloro- fluoromethoxy, trifluoromethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2,2-difluoroethoxy, pentafluoroethoxy, N- methoxyiminomethyl, 1-(N-methoxyimino)-ethyl, methylsulfanyl, trifluoromethylsulfanyl, methylsulfonyl, methylsulfinyl, trifluoromethylsulfonyl and trifluoromethylsulfinyl; Z is selected from methyl, ethyl, 1 , 1 -dimethylethyl, difluoromethyl, trichloromethyl, chlorodifluoromethyl, dichlorofluoromethyl, trifluoromethyl, bromodichloromethyl, 1 -fluoroethyl, 1- fluoro-1-methylethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 1 ,2,2,2-tetrafluoroethyl, 1- chloro- 1 ,2,2,2- tetrafluoroethyl, 2,2,2-trichloroethyl, 2-chloro-2,2-difluoroethyl, 1 , 1 -difluoroethyl, pentafluoroethyl heptafluoro-n-propyl, heptafluoro-isopropyl and nonafluoro-n-butyl;

Z ² is selected from H, halogen, cyano, nitro, amino, methyl, ethyl, 1 , 1 -dimethylethyl, difluoromethyl, trichloromethyl, chlorodifluoromethyl, dichlorofluoromethyl, trifluoromethyl, bromodichloromethyl, 1- fluoroethyl, 1-fluoro-1 methylethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 1 ,2,2,2- tetrafluoroethyl, 1 -chlor- 1 ,2,2,2-tetrafluoroethyl, 2,2,2-trichloroethyl, 2-chloro-2,2-difluoroethyl, 1 , 1 - difluoroethyl, pentafluoroethyl heptafluoro-n-propyl, heptafluoro- isopropyl and nonafluoro-n-butyl; Z ³ is selected from H, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-butyl, ethenyl, 1- propenyl, 1-propinyl, 1 -butinyl, difluoromethyl, trichloromethyl, chlorodifluoromethyl,

dichlorofluoromethyl, trifluoromethyl, 1 -fluoroethyl, 1 fluoro- 1 -methylethyl, 2-fluoroethyl, 2,2- difluoroethyl, 2,2,2-trifluoroethyl, phenyl, 2-chlorophenyl, 3-chlorophenyl, 4-chlorophenyl, 2,5- dichlorophenyl, 3,4-dichlorophenyl, 2,6-dichlorophenyl 2,6-dichloro-4-trifluoromethylphenyl, 3- chlor-5- trifluormethylpyridin-2-yl, 4-N0 ₂ -phenyl and 3-chloro-pyridin-2-yl.

Embodiment 19: A compound or salt according to embodiment 3 or 4, wherein

R ^6a , R ^7a and R ^8a are independently selected from H, methyl and trifluoromethoxy;

R ^6b , R ^7b and R ^8b are independently selected from H and methyl.

R is H;

Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chloropyridin-2-yl.

Embodiment 20: A compound or salt according to any one of embodiments 1 to 19, wherein

R ^a and R ^a are independently selected from H, methyl and trifluoromethoxy; R is H;

Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl.

Embodiment 21 : A compound or salt according to any one of embodiments 1 to 19, wherein

R and R are independently selected from H, methyl and trifluoromethoxy;

R is H;

Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl.

Embodiment 22: A compound or salt according to any one of embodiments 1 to 19, wherein

R is selected from H, methyl and trifluoromethoxy;

R is H; Q is selected from 1-cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamotliioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, metliylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl.

Embodiment 23: A compound or salt according to any one of embodiments 1 to 19, wherein

R ^a is selected from H, methyl and trifluoromethoxy;

R is H;

Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamotliioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, metliylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl. Embodiment 23.1 : A compound or salt according to embodiment 1 , wherein

R' is H;

Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamotliioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, metliylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O; A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl.

Embodiment 23.2: A compound or salt according to any one of embodiments 1 to 19, wherein

R is H;

Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl.

Embodiment 23.3: A compound or salt according to any one of embodiments 1 to 19, wherein

R is H;

Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ; Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl.

Embodiment 23.4: A compound or salt according to any one of embodiments 1 to 19, wherein

R is selected from H, methyl and trifluoromethoxy;

R is H;

Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl.

Embodiment 23.5: A compound or salt according to any one of embodiments 1 to 19, wherein

R is selected from H, methyl and trifluoromethoxy;

R is H;

Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl. Embodiment 23.6: A compound or salt according to any one of embodiments 1 to 19, wherein

R is selected from H, methyl and trifluoromethoxy;

R is H;

Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl.

Embodiment 23.7: A compound or salt according to any one of embodiments 1 to 19, wherein

R is H;

Q is selected from 1 -cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl. Embodiment 23.8: A compound or salt according to any one of embodiments 1 to 19, wherein

R and R are independently selected from H, methyl and trifluoromethoxy;

R is H;

Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl. Embodiment 23.9: A compound or salt according to any one of embodiments 1 to 19, wherein

R and R are selected from H, methyl and trifluoromethoxy;

R is H;

Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z ¹ is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl. Embodiment 23.10: A compound or salt according to any one of embodiments 1 to 19, wherein

R and R are independently selected from H, methyl and trifluoromethoxy;

R is H;

Q is selected from 1-cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl. Embodiment 23.11 : A compound or salt according to any one of embodiments 1 to 19, wherein

R and R are independently selected from H, methyl and trifluoromethoxy;

R is H;

Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl. Embodiment 23.12: A compound or salt according to any one of embodiments 1 to 19, wherein

R and R are independently selected from H, methyl and trifluoromethoxy;

R is H;

Q is selected from 1-cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl. Embodiment 23.13: A compound or salt according to any one of embodiments 1 to 19, wherein

R ^6a and R ^7a are independently selected from H, methyl and trifluoromethoxy;

R is H;

Q is selected from 1-cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl. Embodiment 23.14: A compound or salt according to any one of embodiments 1 to 19, wherein

R ^a is selected from H, methyl and trifluoromethoxy;

R ¹ is H;

Q is selected from 1-cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z ¹ is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl. Embodiment 23.15: A compound or salt according to any one of embodiments 1 to 19, wherein

R and R are independently selected from H, methyl and trifluoromethoxy;

R is H;

Q is selected from 1-cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl. Embodiment 23.16: A compound or salt according to any one of embodiments 1 to 19, wherein

R and R are independently selected from H, methyl and trifluoromethoxy;

R is H;

Q is selected from 1-cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl. Embodiment 23.17: A compound or salt according to any one of embodiments 1 to 19, wherein

R and R are independently selected from H, methyl and trifluoromethoxy;

R is H;

Q is selected from 1-cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl. Embodiment 23.18: A compound or salt according to any one of embodiments 1 to 19, wherein

R ^a is selected from H, methyl and trifluoromethoxy;

R is H;

Q is selected from 1-cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl. Embodiment 23.19: A compound or salt according to any one of embodiments 1 to 19, wherein

R ^a is selected from H, methyl and trifluoromethoxy;

R is H;

Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl. Embodiment 23.20: A compound or salt according to any one of embodiments 1 to 19, wherein

R ^a is selected from H, methyl and trifluoromethoxy;

R is H;

Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl. Embodiment 23.21 : A compound or salt according to any one of embodiments 1 to 19, wherein

R ^a is selected from H, methyl and trifluoromethoxy;

R is H;

Q is selected from 1 -cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z ¹ is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl. Embodiment 23.22: A compound or salt according to any one of embodiments 1 to 19, wherein

R ^a is selected from H, methyl and trifluoromethoxy;

R is H;

Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl. Embodiment 23.23: A compound or salt according to any one of embodiments 1 to 19, wherein

R ^a is selected from H, methyl and trifluoromethoxy;

R is H;

Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl. Embodiment 23.24: A compound or salt according to any one of embodiments 1 to 19, wherein

R ^a is selected from H, methyl and trifluoromethoxy;

R is H;

Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl. Embodiment 23.25: A compound or salt according to any one of embodiments 1 to 19, wherein

R ^6a is selected from H, methyl and trifluoromethoxy;

R is H;

Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl. Embodiment 23.26: A compound or salt according to any one of embodiments 1 to 19, wherein

R is selected from H, methyl and trifluoromethoxy;

R ¹ is H;

Q is selected from 1-cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z ¹ is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl. Embodiment 23.27: A compound or salt according to any one of embodiments 1 to 19, wherein

R is selected from H, methyl and trifluoromethoxy;

R is H;

Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl. Embodiment 23.28: A compound or salt according to any one of embodiments 1 to 19, wherein

R and R are independently selected from H, methyl and trifluoromethoxy;

R is H;

Q is selected from 1-cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl. Embodiment 23.29: A compound or salt according to any one of embodiments 1 to 19, wherein

R is H;

Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl.

Embodiment 23.30: A compound or salt according to any one of embodiments 1 to 19, wherein R is H;

Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl.

Embodiment 23.31 : A compound or salt according to any one of embodiments 1 to 19, wherein

R is H;

R ^6a and R ^7b are independently selected from H, methyl and trifluoromethoxy;

Q is selected from 1- cyano-cyclopropyl, benzyl, cyclopropyl, 2-thienylmethyl,

carbamothioylcyclopropyl, pyrid-4-yl, 2,2,2-trifluorethyl, methylsulfonyl, thietan-3-yl and 1- carbamoylcyclopropyl;

W is O;

A ¹ and A4 are CH;

A ² is CH or CF;

A ³ is CH or CCI;

Z is CF ₂ CF ₃ ;

Z ² is CF ₃ ;

Z ³ is selected from methyl, ethyl, phenyl, 4-N0 ₂ -phenyl and 3-chlorpyridin-2-yl.

Embodiment 24: A compound or salt according to embodiment 1 , wherein the compound is selected from any one of compounds 2 to 98 2 2-chloro-N-(1-cyanocyclopropyl)-5-[4-[2- T methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]pyrazol-1- yl]benzamide

3 2-chloro-N-(1-cyanocyclopropyl)-5-[5-[2- methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-3- yl]benzamide

4 2-chloro-N-(1-cyanocyclopropyl)-5-[3-[2- T methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]benzamide

1

5 2-chloro-N-cyclopropyl-5-[3-[2-methyl-5- γ (1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]pyrazol-1- yl]benzamide

6 2-chloro-N-cyclopropyl-5-[4-[2-methyl-5- (1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]pyrazol-1- yl]benzamide

7 2-chloro-N-cyclopropyl-5-[5-[2-methyl-5- γ (1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-3- yl]benzamide

1

8 2-chloro-N-cyclopropyl-5-[3-[2-methyl-5-

Y (1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]benzamide

1 2-chloro-N-cyclopropyl-5-[3-[2-methyl-5- γ (1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-1 ,2,4- oxadiazol-5-yl]benzamide

I

2-chloro-N-(1-cyanocyclopropyl)-5-[3-[2- T methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-1 ,2,4- oxadiazol-5-yl]benzamide

2-chloro-N-cyclopropyl-5-[5-[2-methyl-5-

Y (1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-1 ,3,4- oxadiazol-2-yl]benzamide

2-chloro-N-(1-cyanocyclopropyl)-5-[5-[2- methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-1 ,3,4- oxadiazol-2-yl]benzamide

1

2-chloro-N-cyclopropyl-5-[5-[2-methyl-5-

Y (1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-1 ,3,4- thiadiazol-2-yl]benzamide

1

2-chloro-N-(1-cyanocyclopropyl)-5-[5-[2- methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-1 ,3,4- thiadiazol-2-yl]benzamide

1 2-chloro-N-cyclopropyl-5-[5-[2-methyl-5- p F F F F 0 / _H (1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-1 ,2,4- oxadiazol-3-yl]benzamide

I 0— N

2-chloro-N-(1-cyanocyclopropyl)-5-[5-[2- methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-1 ,2,4- oxadiazol-3-yl]benzamide

I 0— N

2-chloro-N-cyclopropyl-5-[1-methyl-2-[2- p F F F F 0 / _H methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]imidazol-4- yl]benzamide

2-chloro-N-( 1 -cyanocyclopropyl)-5-[1 - methyl-2-[2-methyl-5-(1 ,1 ,2,2,2- pentafluoroethyl)-4-

(trifluoromethyl)pyrazol-3-yl]imidazol-4- yl]benzamide

2-chloro-N-cyclopropyl-5-[3-methyl-2-[2- methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]imidazol-4- yl]benzamide

I

2-chloro-N-(1-cyanocyclopropyl)-5-[3- methyl-2-[2-methyl-5-(1 ,1 ,2,2,2- pentafluoroethyl)-4-

(trifluoromethyl)pyrazol-3-yl]imidazol-4- yl]benzamide γ 2-chloro-N-cyclopropyl-5-[1-methyl-5-[2- methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]imidazol-2- yl]benzamide

2-chloro-N-( 1 -cyanocyclopropyl)-5-[1 - methyl-5-[2-methyl-5-(1 , 1 ,2,2,2- pentafluoroethyl)-4-

(trifluoromethyl)pyrazol-3-yl]imidazol-2-

I Ϊ yl]benzamide

2-chloro-N-cyclopropyl-5-[1-methyl-4-[2- methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]imidazol-2- yl]benzamide

2-chloro-N-( 1 -cyanocyclopropyl)-5-[1 - methyl-4-[2-methyl-5-(1 , 1 ,2,2,2- Fv_ ° pentafluoroethyl)-4-

(trifluoromethyl)pyrazol-3-yl]imidazol-2-

I H yl]benzamide

2-chloro-N-cyclopropyl-5-[5-[2-methyl-5- (1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-2- furyl]benzamide

2-chloro-N-(1-cyanocyclopropyl)-5-[5-[2- methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-2- furyl]benzamide 2-chloro-N-cyclopropyl-5-[5-[2-methyl-5-

Ϋ (1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-2- thienyl]benzamide

2-chloro-N-(1-cyanocyclopropyl)-5-[5-[2- methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-2- thienyl]benzamide

2-chloro-N-cyclopropyl-5-[3-[2-methyl-5- (1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-1 ,2,4-triazol- 1-yl]benzamide

2-chloro-N-(1-cyanocyclopropyl)-5-[3-[2- 7 methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-1 ,2,4-triazol- 1-yl]benzamide

1

2-chloro-N-cyclopropyl-5-[4-[2-methyl-5- (1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]pyrazol-1- yl]benzamide

2-chloro-N-(1-cyanocyclopropyl)-5-[4-[2- methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]pyrazol-1- yl]benzamide

2-chloro-N-cyclopropyl-5-[1-methyl-5-[2- methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]pyrazol-3- yl]benzamide

I 2-chloro-N-( 1 -cyanocyclopropyl)-5-[1 - methyl-5-[2-methyl-5-(1 ,1 ,2,2,2- pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]pyrazol-3-

I

yl]benzamide

2-chloro-N-cyclopropyl-5-[2-methyl-5-[2- y methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]pyrazol-3- yl]benzamide

I

2-chloro-N-(1-cyanocyclopropyl)-5-[2- methyl-5-[2-methyl-5-(1 ,1 ,2,2,2- pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]pyrazol-3- yl]benzamide

2-chloro-N-cyclopropyl-5-[3-[2-methyl-5- (1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isothiazol-5- yl]benzamide

I

2-chloro-N-(1-cyanocyclopropyl)-5-[3-[2- methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isothiazol-5- yl]benzamide

2-chloro-N-cyclopropyl-5-[5-[2-methyl-5-

Y (1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isothiazol-3- yl]benzamide

I 2-chloro-N-(1-cyanocyclopropyl)-5-[5-[2- methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isothiazol-3- yl]benzamide

I S— N

2-chloro-N-cyclopropyl-5-[2-[2-methyl-5- (1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]thiazol-5- yl]benzamide

2-chloro-N-(1-cyanocyclopropyl)-5-[2-[2- methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]thiazol-5- yl]benzamide

2-chloro-N-cyclopropyl-5-[4-[2-methyl-5- (1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]thiazol-2- yl]benzamide

2-chloro-N-(1-cyanocyclopropyl)-5-[4-[2- methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]thiazol-2- yl]benzamide

2-chloro-N-cyclopropyl-5-[5-[2-methyl-5- (1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]thiazol-2- yl]benzamide

2-chloro-N-(1-cyanocyclopropyl)-5-[5-[2- methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]thiazol-2- yl]benzamide

2-chloro-N-cyclopropyl-5-[2-[2-methyl-5- γ (1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]thiazol-4- yl]benzamide

2-chloro-N-(1-cyanocyclopropyl)-5-[2-[2- p F F F F 0 T methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]thiazol-4- yl]benzamide

2-chloro-N-cyclopropyl-5-[2-[2-methyl-5- p F F F F 0 Y _H (1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]oxazol-4- yl]benzamide

2-chloro-N-(1-cyanocyclopropyl)-5-[2-[2- p F F F F 0 T methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]oxazol-4- yl]benzamide

2-chloro-N-cyclopropyl-5-[5-[2-methyl-5- (1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]oxazol-2- yl]benzamide 2-chloro-N-(1-cyanocyclopropyl)-5-[5-[2- methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]oxazol-2- yl]benzamide

2-chloro-N-cyclopropyl-5-[2-[2-methyl-5-

Ϋ (1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]oxazol-5- yl]benzamide

2-chloro-N-(1-cyanocyclopropyl)-5-[2-[2- methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]oxazol-5- yl]benzamide

I

2-chloro-N-cyclopropyl-5-[4-[2-methyl-5- p (1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]oxazol-2- yl]benzamide

2-chloro-N-(1-cyanocyclopropyl)-5-[4-[2- methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]oxazol-2- yl]benzamide

2-chloro-N-cyclopropyl-5-[4-[2-methyl-5- (1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]imidazol-1- yl]benzamide 64 2-chloro-N-(1-cyanocyclopropyl)-5-[4-[2- methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]imidazol-1- yl]benzamide

65 2-chloro-N-cyclopropyl-5-[5-[2-methyl-5- (1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-1 ,2,4- thiadiazol-3-yl]benzamide

1

66 2-chloro-N-(1-cyanocyclopropyl)-5-[5-[2- methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-1 ,2,4- thiadiazol-3-yl]benzamide

1

67 2-chloro-N-cyclopropyl-5-[3-[2-methyl-5- (1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-1 ,2,4- thiadiazol-5-yl]benzamide

68 2-chloro-N-(1-cyanocyclopropyl)-5-[3-[2- methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-1 ,2,4- thiadiazol-5-yl]benzamide

1

69 2-chloro-N-cyclopropyl-5-[4-[2-methyl-5- (1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-1 H-imidazol- 2-yl]benzamide

1 81 2-chloro-N-(2-fluorocyclopropyl)-5-[3- [2-methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)- 4-(trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]benzamide

82 2-chloro-N-(2-chloroallyl)-5-[3-[2-methyl- 5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]benzamide

83 2-chloro-5-[3-[2-methyl-5-(1 ,1 ,2,2,2- pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]-N-(3,3,3-trifluoropropyl)benzamide

84 2-chloro-N-(3,3-dichloroallyl)-5-[3-[2- methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]benzamide

85 2-chloro-N-(4-chlorophenyl)-5-[3-[2- methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]benzamide

86 2-chloro-N-(2-fluoroallyl)-5-[3-[2-methyl- 5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]benzamide

87 2-chloro-N-isobutyl-5-[3-[2-methyl-5- (1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]benzamide

92 2-chloro-N-methyl-5-[3-[2-methyl-5- (1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]benzamide

93 2-chloro-N-isopropyl-5-[3-[2-methyl-5- (1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]benzamide

94 2-chloro-5-[3-[2-methyl-5-(1 , 1 ,2,2,2- pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]benzamide

95 2-chloro-5-[3-[2-methyl-5-(1 , 1 ,2,2,2- pentafluoroethyl)-4-

H N o (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]-N-[1-(2-pyridyl)cyclopropyl]benzamide

F ^F 96 2-chloro-5-[3-[2-methyl-5-(1 , 1 ,2,2,2- pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]-N-(2,2,2-trifluoroethyl)benzamide

97 2-chloro-N-(2,2-difluoroethyl)-5-[3-[2- methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]benzamide

98 2-chloro-N-(2-methylallyl)-5-[3-[2-methyl- 5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]benzamide

or an agrochemically acceptable salt or N-oxide thereof.

Embodiment 24.1 : A compound or salt according to embodiment 1 , wherein the compound is selected from 2-chloro-N-(1-cyanocyclopropyl)-5-[4-[2- p F F F F 0 T methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]pyrazol-1- yl]benzamide

2-chloro-N-(1-cyanocyclopropyl)-5-[3-[2- p F F F F 0 T methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]benzamide

I N— 0

2-chloro-N-cyclopropyl-5-[4-[2-methyl-5-

F F F F F 0 / _H (1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]pyrazol-1- yl]benzamide

2-chloro-N-cyclopropyl-5-[3-[2-methyl-5- p F F F F O Ϋ / _H (1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]benzamide

1 N— O

2-chloro-N-cyclopropyl-5-[5-[2-methyl-5-

Y (1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-1 ,3,4- oxadiazol-2-yl]benzamide

1 N— N

2-chloro-N-(1-cyanocyclopropyl)-5-[5-[2- methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-1 ,3,4- oxadiazol-2-yl]benzamide

1 N— N

2-chloro-N-cyclopropyl-5-[5-[2-methyl-5- (1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-1 ,3,4- thiadiazol-2-yl]benzamide

1 N— N 2-chloro-N-(1-cyanocyclopropyl)-5-[5-[2- methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-1 ,3,4- thiadiazol-2-yl]benzamide

I N— N

Y 2- chloro-N-cyclopropyl-5-[4-methyl-5-[2- methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-1 ,2,4-triazol-

3- yl]benzamide

I N— N

2- chloro-N-(1-cyanocyclopropyl)-5-[4- methyl-5-[2-methyl-5-(1 , 1 ,2,2,2- pentafluoroethyl)-4-

(trifluoromethyl)pyrazol-3-yl]-1 ,2,4-triazol-

I N— N 3- yl]benzamide

2- chloro-N-(1-cyanocyclopropyl)-5-[2- methyl-5-[2-methyl-5-(1 , 1 ,2,2,2- pentafluoroethyl)-4-

(trifluoromethyl)pyrazol-3-yl]-1 ,2,4-triazol-

3- yl]benzamide

2- chloro-N-( 1 -cyanocyclopropyl)-5-[1 - methyl-5-[2-methyl-5-(1 , 1 ,2,2,2- pentafluoroethyl)-4-

(trifluoromethyl)pyrazol-3-yl]-1 ,2,4-triazol-

I _/N -N 3- yl]benzamide

2-chloro-N-( 1 -cyanocyclopropyl)-5-[1 - methyl-2-[2-methyl-5-(1 , 1 ,2,2,2- pentafluoroethyl)-4-

(trifluoromethyl)pyrazol-3-yl]imidazol-4-

I y yl]benzamide 2-chloro-N-cyclopropyl-5-[3-methyl-2-[2- methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]imidazol-4- yl]benzamide

1

2-chloro-N-(1-cyanocyclopropyl)-5-[3- methyl-2-[2-methyl-5-(1 ,1 ,2,2,2- pentafluoroethyl)-4-

(trifluoromethyl)pyrazol-3-yl]imidazol-4- yl]benzamide

2-chloro-N-cyclopropyl-5-[1-methyl-5-[2- methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]imidazol-2- yl]benzamide

2-chloro-N-( 1 -cyanocyclopropyl)-5-[1 - methyl-5-[2-methyl-5-(1 ,1 ,2,2,2- pentafluoroethyl)-4-

(trifluoromethyl)pyrazol-3-yl]imidazol-2-

1 Ϊ yl]benzamide

2-chloro-N-cyclopropyl-5-[1-methyl-4-[2- methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]imidazol-2- yl]benzamide

2-chloro-N-( 1 -cyanocyclopropyl)-5-[1 - methyl-4-[2-methyl-5-(1 ,1 ,2,2,2- pentafluoroethyl)-4-

(trifluoromethyl)pyrazol-3-yl]imidazol-2- yl]benzamide

2-chloro-N-(1-cyanocyclopropyl)-5-[5-[2- methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-2- furyl]benzamide

2-chloro-N-cyclopropyl-5-[5-[2-methyl-5- (1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-2- thienyl]benzamide

2-chloro-N-(1-cyanocyclopropyl)-5-[5-[2- methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-2- thienyl]benzamide

2-chloro-N-cyclopropyl-5-[3-[2-methyl-5- (1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-1 ,2,4-triazol- 1-yl]benzamide

2-chloro-N-(1-cyanocyclopropyl)-5-[3-[2- methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-1 ,2,4-triazol- 1-yl]benzamide

2-chloro-N-(1-cyanocyclopropyl)-5-[4-[2- methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]pyrazol-1- yl]benzamide

2-chloro-N-cyclopropyl-5-[1-methyl-5-[2- p F F F F 0 / _H methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]pyrazol-3- yl]benzamide

I N— N

1 / 2-chloro-N-( 1 -cyanocyclopropyl)-5-[1 - methyl-5-[2-methyl-5-(1 ,1 ,2,2,2- pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]pyrazol-3-

I

yl]benzamide

2-chloro-N-cyclopropyl-5-[2-methyl-5-[2- y methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]pyrazol-3- yl]benzamide

I

2-chloro-N-(1-cyanocyclopropyl)-5-[2- methyl-5-[2-methyl-5-(1 ,1 ,2,2,2- pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]pyrazol-3- yl]benzamide

2-chloro-N-cyclopropyl-5-[3-[2-methyl-5- (1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isothiazol-5- yl]benzamide

I

2-chloro-N-(1-cyanocyclopropyl)-5-[3-[2- methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isothiazol-5- yl]benzamide

2-chloro-N-cyclopropyl-5-[5-[2-methyl-5-

Y (1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isothiazol-3- yl]benzamide

I 2-chloro-N-(1-cyanocyclopropyl)-5-[5-[2- methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isothiazol-3- yl]benzamide

I S— N

2-chloro-N-cyclopropyl-5-[2-[2-methyl-5- (1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]thiazol-5- yl]benzamide

2-chloro-N-(1-cyanocyclopropyl)-5-[2-[2- methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]thiazol-5- yl]benzamide

2-chloro-N-cyclopropyl-5-[4-[2-methyl-5- (1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]thiazol-2- yl]benzamide

2-chloro-N-(1-cyanocyclopropyl)-5-[4-[2- methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]thiazol-2- yl]benzamide

2-chloro-N-cyclopropyl-5-[5-[2-methyl-5- (1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]thiazol-2- yl]benzamide

2-chloro-N-(1-cyanocyclopropyl)-5-[5-[2- methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]thiazol-2- yl]benzamide

2-chloro-N-cyclopropyl-5-[2-[2-methyl-5- γ (1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]thiazol-4- yl]benzamide

2-chloro-N-(1-cyanocyclopropyl)-5-[2-[2- p F F F F 0 T methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]thiazol-4- yl]benzamide

2-chloro-N-cyclopropyl-5-[2-[2-methyl-5- p F F F F 0 Y _H (1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]oxazol-4- yl]benzamide

2-chloro-N-(1-cyanocyclopropyl)-5-[2-[2- p F F F F 0 T methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]oxazol-4- yl]benzamide

2-chloro-N-cyclopropyl-5-[5-[2-methyl-5- (1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]oxazol-2- yl]benzamide 2-chloro-N-(1-cyanocyclopropyl)-5-[5-[2- methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]oxazol-2- yl]benzamide

2-chloro-N-cyclopropyl-5-[2-[2-methyl-5-

Ϋ (1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]oxazol-5- yl]benzamide

2-chloro-N-(1-cyanocyclopropyl)-5-[2-[2- methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]oxazol-5- yl]benzamide

I

2-chloro-N-cyclopropyl-5-[4-[2-methyl-5- p (1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]oxazol-2- yl]benzamide

2-chloro-N-(1-cyanocyclopropyl)-5-[4-[2- methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]oxazol-2- yl]benzamide

2-chloro-N-cyclopropyl-5-[4-[2-methyl-5- (1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]imidazol-1- yl]benzamide 2-chloro-N-(1-cyanocyclopropyl)-5-[4-[2- methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]imidazol-1- yl]benzamide

2-chloro-N-(1-cyanocyclopropyl)-5-[5-[2- methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-1 ,2,4- thiadiazol-3-yl]benzamide

1 S— N

2-chloro-N-cyclopropyl-5-[3-[2-methyl-5- (1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-1 ,2,4- thiadiazol-5-yl]benzamide

2-chloro-N-(1-cyanocyclopropyl)-5-[3-[2- methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-1 ,2,4- thiadiazol-5-yl]benzamide

1 N— S

2-chloro-N-cyclopropyl-5-[4-[2-methyl-5- (1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-1 H-imidazol- 2-yl]benzamide

2-chloro-N-(1-cyanocyclopropyl)-5-[4-[2- methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-1 H-imidazol- 2-yl]benzamide

71 2-chloro-N-(cyclopropylmethyl)-5-[5-[2- methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-1 ,2,4- oxadiazol-3-yl]benzamide

72 2-chloro-N-(1-cyanocyclopropyl)-5-[3-[2- methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-1 H-pyrazol- 5-yl]benzamide

73 2-chloro-N-cyclopropyl-5-[3-[2-methyl-5- (1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]-1 H-pyrazol- 5-yl]benzamide

74 N-(1-cyanocyclopropyl)-2-methyl-4-[3-[2- methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]benzamide

75 1-[[2-chloro-5-[3-[2-methyl-5-(1 , 1 ,2,2,2- pentafluoroethyl)-4-

(trifluoromethyl)pyrazol-3-yl]isoxazol-5-

\ yl]benzoyl]amino]cyclopropanecarboxylic acid 81 2-chloro-N-(2-fluorocyclopropyl)-5-[3- [2-methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)- 4-(trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]benzamide

82 2-chloro-N-(2-chloroallyl)-5-[3-[2-methyl- 5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]benzamide

83 2-chloro-5-[3-[2-methyl-5-(1 ,1 ,2,2,2- pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]-N-(3,3,3-trifluoropropyl)benzamide

84 2-chloro-N-(3,3-dichloroallyl)-5-[3-[2- methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]benzamide

85 2-chloro-N-(4-chlorophenyl)-5-[3-[2- methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]benzamide

86 2-chloro-N-(2-fluoroallyl)-5-[3-[2-methyl- 5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]benzamide

87 2-chloro-N-isobutyl-5-[3-[2-methyl-5- (1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]benzamide

92 2-chloro-N-methyl-5-[3-[2-methyl-5- (1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]benzamide

93 2-chloro-N-isopropyl-5-[3-[2-methyl-5- (1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]benzamide

94 2-chloro-5-[3-[2-methyl-5-(1 , 1 ,2,2,2- pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]benzamide

95 2-chloro-5-[3-[2-methyl-5-(1 , 1 ,2,2,2- pentafluoroethyl)-4-

H N o (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]-N-[1-(2-pyridyl)cyclopropyl]benzamide

F ^F 96 2-chloro-5-[3-[2-methyl-5-(1 , 1 ,2,2,2- pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]-N-(2,2,2-trifluoroethyl)benzamide

97 2-chloro-N-(2,2-difluoroethyl)-5-[3-[2- methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]benzamide

98 2-chloro-N-(2-methylallyl)-5-[3-[2-methyl- 5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]benzamide

or an agrochemically acceptable salt or N-oxide thereof.

Embodiment 24.2: A compound or salt according to embodiment 1 , wherein the compound is selected from 4 2-chloro-N-(1-cyanocyclopropyl)-5-[3-[2- T methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5- yl]benzamide

1

44 2-chloro-N-(1-cyanocyclopropyl)-5-[3-[2- methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isothiazol-5- yl]benzamide

or an agrochemically acceptable salt or N-oxide thereof.

As used herein, when one embodiment refers to several other embodiments by using the term "according to any one of", for example "according to any one of embodiments 1 to 23",

then said embodiment refers not only to embodiments indicated by integers such as 1

and 2 but also to embodiments indicated by numbers with a decimal component such as 23.1 , 23.2, 23.3, 23.4, 23.20, 23.25, 23.30.

Definitions:

The term "Alkyl" as used herein- in isolation or as part of a chemical group - represents straight-chain or branched hydrocarbons, preferably with 1 bis 6 carbon atoms, for example methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-butyl, pentyl, 1- methylbutyl, 2-methylbutyl, 3-methylbutyl, 1 ,2- dimethylpropyl, 1 , 1 -dimethylpropyl, 2,2- dimethylpropyl, 1 -ethylpropyl, hexyl, 1 -methylpentyl, 2- methylpentyl, 3-methylpentyl, 4- methylpentyl, 1 ,2-dimethylpropyl, 1 ,3-dimethylbutyl, 1 ,4-dimethylbutyl, 2,3-dimethylbutyl, 1 , 1- dimethylbutyl, 2,2-dimethylbutyl, 3,3-dimethylbutyl, 1 ,1 ,2-trimethylpropyl, 1 ,2,2- trimethylpropyl, 1- ethylbutyl and 2-ethylbutyl. Alkyl groups with 1 to 4 carbon atoms are preferred, for example methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl or t-butyl.

The term "Alkenyl" - in isolation or as part of a chemical group - represents straight-chain or branched hydrocarbons, preferably with 2 bis 6 carbon atoms and at least one double bond, for example vinyl, 2- propenyl, 2-butenyl, 3-butenyl, 1- methyl-2-propenyl, 2-methyl-2-propenyl, 2-pentenyl, 3-pentenyl, 4- pentenyl, 1-methyl-2-butenyl, 2- methyl-2-butenyl, 3-methyl-2-butenyl, 1-methyl-3-butenyl, 2-methyl-3- butenyl, 3-methyl-3-butenyl, 1 , 1 - dimethyl-2-propenyl, 1 ,2-dimethyl-2-propenyl, 1 -ethyl-2-propenyl, 2- hexenyl, 3-hexenyl, 4- hexenyl, 5-hexenyl, 1 -methyl-2-pentenyl, 2-methyl-2-pentenyl, 3-methyl-2- pentenyl, 4-methyl-2- pentenyl, 3-methyl-3-pentenyl, 4-methyl-3-pentenyl, 1 -methyl-4-pentenyl, 2- methyl-4-pentenyl, 3- methyl-4-pentenyl, 4-methyl-4-pentenyl, 1 , 1 -dimethyl-2-butenyl, 1 , 1-dimethyl-3- butenyl, 1 ,2- dimethyl-2-butenyl, l,2-dimethyl-3-butenyl, 1 ,3-dimethyl-2-butenyl, 2,2-dimethyl-3-butenyl, 2,3- dimethyl-2-butenyl, 2,3-dimethyl-3-butenyl, 1 -ethyl-2-butenyl, 1-ethyl-3-butenyl, 2-ethyl-2-butenyl, 2-ethyl-3-butenyl, 1 , 1 ,2-trimethyl-2-propenyl, 1 -ethyl- 1 -methyl-2-propenyl und 1-ethyl-2-methyl-2- propenyl. Alkenyl groups with 2 to 4 carbon atoms are preferred, for example 2-propenyl, 2-butenyl or

1- methyl-2-propenyl.

The term "Alkinyl" - in isolation or as part of a chemical group - represents straight-chain or branched hydrocarbons, preferably with 2 bis 6 carbon atoms and at least one triple bond, for example 2- propinyl, 2-butinyl, 3-butinyl, 1-methyl-2- propinyl, 2-pentinyl, 3-pentinyl, 4-pentinyl, 1-methyl-3-butinyl,

2- methyl-3-butinyl, 1-methyl-2- butinyl, 1 , 1 -dimethyl-2-propinyl, 1 -ethyl-2-propinyl, 2-hexinyl, 3- hexinyl, 4-hexinyl, 5-hexinyl, 1- methyl-2-pentinyl, 1-methyl-3-pentinyl, 1 -methyl-4-pentinyl, 2-methyl-

3- pentinyl, 2-methyl-4- pentinyl, 3 -methyl-4-pentinyl, 4-methyl-2-pentinyl, 1 , 1 -dimethyl-3 -butinyl, 1 ,2- dimethyl-3 -butinyl, 2,2- dimethyl-3-butinyl, 1-ethyl-3-butinyl, 2-ethyl-3-butinyl, 1 -ethyl- 1 -methyl, 1 ,2- propinyl and 2,5-hexadiynyl. Alkinyls with 2 to 4 carbon atoms are preferred, for example ethinyl, 2- propinyl or 2-butinyl-2-propenyl.

The term "cycloalkyl" - in isolation or as part of a chemical group - represents saturated or partially unsaturated mono-, bi- or tricyclic hydrocarbons, preferably 3 to 10 carbon atoms, for example cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, bicyclo[2.2.1]heptyl, bicyclo[2.2.2]octyl or adamantyl.

Cycloalkyls with 3, 4, 5, 6 or 7 carbon atoms are preferred, for example cyclopropyl or cyclobutyl.

The term "heterocycloalkyl" - in isolation or as part of a chemical group - represents saturated or partially unsaturated mono-, bi- or tricyclic hydrocarbons, preferably 3 to 10 carbon atoms, for example cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, bicyclo[2.2.1 ]heptyl, bicyclo[2.2.2]octyl or adamantyl, wherein one or more of the ring atoms, preferably 1 to 4, more preferably 1 , 2 or 3 of the ring atoms are independently selected from N, O, S, P, B, Si and Se, more preferably N, O and S, wherein no O atoms can be located next to each other.

The term "Alkylcycloalkyl" represents mono-, bi- oder tricyclic alkylcycloalkyl, preferably with 4 to 10 or 4 to 7 carbon atoms, for example ethylcyclopropyl, isopropylcyclobutyl, 3-methylcyclopentyl und 4- methyl-cyclohexyl. Alkylcycloalkyls with 4, 5 or 7 carbon atoms are preferred, for example

ethylcyclopropyl or 4-methyl-cyclohexyl.

The term "cycloalkylalkyl" represents mono, bi- or tricyclic cycloalkylalkyls, preferably 4 to 10 or 4 to 7 carbon atoms, for example cyclopropylmethyl, cyclobutylmethyl, cyclopentylmethyl,

cyclohexylmethyl and cyclopentylethyl. Cycloalkylalkyls with 4, 5 or 7 carbon atoms are preferred, for example cyclopropylmethyl or cyclobutylmethyl. The term "halogen" represents fluoro, chloro, bromo or iodo, particularly fluoro, chloro or bromo. The chemical groups which are substituted with halogen, for example halogenalkyl, halogencycloalkyl, halogenalkyloxy, halogenalkylsulfanyl, halogenalkylsulfinyl or halogenalkylsulfonyl are substituted one or up to the maximum number of substituents with halogen. If "alkyl", "alkenyl" or "alkinyl" are substituted with halogen, the halogen atoms can be the same or different and can be bound at the same carbon atom or different carbon atoms.

The term "halogencycloalkyl" represents mono-, bi- or tricyclic halogencycloalkyl, preferably with 3 to 10 carbon atoms, for example 1 -fluoro-cyclopropyl, 2-fluoro- cyclopropyl or 1 -fluoro-cyclobutyl. Preferred halogencycloalkyl mit 3, 5 oder 7 carbon atoms.

The term "halogenalkyl", "halogenalkenyl" or "halogenalkinyl" represents alkyls, alkenyls or alkinyls substituted with halogen, preferably with 1 to 9 halogen atoms that are the same or different, for example monohaloalkyls (= monohalogenalkyl) like CH ₂ CH ₂ CI, CH ₂ CH ₂ F, CHCICH ₃ , CHFCH ₃ , CH ₂ CI, CH ₂ F; perhaloalkyls like CCI ₃ or CF ₃ or CF ₂ CF ₃ ; polyhaloalkyls like CHF ₂ , CH ₂ F, CH ₂ CHFCI, CF ₂ CF ₂ H, CH ₂ CF ₃ . The same applies for haloalkenyl and other groups substituted by halogen.

Examples of haloalkoxy are for example OCF ₃ , OCHF ₂ , OCH ₂ F, OCF ₂ CF ₃ , OCH ₂ CF ₃ ,

OCF ₃ , OCHF ₂ , OCH ₂ F, OCF ₂ CF ₃ , OCH ₂ CF ₃ .

Further examples of halogenalkyls are trichloromethyl, chlorodifluoromethyl, dichlorofluoromethyl, 1- fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluorethyl, 2,2,2-trichloroethyl, 2-chloro-2,2- difluoroethyl, pentafluorethyl and pentafluoro-t-butyl.

Halogenalkyls having 1 to 4 carbon atoms and 1 to 9, preferably 1 to 5 of the same or different halogen atoms selected from fluoro, chloro or bromo, are preferred.

Halogenalkyls having 1 or 2 carbon atoms and 1 to 5 gleichen of the same or different halogen atoms selected from fluoro or chloro, for example difluoromethyl, trifluoromethyl or 2,2-difluoroethyl, are particularly preferred.

The term "hydroxyalkyi" represents straight or branched chain alcohols, preferably with 1 to 6 carbon atoms, for example methanol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol, s-butanol and t-butanol. Hydroxyalkyls having 1 to 4 carbon atoms are preferred.

The term "alkoxy" represents straight or branched chain O-alkyl, preferably having 1 to 6 carbon atoms, for example methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, s-butoxy und t- butoxy. Alkoxy having 1 to 4 carbon atoms are preferred. The term "halogenalkoxy" represents straight or branched chain O-alkyl substituted with halogen, preferably with 1 to 6 carbon atoms, for example difluoromethoxy, trifluoromethoxy, 2,2- difluoroethoxy, 1 ,1 ,2,2-tetrafluoroethoxy, 2,2,2-Trifluoroethoxy and 2-Chloro-1 , 1 ,2-trifluorethoxy. Halogenalkoxy having 1 to 4 carbon atoms are preferred. The term "alkylsulfanyl" represents straight or branched chain S-alkyl, preferably with 1 to 6 carbon atoms, for example methylthio, ethylthio, n-propylthio, isopropylthio, n- butylthio, isobutylthio, s- butylthio and t-butylthio. Alkylsulfanyl having 1 to 4 carbon atoms are preferred. Examples for halogenalkylsulfanyl, i.e. with halogen substituted alkylsulfanyl, are for example difluoromethylthio, trifluoromethylthio, trichloromethylthio, chlorodifluormethylthio, 1- fluoroethylthio, 2-fluoroethylthio, 2,2- difluoroethylthio, 1 ,1 ,2,2-tetrafluoroethylthio, 2,2,2- trifluoroethylthio or 2-chloro-1 ,1 ,2-trifluoroethylthio.

The term "alkylsulfinyl" represents straight or branched chain alkylsulfinyl, preferably having 1 to 6 carbon atoms, for example methylsulfinyl, ethylsulfinyl, n-propylsulfinyl, isopropylsulfinyl, n- butylsulfinyl, isobutylsulfinyl, s-butylsulfinyl und t-butylsulfinyl.

Alkylsulfinyls having 1 to 4 carbon atoms are preferred.

Examples of halogenalkylsulfinyls, i.e. with halogen substituted alkylsulfinyls, are

difluoromethylsulfinyl, trifluoromethylsulfinyl, trichloromethylsulfinyl, chlorodifluoromethylsulfinyl, 1 - fluoroethylsulfinyl, 2-fluoroethylsulfinyl, 2,2-difluoroethylsulfinyl, 1 ,1 ,2,2- tetrafluoroethylsulfinyl, 2,2,2- trifluoroethylsulfinyl and 2-chloro-1 ,1 ,2-trifluoroethylsulfinyl.

The term "alkylsulfonyl" represents straight or branched chain alkylsulfonyl, preferably having 1 to 6 carbon atoms, for example methylsulfonyl, ethylsulfonyl, n-propylsulfonyl, isopropylsulfonyl, n- butylsulfonyl, isobutylsulfonyl, s-butylsulfonyl and t-butylsulfonyl.

Alkylsulfonyls having 1 to 4 carbon atoms are preferred.

Examples of halogenalkylsulfonyls, i.e.with halogen substituted alkylsulfonyls, are for example difluoromethylsulfonyl, trifluoromethylsulfonyl, trichloromethylsulfonyl, chlorodifluoromethylsulfonyl, 1 - fluoroethylsulfonyl, 2-fluoroethylsulfonyl, 2,2-difluoroethylsulfonyl, 1 ,1 ,2,2-tetrafluoroethylsulfonyl, 2,2,2-trifluoroethylsulfonyl and 2-chloro- 1 ,1 ,2-trifluorethylsulfonyl.

The term "alkylcarbonyl" represents straight or branched chain alkyl-C(=0), preferably having 2 to 7 carbon atoms, for example methylcarbonyl, ethylcarbonyl, n-propylcarbonyl, isopropylcarbonyl, s- butylcarbonyl and t-butylcarbonyl.

Alkylcarbonyls having 1 to 4 carbon atoms are preferred.

The term "cycloalkylcarbonyl" represents cycloalkyl-carbonyl, preferably 3 to 10 carbon atoms in the cycloalkyi part, for example cyclopropylcarbonyl, cyclobutylcarbonyl, cyclopentylcarbonyl, cyclohexyl- carbonyl, cycloheptyl- carbonyl, cyclooctylcarbonyl, bicyclo[2.2.1]heptyl, bycyclo[2.2.2]octylcarbonyl and adamantylcarbonyl. Cycloalkylcarbonyls having 3, 5 or 7 carbon atoms in the cycloalkyi part are preferred. The term "alkoxycarbonyl" " - in isolation or as part of a chemical group - represents straight or branched chain alkoxycarbonyl, preferably having 1 to 6 carbon atoms or 1 to 4 carbon atoms in the alkoxy part, for example methoxycarbonyl, ethoxycarbonyl, n-propoxycarbonyl, isopropoxycarbonyl, s- butoxycarbonyl and t- butoxycarbonyl.

The term "alkylaminocarbonyl" represents straight or branched chain alkylaminocarbonyl having preferably 1 to 6 carbon atoms orr 1 to 4 carbon atoms in the alkyl part, for example

methylaminocarbonyl, ethylaminocarbonyl, n-proylaminocarbonyl, isopropyl- aminocarbonyl, s- butylaminocarbonyl and t-butylaminocarbonyl.

The term "Ν,Ν-Dialkylamino-carbonyl" " represents straight or branched chain N,N- dialkylaminocarbonyl with preferablyl to 6 carbon atoms or 1 to 4 carbon atoms in the alkyl part, for example N,N-Dimethylamino-carbonyl, Ν,Ν-diethylamino-carbonyl, N,N-di(n- propylamino)-carbonyl, N,N-di-(isopropylamino)-carbonyl and N,N-di-(s-butylamino)-carbonyl.

The term "aryl" represents a mono-, bi- or polycyclical aromatic system with preferably 6 to 14, more preferably 6 to 10 ring-carbon atoms, for example phenyl, naphthyl, anthryl, phenanthrenyl, preferably phenyl. "Aryl" also represents polycyclic systems, for example tetrahydronaphtyl, indenyl, indanyl, fluorenyl, biphenyl. Arylalkyls are examples of substituted aryls, which may be further substituted with the same or different substituents both at the aryl or alkyl part. Benzyl and 1 -phenylethyl are examples of such arylalkyls.

The term "heterocyclyl", "heterocyclic ring" or "heterocyclic ring system" represents a carbocyclic ring system with at least one ring, in which ring at least one carbon atom is replaced by a heteroatom, preferably selected from N, O, S, P, B, Si, Se, and which ring is saturated, unsaturated or partially saturated, and which ring is unsubstituted or substituted with a substituent Z, wherein the connecting bond is located at a ring atom. Unless otherwise defined, the heterocyclic ring has preferably 3 to 9 ring atoms, preferably 3 to 6 ring atoms, and one or more, preferably 1 to 4, more preferably 1 , 2 or 3 heteroatoms in the heterocyclic ring, preferably selected from N, O, and S, wherein no O atoms can be located next to each other. The heterocyclic rings normally contain no more than 4 nitrogens, and/or no more than 2 oxygen atoms and/or no more than 2 sulfur atoms. In case that the heterocyclic substituent or the heterocyclic ring are further substituted, it can be further annulated wth other heterocyclic rings. The term ..heterocyclic" also includes polycyclic systems, for example 8-aza-bicyclo[3.2.1 ]octanyl or 1 -aza-bicyclo[2.2.1 ] heptyl .

The term ..heterocyclic" also includes spirocyclic systems, for example 1-oxa-5-aza-spiro[2.3]hexyl. Examples of heterocyclyls are for example piperidinyl, piperazinyl, morpholinyl, thiomorpholinyl, dihydropyranyl, tetrahydropyranyl, dioxanyl, pyrrolinyl, pyrrolidinyl, imidazolinyl, imidazolidinyl, thiazolidinyl, oxazolidinyl, dioxolanyl, dioxolyl, pyrazolidinyl, tetrahydrofuranyl, dihydrofuranyl, oxetanyl, oxiranyl, azetidinyl, aziridinyl, oxazetidinyl, oxaziridinyl, oxazepanyl, oxazinanyl, azepanyl, oxopyrrolidinyl, dioxopyrrolidinyl, oxomorpholinyl, oxopiperazinyl und oxepanyl.

Particularly important are heteroaryls, i.e. heteroaromatic systems.

The term„heteroaryl" represents heteroaromatic groups, i.e. completely unsaturated aromatic heterocyclic groups, which fall under the above definition of heterocycls.„Heteroaryls" with 5 to 7- membered rings with 1 to 3, preferably 1 or 2 of the same or different heteroatoms selected from N, O, and S. Examples of "heteroaryls" are furyl, thienyl, pyrazolyl, imidazolyl, 1 ,2,3- and 1 ,2,4-triazolyl, isoxazolyl, thiazolyl, isothiazolyl, 1 ,2,3-, 1 ,3,4-, 1 ,2,4- and 1 ,2,5-oxadiazolyl, azepinyl, pyrrolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, 1 ,3,5-, 1 ,2,4- and 1 ,2,3-triazinyl, 1 ,2,4-, 1 ,3,2-, 1 ,3,6- and 1 ,2,6-oxazinyl, oxepinyl, thiepinyl, 1 ,2,4-triazolonyl und 1 ,2,4-diazepinyl.

Halogen is generally fluorine, chlorine, bromine or iodine. This also applies, correspondingly, to halogen in combination with other meanings, such as haloalkyl or halophenyl.

HaloalkyI groups preferably have a chain length of from 1 to 6 carbon atoms. Haloalkyl is, for example, fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, 2,2,2- trifluoroethyl, 2-fluoroethyl, 2-chloroethyl, pentafluoroethyl, 1 ,1-difluoro-2,2,2-trichloroethyl, 2,2,3,3- tetrafluoroethyl and 2,2,2-trichloroethyl.

Alkoxy is, for example, methoxy, ethoxy, propoxy, i-propoxy, n-butoxy, isobutoxy, sec-butoxy and tert- butoxy and also the isomeric pentyloxy and hexyloxy radicals.

Alkoxyalkyl groups preferably have a chain length of 1 to 6 carbon atoms.

Alkoxyalkyl is, for example, methoxymethyl, methoxyethyl, ethoxymethyl, ethoxyethyl, n- propoxymethyl, n-propoxyethyl, isopropoxymethyl or isopropoxyethyl.

Alkoxycarbonyl is for example methoxycarbonyl (which is Cialkoxycarbonyl), ethoxycarbonyl, propoxycarbonyl, isopropoxycarbonyl, n-butoxycarbonyl, tert-butoxycarbonyl, n-pentoxycarbonyl or hexoxycarbonyl. The cycloalkyl groups preferably have from 3 to 6 ring carbon atoms, for example cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl. A compound according to any one of embodiments 1 to 24 which has at least one basic centre can form, for example, acid addition salts, for example with strong inorganic acids such as mineral acids, for example perchloric acid, sulfuric acid, nitric acid, nitrose acid, a phosphorus acid or a hydrohalic acid, with strong organic carboxylic acids, such as Ci-C ₄ alkanecarboxylic acids which are unsubstitu- ted or substituted, for example by halogen, for example acetic acid, such as saturated or unsaturated dicarboxylic acids, for example oxalic acid, malonic acid, succinic acid, maleic acid, fumaric acid or phthalic acid, such as hydroxycarboxylic acids, for example ascorbic acid, lactic acid, malic acid, tartaric acid or citric acid, or such as benzoic acid, or with organic sulfonic acids, such as d-C ₄ alkane- or arylsulfonic acids which are unsubstituted or substituted, for example by halogen, for example methane- or p-toluenesulfonic acid. A compounds according to any one of embodiments 1 to 20 which have at least one acidic group can form, for example, salts with bases, for example mineral salts such as alkali metal or alkaline earth metal salts, for example sodium, potassium or magnesium salts, or salts with ammonia or an organic amine, such as morpholine, piperidine, pyrrolidine, a mono-, di- or tri-lower-alkylamine, for example ethyl-, diethyl-, triethyl- or dimethylpropylamine, or a mono-, di- or trihydroxy-lower-alkylamine, for example mono-, di- or triethanolamine.

Compounds according to any one of embodiments 1 to 24 also include hydrates which may be formed during the salt formation.

The compounds according to any one of embodiments 1 to 24 may be made by a variety of methods well known to a person skilled in the art or as shown in Schemes 1 to 4. Further instructions regarding the preparation can be found in WO2015/067646, WO2014/122083 and WO2012/107434.

Compounds wherein T is T10 can be prepared, for example, according to Scheme 1 Scheme 1 :

wherein R , Q, A ¹ , A ² , A ³ , A ⁴ , R ^6a , R ^7a ,∑ Z ² , Z ³ and alkyl are as defined in any one of embodiments 1 to 24, X represents CI, Br, I or a boronic acid / boronic acid ester group.

Compounds (1 ) (for example Filler, Robert; Kong, Zhengong; Zhang; Zhaoxu; Sinha, Arun Kr.; Li, Xiaofang Journal of Fluorine Chemistry, 80 (1996), p. 71-76; US2003/0187233, p. 14, Example 21 ) and (5) are known or may be prepared according to known methods. Compounds (3) may be prepared in analogy with literature methods from compounds (1 ) and carbonic acid amide acetal compounds (2) (for example WO2006/044505, compound 60, part A;

WO2012/4604, intermediate 2). Compounds (4) may be prepared in analogy with literature methods from compounds (3) and hydrazine (for example WO2013/009791 , p. 50, example 43;

WO2004/099146, p. 75-76). Compounds (6) may be prepared in analogy with literature methods from compounds (4) and (5) (for example WO2013/009791 , p. 50, example 44, X = Br). Compounds (7) may be prepared in analogy with literature methods from compound (6) via ester cleavage (for example WO2010/051926 or WO2010/133312). Compounds of formula (la) may be prepared in analogy with literature methods from compounds (7) and (8) via known peptide coupling methods (for example WO2010/051926 and WO2010/133312). Compounds (8) are known or maybe prepared according to known methods.

Compounds wherein T is T1 1 can be prepared, for example, according to Scheme 2.

Scheme 2:

wherein R , Q, A ¹ , A ² , A ³ , A ⁴ , R ^6a , R ^8a ,∑ Z ² , Z ³ and alkyl are as defined in any one of embodiments 1 to 24, X represents CI, Br or I. Compounds (10) (for example EP2319830, page 330) and (5) are known or may be prepared according to known methods. The reactions can be carried out as described in the literature, for example in WO2012/149236, Majunder, Supriyo et al., Advanced Synthesis and Catalysis, 351 (2009),

2013-2023, or US5,061 ,705. Compounds (1 1 ) may be prepared in analogy with literature methods from compounds (10) (for example WO2008/148868A1 , p. 87). Compounds (13) may be prepared in analogy with literature methods from compounds (1 1 ) and (12). Compounds (14) may be prepared according to literature methods from compounds (13) and hydrazine (for example WO2008/080969, p. 102-103, example 104). Compounds (15) may be prepared in analogy with literature methods from compounds (14) and (5) (for example WO2013/009791 , p. 50, example 44). Compounds (16) may be prepared in analogy with literature methods from compounds (15) via ester cleavage (for example WO2010/051926 and WO2010/133312). Compounds of formula (lb) may be prepared in analogy with literature methods from compounds (16) and (8) via known peptide coupling methods (for example WO2010/051926 and WO2010/133312).

Compounds wherein T is T14 can be prepared, for example, according to scheme 3.

Scheme 3:

R , Q, A ¹ , A ² , A ³ , A ⁴ , R ^8a , z Z ² , Z ³ and alkyl are as defined in any one of embodiments 1 to 24, X ₂ represents chlorine, bromine or iodine, U represents a leaving group such as CI, Br, I or triflate.

Compound (17) are known or may be prepared according to known methods. Compounds (18) may be prepared in analogy with literature methods from compounds (17). For example, known methods for the preparation of oximes from aldehydes may be used (for example H. Metzger in Houben-Weyl, Band X/4, p. 55 ff, Georg Thieme Verlag Stuttgart, 1968). Compounds (19) may be prepared in analogy with literature methods by reacting them with halogenating agents such as Cl ₂ , Br ₂ , l ₂ , N-chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide, etc. Compounds (20) may be prepared in analogy with literature methods by reacting compounds (21 ) with (22) in the presence of a transition metal catalyst such as palladium or copper and a suitable base (for example Chinchilla, Rafael et al., Chemical Reviews (Washington DC, USA), 2007, 40(10), p. 5084-5121 ; Chinchilla, Rafael et al., Chemical Reviews (Washington DC, USA), 2007, 107(3), p. 874-922).

Compounds (22) are known or can be prepared according to known methods (for example see pages 8-10 of EP1253128). Compounds (21 ) are known or may be prepared according to known methods. If R ^8a is H, then a suitable protecting group can be used instead of R ^8a . Suitable protecting groups are for example trimethylsilyl, triethylsilyl and dimethylhydroxymethyl. Further suitable protecting groups and methods for introducing and removing such protecting groups are described in literature (for example see "Greene's protective groups in organic synthesis", 4 ^th edition, P.G.M. Wuts, T.W. Greene, John Wiley & Sons, Inc., Hoboken, New Jersey, 2007, p. 927-933). Compounds (23) may be prepared according to known literature methods by reacting compounds (19) with compounds (20) in the presence of a base in a suitable solvent and at a suitable temperature (information can be found in WO2015/067646, p. 145-147). The last two reaction steps to obtain compounds (24) and then compounds of formula (lc)

are well known in the literature and may be carried out as previously described in Scheme 1 and 2. Compounds wherein T is T13 can be prepared, for example, according to Scheme 4.

Scheme 4:

24, X represents a leaving group such as CI, Br, I or triflate. Compounds (5) are known or may be prepared in analogy with literature methods. Compounds (29) may be prepared by reacting compounds (5) with compounds (21 ) according to literature methods (for example WO2012/175474, p. 1 17-1 18). Compounds (26) may be prepared in analogy with literature (for example US201 1/53904, p. 19) or by reacting compounds (25) with a hydride source also according to known methods. Compounds (27) may be prepared in analogy with literature methods for the preparation of oximes from aldehyde compounds (26) (for example H. Metzger in Houben-Weyl, Band X/4, p. 55 ff, Georg Thieme Verlag Stuttgart 1968). Compounds (28) may be prepared according to literature methods by reacting compounds (27) with a suitable halogenating agent such as Cl ₂ , Br ₂ , l ₂ , N-chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide, etc. Compounds (30) may be prepared in analogy with literature methods by reacting compounds (28) with compounds (29) in the presence of a suitable base (see WO2015/067646, p. 138-141 ). The last two reaction steps to obtain compounds (31 ) and then compounds of formula (lc) are well known in the literature and may be carried out as previously described in Scheme 1 and 2.

Compounds wherein T is T8 can be prepared, for example, according to Scheme 5.

Scheme 5:

wherein R , Q, A ¹ , A ² , A ³ , A ⁴ , Z , Z ² , Z ³ and alkyl are as defined in any one of embodiments 1 to 24. Compounds (32) (for example EP2184273 p. 62) and (34) are known or may be prepared according to known methods. Compound (33) can be prepared in analogy to W010/078905 or WO2010/078910. Compound (37) can be prepared in analogy to Quian Li et al, Org. Lett. 2014, 16, 1622 or

WO2012/166951. Compound (35) can be prepared in analogy to WO201 1/088181.

A compound according to any one of embodiments 1 to 24 can be converted in a manner known per se into another compound according to any one of embodiments 1 to 24 by replacing one or more substituents of the starting compound according to any one of embodiments 1 to 24 in the customary manner by (an)other substituent(s) according to the invention.

Depending on the choice of the reaction conditions and starting materials which are suitable in each case, it is possible, for example, in one reaction step only to replace one substituent by another substituent according to the invention, or a plurality of substituents can be replaced by other substituents according to the invention in the same reaction step.

Salts of compounds of formula (I) can be prepared in a manner known per se. Thus, for example, acid addition salts of compounds according to any one of embodiments 1 to 24 are obtained by treatment with a suitable acid or a suitable ion exchanger reagent and salts with bases are obtained by treatment with a suitable base or with a suitable ion exchanger reagent.

Salts of compounds according to any one of embodiments 1 to 24 can be converted in the customary manner into the free compounds, acid addition salts, for example, by treatment with a suitable basic compound or with a suitable ion exchanger reagent and salts with bases, for example, by treatment with a suitable acid or with a suitable ion exchanger reagent.

Salts of compounds according to any one of embodiments 1 to 24 can be converted in a manner known per se into other salts of compounds according to any one of embodiments 1 to 24, acid addition salts, for example, into other acid addition salts, for example by treatment of a salt of inorganic acid such as hydrochloride with a suitable metal salt such as a sodium, barium or silver salt, of an acid, for example with silver acetate, in a suitable solvent in which an inorganic salt which forms, for example silver chloride, is insoluble and thus precipitates from the reaction mixture.

Depending on the procedure or the reaction conditions, the compounds according to any one of embodiments 1 to 24, which have salt-forming properties can be obtained in free form or in the form of salts. The compounds according to any one of embodiments 1 to 24 and, where appropriate, the tautomers thereof, in each case in free form or in salt form, can be present in the form of one of the

stereoisomers which are possible or as a mixture of these, for example in the form of pure stereoisomers, such as antipodes and/or diastereomers, or as stereoisomer mixtures, such as enantiomer mixtures, for example racemates, diastereomer mixtures or racemate mixtures, depending on the number, absolute and relative configuration of asymmetric carbon atoms which occur in the molecule and/or depending on the configuration of non-aromatic double bonds which occur in the molecule; the invention relates to the pure stereoisomers and also to all stereoisomer mixtures which are possible and is to be understood in each case in this sense hereinabove and hereinbelow, even when stereochemical details are not mentioned specifically in each case.

Diastereomer mixtures or racemate mixtures of compounds according to any one of embodiments 1 to 24, in free form or in salt form, which can be obtained depending on which starting materials and procedures have been chosen can be separated in a known manner into the pure diasteromers or racemates on the basis of the physicochemical differences of the components, for example by fractional crystallization, distillation and/or chromatography.

Enantiomer mixtures, such as racemates, which can be obtained in a similar manner can be resolved into the optical antipodes by known methods, for example by recrystallization from an optically active solvent, by chromatography on chiral adsorbents, for example high-performance liquid

chromatography (HPLC) on acetyl celulose, with the aid of suitable microorganisms, by cleavage with specific, immobilized enzymes, via the formation of inclusion compounds, for example using chiral crown ethers, where only one enantiomer is complexed, or by conversion into diastereomeric salts, for example by reacting a basic end-product racemate with an optically active acid, such as a carboxylic acid, for example camphor, tartaric or malic acid, or sulfonic acid, for example camphorsulfonic acid, and separating the diastereomer mixture which can be obtained in this manner, for example by fractional crystallization based on their differing solubilities, to give the diastereomers, from which the desired enantiomer can be set free by the action of suitable agents, for example basic agents.

Pure diastereomers or enantiomers can be obtained according to the invention not only by separating suitable stereoisomer mixtures, but also by generally known methods of diastereoselective or enantioselective synthesis, for example by carrying out the process according to the invention with starting materials of a suitable stereochemistry.

N-oxides can be prepared by reacting a compound according to any one of embodiments 1 to 24 with a suitable oxidizing agent, for example the H ₂ 0 ₂ /urea adduct in the presence of an acid anhydride, e.g. trifluoroacetic anhydride. Such oxidations are known from the literature, for example from J. Med. Chem., 32 (12), 2561-73, 1989 or WO 00/15615.

It is advantageous to isolate or synthesize in each case the biologically more effective stereoisomer, for example enantiomer or diastereomer, or stereoisomer mixture, for example enantiomer mixture or diastereomer mixture, if the individual components have a different biological activity.

The compounds according to any one of embodiments 1 to 24 and, where appropriate, the tautomers thereof, in each case in free form or in salt form, can, if appropriate, also be obtained in the form of hydrates and/or include other solvents, for example those which may have been used for the crystallization of compounds which are present in solid form.

The following Examples illustrate, but do not limit, the invention.

The compounds of the invention can be distinguished from known compounds by virtue of greater efficacy at low application rates, which can be verified by the person skilled in the art using the experimental procedures outlined in the Examples, using lower application rates if necessary, for example 50 ppm, 12.5 ppm, 6 ppm, 3 ppm, 1.5 ppm or 0.8 ppm.

The present invention also provides intermediates useful for the preparation of compounds according to any one of embodiments 1 to 24. Certain intermediates are novel and as such form a further aspect of the invention.

One group of novel intermediates are compounds of formula II)

(II)

wherein A ¹ , A ² , A ³ , A ⁴ , T, Z , Z ² and Z ³ are as defined in any one of embodiments 1 to 24. The preferences for A ¹ , A ² , A ³ , A ⁴ , T, Z , Z ² and Z ³ are the same as the preferences set out for the corresponding substituents of a compound according to any one of embodiments 1 to 24.

Another group of novel intermediates are compounds of formula III)

wherein A ¹ , A ² , A ³ , A ⁴ , T, Z , Z ² , Z ³ and alkyl are as defined in any one of embodiments 1 to 24. The preferences for A ¹ , A ² , A ³ , A ⁴ , T, Z , Z ² , Z ³ are the same as the preferences set out for the

corresponding substituents of a compound according to any one of embodiments 1 to 24.

Another group of novel intermediates are compounds of formula (6)

wherein A ¹ , A ² , A ³ , A ⁴ , R ^6a , R ^7a , Z , Z ² and Z ³ and alkyl are as defined in any one of embodiments 1 to 24. The preferences for A ¹ , A ² , A ³ , A ⁴ , R ^6a , R ^7a , Z Z ² and Z ³ are the same as the preferences set out for the corresponding substituents of a compound according to any one of embodiments 1 to 24.

Another group of novel intermediates are com ounds of formula (7)

(7)

wherein A ¹ , A ² , A ³ , A ⁴ , R ^6a , R ^7a , Z Z ² and Z ³ are as defined in any one of embodiments 1 to 24. The preferences for A ¹ , A ² , A ³ , A ⁴ , R ^6a , R ^7a , Z Z ² and Z ³ are the same as the preferences set out for the corresponding substituents of a compound according to any one of embodiments 1 to 24.

Another group of novel intermediates are com ounds of formula (16)

wherein A ¹ , A ² , A ³ , A ⁴ , R ^6a , R ^8a , Z Z ² and Z ³ are as defined in any one of embodiments 1 to 24. The preferences for A ¹ , A ² , A ³ , A ⁴ , R ^6a , R ^8a , Z Z ² and Z ³ are the same as the preferences set out for the corresponding substituents of a compound according to any one of embodiments 1 to 24. Another group of novel intermediates are compounds of formula 15)

(15)

wherein A ¹ , A ² , A ³ , A ⁴ , R ^6a , R ^8a , Z Z ² , Z ³ and alkyl are as defined in any one of embodiments 1 to 24. The preferences for A ¹ , A ² , A ³ , A ⁴ , R ^6a , R ^8a , Z Z ² , Z ³ and alkyl are the same as the preferences set out for the corresponding substituents of a compound according to any one of embodiments 1 to 24.

Another group of novel intermediates are com ounds of formula (24)

(24)

wherein A ¹ , A ² , A ³ , A ⁴ , R ^8a , Z Z ² and Z ³ are as defined in any one of embodiments 1 to 24. The preferences for A ¹ , A ² , A ³ , A ⁴ , R ^8a , Z Z ² and Z ³ are the same as the preferences set out for the corresponding substituents of a compound according to any one of embodiments 1 to 24. Another group of novel intermediates are compounds of formula (23)

(23)

wherein A ¹ , A ² , A ³ , A ⁴ , R ^8a , Z Z ² , Z ³ and alkyl are as defined in any one of embodiments 1 to 24. The preferences for A ¹ , A ² , A ³ , A ⁴ , R ^8a , Z Z ² , Z ³ and alkyl are the same as the preferences set out for the corresponding substituents of a compound according to any one of embodiments 1 to 24. Another group of novel intermediates are com ounds of formula (31 )

wherein A ¹ , A ² , A ³ , A ⁴ , R ^8a , Z , Z ² and Z ³ are as defined in any one of embodiments 1 to 24. The preferences for A ¹ , A ² , A ³ , A ⁴ , R ^8a , Z , Z ² and Z ³ are the same as the preferences set out for the corresponding substituents of a compound according to any one of embodiments 1 to 24.

Another group of novel intermediates are compounds of formula 30)

wherein A ¹ , A ² , A ³ , A ⁴ , R ^8a , Z , Z ² , Z ³ and alkyl are as defined in any one of embodiments 1 to 24. The preferences for A ¹ , A ² , A ³ , A ⁴ , R ^8a , Z , Z ² , Z ³ and alkyl are the same as the preferences set out for the corresponding substituents of a compound according to any one of embodiments 1 to 24.

Another group of novel intermediates are compounds of formula 39)

(39)

wherein A ¹ , A ² , A ³ , A ⁴ , Z , Z ² and Z ³ are as defined in any one of embodiments 1 to 24. The preferences for A ¹ , A ² , A ³ , A ⁴ , Z , Z ² and Z ³ are the same as the preferences set out for the corresponding substituents of a compound according to any one of embodiments 1 to 24. Another group of novel intermediates are compounds of formula (37)

wherein A ¹ , A ² , A ³ , A ⁴ , Z , Z ² and Z ³ are as defined in any one of embodiments 1 to 24. The preferences for A ¹ , A ² , A ³ , A ⁴ , Z , Z ² and Z ³ are the same as the preferences set out for the corresponding substituents of a compound according to any one of embodiments 1 to 24.

The compounds according to any one of embodiments 1 to 24 are preventively and/or curatively valuable active ingredients in the field of pest control, even at low rates of application, which have a very favorable biocidal spectrum and are well tolerated by warm-blooded species, fish and plants. The active ingredients according to the invention act against all or individual developmental stages of normally sensitive, but also resistant, animal pests, such as insects or representatives of the order Acarina. The insecticidal or acaricidal activity of the active ingredients according to the invention can manifest itself directly, i. e. in destruction of the pests, which takes place either immediately or only after some time has elapsed, for example during ecdysis, or indirectly, for example in a reduced oviposition and/or hatching rate.

Examples of the above mentioned animal pests are:

from the order Acarina, for example,

Acalitus spp, Aculus spp, Acaricalus spp, Aceria spp, Acarus siro, Amblyomma spp., Argas spp., Boophilus spp., Brevipalpus spp., Bryobia spp, Calipitrimerus spp., Chorioptes spp., Dermanyssus gallinae, Dermatophagoides spp, Eotetranychus spp, Eriophyes spp., Hemitarsonemus spp, Hyalomma spp., Ixodes spp., Olygonychus spp, Ornithodoros spp., Polyphagotarsone latus, Panonychus spp., Phyllocoptruta oleivora, Phytonemus spp, Polyphagotarsonemus spp, Psoroptes spp., Rhipicephalus spp., Rhizoglyphus spp., Sarcoptes spp., Steneotarsonemus spp, Tarsonemus spp. and Tetranychus spp.;

from the order Anoplura, for example,

Haematopinus spp., Linognathus spp., Pediculus spp., Pemphigus spp. and Phylloxera spp.;

from the order Coleoptera, for example,

Agriotes spp., Amphimallon majale, Anomala orientalis, Anthonomus spp., Aphodius spp, Astylus atromaculatus, Ataenius spp, Atomaria linearis, Chaetocnema tibialis, Cerotoma spp, Conoderus spp, Cosmopolites spp., Cotinis nitida, Curculio spp., Cyclocephala spp, Dermestes spp., Diabrotica spp., Diloboderus abderus, Epilachna spp., Eremnus spp., Heteronychus arator, Hypothenemus hampei, Lagria vilosa, Leptinotarsa decemLineata, Lissorhoptrus spp., Liogenys spp, Maecolaspis spp, Maladera castanea, Megascelis spp, Melighetes aeneus, Melolontha spp., Myochrous armatus, Orycaephilus spp., Otiorhynchus spp., Phyllophaga spp, Phlyctinus spp., Popillia spp., Psylliodes spp., Rhyssomatus aubtilis, Rhizopertha spp., Scarabeidae, Sitophilus spp., Sitotroga spp., Somaticus spp, Sphenophorus spp, Sternechus subsignatus, Tenebrio spp., Tribolium spp. and Trogoderma spp.; from the order Diptera, for example,

Aedes spp., Anopheles spp, Antherigona soccata,Bactrocea oleae, Bibio hortulanus, Bradysia spp, Calliphora erythrocephala, Ceratitis spp., Chrysomyia spp., Culex spp., Cuterebra spp., Dacus spp., Delia spp, Drosophila melanogaster, Fannia spp., Gastrophilus spp., Geomyza tripunctata, Glossina spp., Hypoderma spp., Hyppobosca spp., Liriomyza spp., Lucilia spp., Melanagromyza spp., Musca spp., Oestrus spp., Orseolia spp., Oscinella frit, Pegomyia hyoscyami, Phorbia spp., Rhagoletis spp, Rivelia quadrifasciata, Scatella spp, Sciara spp., Stomoxys spp., Tabanus spp., Tannia spp. and Tipula spp.;

from the order Hemiptera, for example,

Acanthocoris scabrator, Acrosternum spp, Adelphocoris lineolatus, Amblypelta nitida, Bathycoelia thalassina, Blissus spp, Cimex spp., Clavigralla tomentosicollis, Creontiades spp, Distantiella theobroma, Dichelops furcatus, Dysdercus spp., Edessa spp, Euchistus spp., Eurydema pulchrum, Eurygaster spp., Halyomorpha halys, Horcias nobilellus, Leptocorisa spp., Lygus spp, Margarodes spp, Murgantia histrionic, Neomegalotomus spp, Nesidiocoris tenuis, Nezara spp., Nysius simulans, Oebalus insularis, Piesma spp., Piezodorus spp, Rhodnius spp., Sahlbergella singularis, Scaptocoris castanea, Scotinophara spp. , Thyanta spp , Triatoma spp., Vatiga illudens;

Acyrthosium pisum, Adalges spp, Agalliana ensigera, Agonoscena targionii, Aleurodicus spp, Aleurocanthus spp, Aleurolobus barodensis, Aleurothrixus floccosus, Aleyrodes brassicae, Amarasca biguttula, Amritodus atkinsoni, Aonidiella spp., Aphididae, Aphis spp., Aspidiotus spp., Aulacorthum solani, Bactericera cockerelli, Bemisia spp, Brachycaudus spp, Brevicoryne brassicae, Cacopsylla spp, Cavariella aegopodii Scop., Ceroplaster spp., Chrysomphalus aonidium, Chrysomphalus dictyospermi, Cicadella spp, Cofana spectra, Cryptomyzus spp, Cicadulina spp, Coccus hesperidum, Dalbulus maidis, Dialeurodes spp, Diaphorina citri, Diuraphis noxia, Dysaphis spp, Empoasca spp., Eriosoma larigerum, Erythroneura spp., Gascardia spp., Glycaspis brimblecombei, Hyadaphis pseudobrassicae, Hyalopterus spp, Hyperomyzus pallidus, Idioscopus clypealis, Jacobiasca lybica, Laodelphax spp., Lecanium corni, Lepidosaphes spp., Lopaphis erysimi, Lyogenys maidis,

Macrosiphum spp., Mahanarva spp, Metcalfa pruinosa, Metopolophium dirhodum, Myndus crudus, Myzus spp., Neotoxoptera sp, Nephotettix spp., Nilaparvata spp., Nippolachnus piri Mats, Odonaspis ruthae, Oregma lanigera Zehnter, Parabemisia myricae, Paratrioza cockerelli, Parlatoria spp., Pemphigus spp., Peregrinus maidis, Perkinsiella spp, Phorodon humuli, Phylloxera spp, Planococcus spp., Pseudaulacaspis spp., Pseudococcus spp., Pseudatomoscelis seriatus, Psylla spp., Pulvinaria aethiopica, Quadraspidiotus spp., Quesada gigas, Recilia dorsalis, Rhopalosiphum spp., Saissetia spp., Scaphoideus spp., Schizaphis spp., Sitobion spp., Sogatella furcifera, Spissistilus festinus, Tarophagus Proserpina, Toxoptera spp, Trialeurodes spp, Tridiscus sporoboli, Trionymus spp, Trioza erytreae , Unaspis citri, Zygina flammigera, Zyginidia scutellaris, ;

from the order Hymenoptera, for example,

Acromyrmex, Arge spp, Atta spp., Cephus spp., Diprion spp., Diprionidae, Gilpinia polytoma, Hoplo- campa spp., Lasius spp., Monomorium pharaonis, Neodiprion spp., Pogonomyrmex spp, Slenopsis invicta, Solenopsis spp. and Vespa spp.;

from the order Isoptera, for example,

Coptotermes spp, Corniternes cumulans, Incisitermes spp, Macrotermes spp, Mastotermes spp, Microtermes spp, Reticulitermes spp.; Solenopsis geminate

from the order Lepidoptera, for example,

Acleris spp., Adoxophyes spp., Aegeria spp., Agrotis spp., Alabama argillaceae, Amylois spp., Anticarsia gemmatalis, Archips spp., Argyresthia spp, Argyrotaenia spp., Autographa spp., Bucculatrix thurberiella, Busseola fusca, Cadra cautella, Carposina nipponensis, Chilo spp., Choristoneura spp., Chrysoteuchia topiaria, Clysia ambiguella, Cnaphalocrocis spp., Cnephasia spp., Cochylis spp., Coleophora spp., Colias lesbia, Cosmophila flava, Crambus spp, Crocidolomia binotalis, Cryptophlebia leucotreta, Cydalima perspectalis, Cydia spp., Diaphania perspectalis, Diatraea spp., Diparopsis castanea, Earias spp., Eldana saccharina, Ephestia spp., Epinotia spp, Estigmene acrea, Etiella zinckinella, Eucosma spp., Eupoecilia ambiguella, Euproctis spp., Euxoa spp., Feltia jaculiferia, Gra- pholita spp., Hedya nubiferana, Heliothis spp., Hellula undalis, Herpetogramma spp, Hyphantria cunea, Keiferia lycopersicella, Lasmopalpus lignosellus, Leucoptera scitella, Lithocollethis spp., Lobesia botrana, Loxostege bifidalis, Lymantria spp., Lyonetia spp., Malacosoma spp., Mamestra brassicae, Manduca sexta, Mythimna spp, Noctua spp, Operophtera spp., Orniodes indica, Ostrinia nubilalis, Pammene spp., Pandemis spp., Panolis flammea, Papaipema nebris, Pectinophora gossypi- ela, Perileucoptera coffeella, Pseudaletia unipuncta, Phthorimaea operculella, Pieris rapae, Pieris spp., Plutella xylostella, Prays spp., Pseudoplusia spp, Rachiplusia nu, Richia albicosta, Scirpophaga spp., Sesamia spp., Sparganothis spp., Spodoptera spp., Sylepta derogate, Synanthedon spp., Thaumetopoea spp., Tortrix spp., Trichoplusia ni, Tuta absoluta, and Yponomeuta spp.;

from the order Mallophaga, for example,

Damalinea spp. and Trichodectes spp.;

from the order Orthoptera, for example,

Blatta spp., Blattella spp., Gryllotalpa spp., Leucophaea maderae, Locusta spp., Neocurtilla hexadactyla, Periplaneta spp. , Scapteriscus spp, and Schistocerca spp.;

from the order Psocoptera, for example,

Liposcelis spp.;

from the order Siphonaptera, for example,

Ceratophyllus spp., Ctenocephalides spp. and Xenopsylla cheopis;

from the order Thysanoptera, for example, Calliothrips phaseoli, Frankliniella spp., Heliothrips spp, Hercinothrips spp., Parthenothrips spp, Scirtothrips aurantii, Sericothrips variabilis, Taeniothrips spp., Thrips spp;

from the order Thysanura, for example, Lepisma saccharina. The active ingredients according to the invention can be used for controlling, i. e. containing or destroying, pests of the abovementioned type which occur in particular on plants, especially on useful plants and ornamentals in agriculture, in horticulture and in forests, or on organs, such as fruits, flowers, foliage, stalks, tubers or roots, of such plants, and in some cases even plant organs which are formed at a later point in time remain protected against these pests.

Suitable target crops are, in particular, cereals, such as wheat, barley, rye, oats, rice, maize or sorghum; beet, such as sugar or fodder beet; fruit, for example pomaceous fruit, stone fruit or soft fruit, such as apples, pears, plums, peaches, almonds, cherries or berries, for example strawberries, raspberries or blackberries; leguminous crops, such as beans, lentils, peas or soya; oil crops, such as oilseed rape, mustard, poppies, olives, sunflowers, coconut, castor, cocoa or ground nuts; cucurbits, such as pumpkins, cucumbers or melons; fibre plants, such as cotton, flax, hemp or jute; citrus fruit, such as oranges, lemons, grapefruit or tangerines; vegetables, such as spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes or bell peppers; Lauraceae, such as avocado, Cinnamonium or camphor; and also tobacco, nuts, coffee, eggplants, sugarcane, tea, pepper, grapevines, hops, the plantain family, latex plants and ornamentals.

The active ingredients according to the invention are especially suitable for controlling Aphis craccivora, Diabrotica balteata, Heliothis virescens, Myzus persicae, Plutella xylostella and

Spodoptera littoralis in cotton, vegetable, maize, rice and soya crops. The active ingredients according to the invention are further especially suitable for controlling Mamestra (preferably in vegetables),

Cydia pomonella (preferably in apples), Empoasca(preferably in vegetables, vineyards), Leptinotarsa (preferably in potatos) and Chilo supressalis (preferably in rice).

In a further aspect, the invention may also relate to a method of controlling damage to plant and parts thereof by plant parasitic nematodes (Endoparasitic-, Semiendoparasitic- and Ectoparasitic nematodes), especially plant parasitic nematodes such as root knot nematodes, Meloidogyne hapla, Meloidogyne incognita, Meloidogyne javanica, Meloidogyne arenaria and other Meloidogyne species; cyst-forming nematodes, Globodera rostochiensis and other Globodera species; Heterodera avenae, Heterodera glycines, Heterodera schachtii, Heterodera trifolii, and other Heterodera species; Seed gall nematodes, Anguina species; Stem and foliar nematodes, Aphelenchoides species; Sting nematodes, Belonolaimus longicaudatus and other Belonolaimus species; Pine nematodes, Bursaphelenchus xylophilus and other Bursaphelenchus species; Ring nematodes, Criconema species, Criconemella species, Criconemoides species, Mesocriconema species; Stem and bulb nematodes, Ditylenchus destructor, Ditylenchus dipsaci and other Ditylenchus species; Awl nematodes, Dolichodorus species; Spiral nematodes, Heliocotylenchus multicinctus and other Helicotylenchus species; Sheath and sheathoid nematodes, Hemicycliophora species and Hemicriconemoides species; Hirshmanniella species; Lance nematodes, Hoploaimus species; false rootknot nematodes, Nacobbus species;

Needle nematodes, Longidorus elongatus and other Longidorus species; Pin nematodes,

Pratylenchus species; Lesion nematodes, Pratylenchus neglectus, Pratylenchus penetrans,

Pratylenchus curvitatus, Pratylenchus goodeyi and other Pratylenchus species; Burrowing nematodes, Radopholus similis and other Radopholus species; Reniform nematodes, Rotylenchus robustus, Rotylenchus reniformis and other Rotylenchus species; Scutellonema species; Stubby root nematodes, Trichodorus primitivus and other Trichodorus species, Paratrichodorus species; Stunt nematodes, Tylenchorhynchus claytoni, Tylenchorhynchus dubius and other Tylenchorhynchus species; Citrus nematodes, Tylenchulus species; Dagger nematodes, Xiphinema species; and other plant parasitic nematode species, such as Subanguina spp., Hypsoperine spp., Macroposthonia spp., Melinius spp., Punctodera spp., and Quinisulcius spp..

The compounds according to any one of embodiments 1 to 24 may also have activity against the molluscs. Examples of which include, for example, Ampullariidae; Arion (A. ater, A. circumscriptus, A. hortensis, A. rufus); Bradybaenidae (Bradybaena fruticum); Cepaea (C. hortensis, C. Nemoralis); ochlodina; Deroceras (D. agrestis, D. empiricorum, D. laeve, D. reticulatum); Discus (D. rotundatus); Euomphalia; Galba (G. trunculata); Helicelia (H. itala, H. obvia); Helicidae Helicigona arbustorum); Helicodiscus; Helix (H. aperta); Limax (L. cinereoniger, L. flavus, L. marginatus, L. maximus, L.

tenellus); Lymnaea; Milax (M. gagates, M. marginatus, M. sowerbyi); Opeas; Pomacea (P.

canaticulata); Vallonia and Zanitoides. The term "crops" is to be understood as including also crop plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising one or more selectively acting toxins, such as are known, for example, from toxin-producing bacteria, especially those of the genus Bacillus. Toxins that can be expressed by such transgenic plants include, for example, insecticidal proteins, for example insecticidal proteins from Bacillus cereus or Bacillus popilliae; or insecticidal proteins from Bacillus thuringiensis, such as δ-endotoxins, e.g. CrylAb, CrylAc, Cryl F, Cry1 Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), e.g. Vip1 , Vip2, Vip3 or Vip3A; or insecticidal proteins of bacteria colonising nematodes, for example Photorhabdus spp. or

Xenorhabdus spp., such as Photorhabdus luminescens, Xenorhabdus nematophilus; toxins produced by animals, such as scorpion toxins, arachnid toxins, wasp toxins and other insect-specific neurotoxins; toxins produced by fungi, such as Streptomycetes toxins, plant lectins, such as pea lectins, barley lectins or snowdrop lectins; agglutinins; proteinase inhibitors, such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin, papain inhibitors; ribosome-inactivating proteins (RIP), such as ricin, maize-RIP, abrin, luffin, saporin or bryodin; steroid metabolism enzymes, such as 3-hydroxysteroidoxidase, ecdysteroid-UDP-glycosyl-transferase, cholesterol oxidases, ecdysone inhibitors, HMG-COA-reductase, ion channel blockers, such as blockers of sodium or calcium channels, juvenile hormone esterase, diuretic hormone receptors, stilbene synthase, bibenzyl synthase, chitinases and glucanases.

In the context of the present invention there are to be understood by δ-endotoxins, for example CrylAb, CrylAc, Cryl F, Cry1 Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), for example Vip1 , Vip2, Vip3 or Vip3A, expressly also hybrid toxins, truncated toxins and modified toxins. Hybrid toxins are produced recombinantly by a new combination of different domains of those proteins (see, for example, WO 02/15701 ). Truncated toxins, for example a truncated CrylAb, are known. In the case of modified toxins, one or more amino acids of the naturally occurring toxin are replaced. In such amino acid replacements, preferably non-naturally present protease recognition sequences are inserted into the toxin, such as, for example, in the case of Cry3A055, a cathepsin-G-recognition sequence is inserted into a Cry3A toxin (see WO 03/018810). Examples of such toxins or transgenic plants capable of synthesising such toxins are disclosed, for example, in EP-A-0 374 753, WO93/07278, W095/34656, EP-A-0 427 529, EP-A-451 878 and WO 03/052073.

The processes for the preparation of such transgenic plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above. Cryl-type

deoxyribonucleic acids and their preparation are known, for example, from WO 95/34656, EP-A-0 367 474, EP-A-0 401 979 and WO 90/13651.

The toxin contained in the transgenic plants imparts to the plants tolerance to harmful insects. Such insects can occur in any taxonomic group of insects, but are especially commonly found in the beetles (Coleoptera), two-winged insects (Diptera) and moths (Lepidoptera).

Transgenic plants containing one or more genes that code for an insecticidal resistance and express one or more toxins are known and some of them are commercially available. Examples of such plants are: YieldGard® (maize variety that expresses a CrylAb toxin); YieldGard Rootworm® (maize variety that expresses a Cry3Bb1 toxin); YieldGard Plus® (maize variety that expresses a CrylAb and a Cry3Bb1 toxin); Starlink® (maize variety that expresses a Cry9C toxin); Herculex I® (maize variety that expresses a Cry1 Fa2 toxin and the enzyme phosphinothricine N-acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium); NuCOTN 33B® (cotton variety that expresses a CrylAc toxin); Bollgard I® (cotton variety that expresses a CrylAc toxin); Bollgard II® (cotton variety that expresses a CrylAc and a Cry2Ab toxin); VipCot® (cotton variety that expresses a Vip3A and a CrylAb toxin); NewLeaf® (potato variety that expresses a Cry3A toxin); NatureGard®, Agrisure® GT Advantage (GA21 glyphosate-tolerant trait), Agrisure® CB Advantage (Bt1 1 corn borer

(CB) trait) and Protecta®.

Further examples of such transgenic crops are:

1. Bt11 Maize from Syngenta Seeds SAS, Chemin de I'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Genetically modified Zea mays which has been rendered resistant to attack by the European corn borer (Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of a truncated Cry1 Ab toxin. Bt1 1 maize also transgenically expresses the enzyme PAT to achieve tolerance to the herbicide glufosinate ammonium.

2. Bt176 Maize from Syngenta Seeds SAS, Chemin de I'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Genetically modified Zea mays which has been rendered resistant to attack by the European corn borer (Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of a CrylAb toxin. Bt176 maize also transgenically expresses the enzyme PAT to achieve tolerance to the herbicide glufosinate ammonium.

3. MIR604 Maize from Syngenta Seeds SAS, Chemin de I'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Maize which has been rendered insect-resistant by transgenic expression of a modified Cry3A toxin. This toxin is Cry3A055 modified by insertion of a cathepsin-G- protease recognition sequence. The preparation of such transgenic maize plants is described in WO 03/018810.

4. MON 863 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1 150 Brussels, Belgium, registration number C/DE/02/9. MON 863 expresses a Cry3Bb1 toxin and has resistance to certain Coleoptera insects.

5. IPC 531 Cotton from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1 150 Brussels, Belgium, registration number C/ES/96/02.

6. 1507 Maize from Pioneer Overseas Corporation, Avenue Tedesco, 7 B-1 160 Brussels, Belgium, registration number C/NL/00/10. Genetically modified maize for the expression of the protein Cry1 F for achieving resistance to certain Lepidoptera insects and of the PAT protein for achieving tolerance to the herbicide glufosinate ammonium.

7. NK603 x MON 810 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1 150 Brussels, Belgium, registration number C/GB/02/M3/03. Consists of conventionally bred hybrid maize varieties by crossing the genetically modified varieties NK603 and MON 810. NK603 * MON 810

Maize transgenically expresses the protein CP4 EPSPS, obtained from Agrobacterium sp. strain CP4, which imparts tolerance to the herbicide Roundup® (contains glyphosate), and also a CrylAb toxin obtained from Bacillus thuringiensis subsp. kurstaki which brings about tolerance to certain

Lepidoptera, include the European corn borer.

Transgenic crops of insect-resistant plants are also described in BATS (Zentrum fur Biosicherheit und Nachhaltigkeit, Zentrum BATS, Clarastrasse 13, 4058 Basel, Switzerland) Report 2003,

(http://bats.ch). The term "crops" is to be understood as including also crop plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising antipathogenic substances having a selective action, such as, for example, the so-called "pathogenesis-related proteins" (PRPs, see e.g. EP-A-0 392 225). Examples of such antipathogenic substances and transgenic plants capable of synthesising such antipathogenic substances are known, for example, from EP-A-0 392 225, W095/33818 and EP-A-0 353 191. The methods of producing such transgenic plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above. Crops may also be modified for enhanced resistance to fungal (for example Fusarium, Anthracnose, or Phytophthora), bacterial (for example Pseudomonas) or viral (for example potato leafroll virus, tomato spotted wilt virus, cucumber mosaic virus) pathogens.

Crops also include those that have enhanced resistance to nematodes, such as the soybean cyst nematode.

Crops that are tolerant to abiotic stress include those that have enhanced tolerance to drought, high salt, high temperature, chill, frost, or light radiation, for example through expression of NF-YB or other proteins known in the art.

Antipathogenic substances which can be expressed by such transgenic plants include, for example, ion channel blockers, such as blockers for sodium and calcium channels, for example the viral KP1 , KP4 or KP6 toxins; stilbene synthases; bibenzyl synthases; chitinases; glucanases; the so-called "pathogenesis-related proteins" (PRPs; see e.g. EP-A-0 392 225); antipathogenic substances produced by microorganisms, for example peptide antibiotics or heterocyclic antibiotics (see e.g. W095/33818) or protein or polypeptide factors involved in plant pathogen defence (so-called "plant disease resistance genes", as described in WO 03/000906).

Further areas of use of the compositions according to the invention are the protection of stored goods and store rooms and the protection of raw materials, such as wood, textiles, floor coverings or buildings, and also in the hygiene sector, especially the protection of humans, domestic animals and productive livestock against pests of the mentioned type.

The present invention also provides a method for controlling pests (such as mosquitoes and other disease vectors; see also http://www.who.int/malaria/vector_control/irs/en/). In one embodiment, the method for controlling pests comprises applying the compositions of the invention to the target pests, to their locus or to a surface or substrate by brushing, rolling, spraying, spreading or dipping. By way of example, an IRS (indoor residual spraying) application of a surface such as a wall, ceiling or floor surface is contemplated by the method of the invention. In another embodiment, it is contemplated to apply such compositions to a substrate such as non-woven or a fabric material in the form of (or which can be used in the manufacture of) netting, clothing, bedding, curtains and tents.

In another embodiment, the method for controlling such pests comprises applying a pesticidally effective amount of the compositions of the invention to the target pests, to their locus, or to a surface or substrate so as to provide effective residual pesticidal activity on the surface or substrate. Such application may be made by brushing, rolling, spraying, spreading or dipping the pesticidal composition of the invention. By way of example, an IRS application of a surface such as a wall, ceiling or floor surface is contemplated by the method of the invention so as to provide effective residual pesticidal activity on the surface. In another embodiment, it is contemplated to apply such compositions for residual control of pests on a substrate such as a fabric material in the form of (or which can be used in the manufacture of) netting, clothing, bedding, curtains and tents.

Substrates including non-woven, fabrics or netting to be treated may be made of natural fibres such as cotton, raffia, jute, flax, sisal, hessian, or wool, or synthetic fibres such as polyamide, polyester, polypropylene, polyacrylonitrile or the like. The polyesters are particularly suitable. The methods of textile treatment are known, e.g. WO 2008/151984, WO 2003/034823, US 5631072, WO 2005/64072, WO2006/128870, EP 1724392, WO20051 13886 or WO 2007/090739.

Further areas of use of the compositions according to the invention are the field of tree injection/trunk treatment for all ornamental trees as well all sort of fruit and nut trees.

In the field of tree injection/trunk treatment, the compounds according to the present invention are especially suitable against wood-boring insects from the order Lepidoptera as mentioned above and from the order Coleoptera, especially against woodborers listed in the following tables A and B:

Table A. Examples of exotic woodborers of economic importance.

Family Species Host or Crop Infested

Buprestidae Agrilus planipennis Ash

Cerambycidae Anoplura glabripennis Hardwoods

Xylosandrus crassiusculus Hardwoods

Scolytidae X. mutilatus Hardwoods

Tomicus piniperda Conifers

Table B. Examples of native woodborers of economic importance.

Family Species Host or Crop Infested

Agrilus anxius Birch

Buprestidae

Agrilus politus Willow, Maple Family Species Host or Crop Infested

Agrilus sayi Bayberry, Sweetfern Agrilus vittaticolllis Apple, Pear, Cranberry,

Serviceberry, Hawthorn

Chrysobothris femorata Apple, Apricot, Beech, Boxelder,

Cherry, Chestnut, Currant, Elm, Hawthorn, Hackberry, Hickory, Horsechestnut, Linden, Maple, Mountain-ash, Oak, Pecan, Pear, Peach, Persimmon, Plum, Poplar, Quince, Redbud, Serviceberry, Sycamore, Walnut, Willow

Texania campestris Basswood, Beech, Maple, Oak,

Sycamore, Willow, Yellow-poplar

Goes pulverulentus Beech, Elm, Nuttall, Willow, Black oak, Cherrybark oak, Water oak, Sycamore

Goes tigrinus Oak

Neoclytus acuminatus Ash, Hickory, Oak, Walnut, Birch,

Beech, Maple, Eastern

hophornbeam, Dogwood,

Persimmon, Redbud, Holly, Hackberry, Black locust,

Honeylocust, Yellow-poplar, Chestnut, Osage-orange, Sassafras,

Cerambycidae Lilac, Mountain-mahogany, Pear,

Cherry, Plum, Peach, Apple, Elm, Basswood, Sweetgum

Neoptychodes trilineatus Fig, Alder, Mulberry, Willow, Netleaf hackberry

Oberea ocellata Sumac, Apple, Peach, Plum, Pear,

Currant, Blackberry

Oberea tripunctata Dogwood, Viburnum, Elm,

Sourwood, Blueberry,

Rhododendron, Azalea, Laurel, Poplar, Willow, Mulberry

Oncideres cingulata Hickory, Pecan, Persimmon, Elm, Family Species Host or Crop Infested

Sourwood, Basswood, Honeylocust,

Dogwood, Eucalyptus, Oak,

Hackberry, Maple, Fruit trees

Saperda calcarata Poplar

Strophiona nitens Chestnut, Oak, Hickory, Walnut,

Beech, Maple

Corthylus columbianus Maple, Oak, Yellow-poplar, Beech,

Boxelder, Sycamore, Birch,

Basswood, Chestnut, Elm

Dendroctonus frontalis Pine

Dryocoetes betulae Birch, Sweetgum, Wild cherry,

Beech, Pear

Monarthrum fasciatum Oak, Maple, Birch, Chestnut,

Scolytidae

Sweetgum, Blackgum, Poplar,

Hickory, Mimosa, Apple, Peach, Pine

Phloeotribus liminaris Peach, Cherry, Plum, Black cherry,

Elm, Mulberry, Mountain-ash

Pseudopityophthorus pruinosus Oak, American beech, Black cherry,

Chickasaw plum, Chestnut, Maple,

Hickory, Hornbeam, Hophornbeam

Paranthrene simulans Oak, American chestnut

Sannina uroceriformis Persimmon

Synanthedon exitiosa Peach, Plum, Nectarine, Cherry,

Apricot, Almond, Black cherry

Synanthedon pictipes Peach, Plum, Cherry, Beach, Black

Cherry

Sesiidae Synanthedon rubrofascia Tupelo

Synanthedon scitula Dogwood, Pecan, Hickory, Oak,

Chestnut, Beech, Birch, Black cherry,

Elm, Mountain-ash, Viburnum,

Willow, Apple, Loquat, Ninebark,

Bayberry

Vitacea polistiformis Grape

In the hygiene sector, the compositions according to the invention are active against ectoparasites such as hard ticks, soft ticks, mange mites, harvest mites, flies (biting and licking), parasitic fly larvae, lice, hair lice, bird lice and fleas. Examples of such parasites are:

Of the order Anoplurida: Haematopinus spp., Linognathus spp., Pediculus spp. and Phtirus spp., Solenopotes spp.. Of the order Mallophagida: Trimenopon spp., Menopon spp., Trinoton spp., Bovicola spp.,

Werneckiella spp., Lepikentron spp., Damalina spp., Trichodectes spp. and Felicola spp..

Of the order Diptera and the suborders Nematocerina and Brachycerina, for example Aedes spp., Anopheles spp., Culex spp., Simulium spp., Eusimulium spp., Phlebotomus spp., Lutzomyia spp., Culicoides spp., Chrysops spp., Hybomitra spp., Atylotus spp., Tabanus spp., Haematopota spp.,

Philipomyia spp., Braula spp., Musca spp., Hydrotaea spp., Stomoxys spp., Haematobia spp., Morellia spp., Fannia spp., Glossina spp., Calliphora spp., Lucilia spp., Chrysomyia spp., Wohlfahrtia spp., Sarcophaga spp., Oestrus spp., Hypoderma spp., Gasterophilus spp., Hippobosca spp., Lipoptena spp. and Melophagus spp..

Of the order Siphonapterida, for example Pulex spp., Ctenocephalides spp., Xenopsylla spp., Ceratophyllus spp..

Of the order Heteropterida, for example Cimex spp., Triatoma spp., Rhodnius spp., Panstrongylus spp..

Of the order Blattarida, for example Blatta orientalis, Periplaneta americana, Blattelagermanica and Supella spp.. Of the subclass Acaria (Acarida) and the orders Meta- and Meso-stigmata, for example Argas spp., Ornithodorus spp., Otobius spp., Ixodes spp., Amblyomma spp., Boophilus spp., Dermacentor spp., Haemophysalis spp., Hyalomma spp., Rhipicephalus spp., Dermanyssus spp., Raillietia spp., Pneumonyssus spp., Sternostoma spp. and Varroa spp.. Of the orders Actinedida (Prostigmata) and Acaridida (Astigmata), for example Acarapis spp.,

Cheyletiella spp., Ornithocheyletia spp., Myobia spp., Psorergatesspp., Demodex spp., Trombicula spp., Listrophorus spp., Acarus spp., Tyrophagus spp., Caloglyphus spp., Hypodectes spp.,

Pterolichus spp., Psoroptes spp., Chorioptes spp., Otodectes spp., Sarcoptes spp., Notoedres spp., Knemidocoptes spp., Cytodites spp. and Laminosioptes spp..

The compositions according to the invention are also suitable for protecting against insect infestation in the case of materials such as wood, textiles, plastics, adhesives, glues, paints, paper and card, leather, floor coverings and buildings. The compositions according to the invention can be used, for example, against the following pests: beetles such as Hylotrupes bajulus, Chlorophorus pilosis, Anobium punctatum, Xestobium

rufovillosum, Ptilinuspecticornis, Dendrobium pertinex, Ernobius mollis, Priobium carpini, Lyctus brunneus, Lyctus africanus, Lyctus planicollis, Lyctus linearis, Lyctus pubescens, Trogoxylon aequale, Minthesrugicollis, Xyleborus spec.,Tryptodendron spec, Apate monachus, Bostrychus capucins, Heterobostrychus brunneus, Sinoxylon spec, and Dinoderus minutus, and also hymenopterans such as Sirex juvencus, Urocerus gigas, Urocerus gigas taignus and Urocerus augur, and termites such as Kalotermes flavicollis, Cryptotermes brevis, Heterotermes indicola, Reticulitermes flavipes,

Reticulitermes santonensis, Reticulitermes lucifugus, Mastotermes darwiniensis, Zootermopsis nevadensis and Coptotermes formosanus, and bristletails such as Lepisma saccharina.

In one aspect, the invention therefore also relates to pesticidal compositions such as emulsifiable concentrates, suspension concentrates, microemulsions, oil dispersibles, directly sprayable or dilutable solutions, spreadable pastes, dilute emulsions, soluble powders, dispersible powders, wettable powders, dusts, granules or encapsulations in polymeric substances, which comprise - at least - one of the active ingredients according to any one of embodiments 1 to 24 and which are to be selected to suit the intended aims and the prevailing circumstances. In these compositions, the active ingredient is employed in pure form, a solid active ingredient for example in a specific particle size, or, preferably, together with - at least - one of the auxiliaries conventionally used in the art of formulation, such as extenders, for example solvents or solid carriers, or such as surface-active compounds (surfactants).

Examples of suitable solvents are: unhydrogenated or partially hydrogenated aromatic hydrocarbons, preferably the fractions C ₈ to d ₂ of alkylbenzenes, such as xylene mixtures, alkylated naphthalenes or tetrahydronaphthalene, aliphatic or cycloaliphatic hydrocarbons, such as paraffins or cyclohexane, alcohols such as ethanol, propanol or butanol, glycols and their ethers and esters such as propylene glycol, dipropylene glycol ether, ethylene glycol or ethylene glycol monomethyl ether or ethylene glycol monoethyl ether, ketones, such as cyclohexanone, isophorone or diacetone alcohol, strongly polar solvents, such as N-methylpyrrolid-2-one, dimethyl sulfoxide or Ν,Ν-dimethylformamide, water, unepoxidized or epoxidized vegetable oils, such as unexpodized or epoxidized rapeseed, castor, coconut or soya oil, and silicone oils.

Solid carriers which are used for example for dusts and dispersible powders are, as a rule, ground natural minerals such as calcite, talc, kaolin, montmorillonite or attapulgite. To improve the physical properties, it is also possible to add highly disperse silicas or highly disperse absorbtive polymers. Suitable adsorptive carriers for granules are porous types, such as pumice, brick grit, sepiolite or bentonite, and suitable non-sorptive carrier materials are calcite or sand. In addition, a large number of granulated materials of inorganic or organic nature can be used, in particular dolomite or comminuted plant residues.

Suitable surface-active compounds are, depending on the type of the active ingredient to be formulated, non-ionic, cationic and/or anionic surfactants or surfactant mixtures which have good emulsifying, dispersing and wetting properties. The surfactants mentioned below are only to be considered as examples; a large number of further surfactants which are conventionally used in the art of formulation and suitable according to the invention are described in the relevant literature.

Suitable non-ionic surfactants are, especially, polyglycol ether derivatives of aliphatic or cycloaliphatic alcohols, of saturated or unsaturated fatty acids or of alkyl phenols which may contain approximately 3 to approximately 30 glycol ether groups and approximately 8 to approximately 20 carbon atoms in the (cyclo)aliphatic hydrocarbon radical or approximately 6 to approximately 18 carbon atoms in the alkyl moiety of the alkyl phenols. Also suitable are water-soluble polyethylene oxide adducts with polypropylene glycol, ethylenediaminopolypropylene glycol or alkyl polypropylene glycol having 1 to approximately 10 carbon atoms in the alkyl chain and approximately 20 to approximately 250 ethylene glycol ether groups and approximately 10 to approximately 100 propylene glycol ether groups.

Normally, the abovementioned compounds contain 1 to approximately 5 ethylene glycol units per propylene glycol unit. Examples which may be mentioned are nonylphenoxypolyethoxyethanol, castor oil polyglycol ether, polypropylene glycol/polyethylene oxide adducts, tributylpheno- xypolyethoxyethanol, polyethylene glycol or octylphenoxypolyethoxyethanol. Also suitable are fatty acid esters of polyoxyethylene sorbitan, such as polyoxyethylene sorbitan trioleate.

The cationic surfactants are, especially, quarternary ammonium salts which generally have at least one alkyl radical of approximately 8 to approximately 22 C atoms as substituents and as further substituents (unhalogenated or halogenated) lower alkyl or hydroxyalkyl or benzyl radicals. The salts are preferably in the form of halides, methylsulfates or ethyls u If ates. Examples are

stearyltrimethylammonium chloride and benzylbis(2-chloroethyl)ethylammonium bromide.

Examples of suitable anionic surfactants are water-soluble soaps or water-soluble synthetic surface- active compounds. Examples of suitable soaps are the alkali, alkaline earth or (unsubstituted or substituted) ammonium salts of fatty acids having approximately 10 to approximately 22 C atoms, such as the sodium or potassium salts of oleic or stearic acid, or of natural fatty acid mixtures which are obtainable for example from coconut or tall oil; mention must also be made of the fatty acid methyl taurates. However, synthetic surfactants are used more frequently, in particular fatty sulfonates, fatty sulfates, sulfonated benzimidazole derivatives or alkylaryl sulfonates. As a rule, the fatty sulfonates and fatty sulfates are present as alkali, alkaline earth or (substituted or unsubstituted) ammonium salts and they generally have an alkyl radical of approximately 8 to approximately 22 C atoms, alkyl also to be understood as including the alkyl moiety of acyl radicals; examples which may be mentioned are the sodium or calcium salts of lignosulfonic acid, of the dodecylsulfuric ester or of a fatty alcohol sulfate mixture prepared from natural fatty acids. This group also includes the salts of the sulfuric esters and sulfonic acids of fatty alcohol/ethylene oxide adducts. The sulfonated benzimidazole derivatives preferably contain 2 sulfonyl groups and a fatty acid radical of approximately 8 to approximately 22 C atoms. Examples of alkylarylsulfonates are the sodium, calcium or

triethanolammonium salts of decylbenzenesulfonic acid, of dibutylnaphthalenesulfonic acid or of a naphthalenesulfonic acid/formaldehyde condensate. Also possible are, furthermore, suitable phosphates, such as salts of the phosphoric ester of a p-nonylphenol/(4-14)ethylene oxide adduct, or phospholipids.

As a rule, the compositions comprise 0.1 to 99%, especially 0.1 to 95%, of active ingredient and 1 to 99.9%, especially 5 to 99.9%, of at least one solid or liquid adjuvant, it being possible as a rule for 0 to 25%, especially 0.1 to 20%, of the composition to be surfactants(% in each case meaning percent by weight). Whereas concentrated compositions tend to be preferred for commercial goods, the end consumer as a rule uses dilute compositions which have substantially lower concentrations of active ingredient. Typically, a pre-mix formulation for foliar application comprises 0.1 to 99.9 %, especially 1 to 95 %, of the desired ingredients, and 99.9 to 0.1 %, especially 99 to 5 %, of a solid or liquid adjuvant (including, for example, a solvent such as water), where the auxiliaries can be a surfactant in an amount of 0 to 50 %, especially 0.5 to 40 %, based on the pre-mix formulation.

Normally, a tank-mix formulation for seed treatment application comprises 0.25 to 80%, especially 1 to 75 %, of the desired ingredients, and 99.75 to 20 %, especially 99 to 25 %, of a solid or liquid auxiliaries (including, for example, a solvent such as water), where the auxiliaries can be a surfactant in an amount of 0 to 40 %, especially 0.5 to 30 %, based on the tank-mix formulation.

Typically, a pre-mix formulation for seed treatment application comprises 0.5 to 99.9 %, especially 1 to 95 %, of the desired ingredients, and 99.5 to 0.1 %, especially 99 to 5 %, of a solid or liquid adjuvant (including, for example, a solvent such as water), where the auxiliaries can be a surfactant in an amount of 0 to 50 %, especially 0.5 to 40 %, based on the pre-mix formulation.

Whereas commercial products will preferably be formulated as concentrates (e.g., pre-mix composition (formulation)), the end user will normally employ dilute formulations (e.g., tank mix composition).

Preferred seed treatment pre-mix formulations are aqueous suspension concentrates. The formulation can be applied to the seeds using conventional treating techniques and machines, such as fluidized bed techniques, the roller mill method, rotostatic seed treaters, and drum coaters. Other methods, such as spouted beds may also be useful. The seeds may be presized before coating. After coating, the seeds are typically dried and then transferred to a sizing machine for sizing. Such procedures are known in the art.

In general, the pre-mix compositions of the invention contain 0.5 to 99.9 especially 1 to 95, advantageously 1 to 50 %, by mass of the desired ingredients, and 99.5 to 0.1 , especially 99 to 5 %, by mass of a solid or liquid adjuvant (including, for example, a solvent such as water), where the auxiliaries (or adjuvant) can be a surfactant in an amount of 0 to 50, especially 0.5 to 40 %, by mass based on the mass of the pre-mix formulation. Examples of foliar formulation types for pre-mix compositions are:

GR: Granules

WP: wettable powders

WG: water dispersable granules (powders)

SG: water soluble granules

SL: soluble concentrates

EC: emulsifiable concentrate

EW: emulsions, oil in water

ME: micro-emulsion

SC: aqueous suspension concentrate

CS: aqueous capsule suspension

OD: oil-based suspension concentrate, and

SE: aqueous suspo-emulsion.

Whereas, examples of seed treatment formulation types for pre-mix compositions are:

WS: wettable powders for seed treatment slurry

LS: solution for seed treatment

ES: emulsions for seed treatment

FS: suspension concentrate for seed treatment

WG: water dispersible granules, and

CS: aqueous capsule suspension.

Examples of formulation types suitable for tank-mix compositions are solutions, dilute emulsions, suspensions, or a mixture thereof, and dusts.

Preferred compositions are composed in particular as follows (%

Emulsifiable concentrates:

active ingredient: 1 to 95%, preferably 5 to 20%

surfactant: 1 to 30%, preferably 10 to 20 %

solvent: 5 to 98%, preferably 70 to 85%

Dusts:

active ingredient: 0.1 to 10%, preferably 0.1 to 1 %

solid carrier: 99.9 to 90%, preferably 99.9 to 99%

Suspension concentrates: active ingredient: 5 to 75%, preferably 10 to 50%

water: 94 to 24%, preferably 88 to 30%

surfactant: 1 to 40%, preferably 2 to 30%

Wettable powders:

active ingredient: 0.5 to 90%, preferably 1 to 80%

surfactant: 0.5 to 20%, preferably 1 to 15%

solid carrier: 5 to 99%, preferably 15 to 98%

Granulates:

active ingredient: 0.5 to 30%, preferably 3 to 15%

solid carrier: 99.5 to 70%, preferably 97 to 85%

Examples:

The following compounds according to embodiment 1 may be prepared according to the methods described herein or according to known methods.

Experimental

The following examples are intended to illustrate the invention and are not to be construed as being limitations thereon.

"Mp" means melting point in °C. H NMR measurements were recorded on a Brucker 400MHz spectrometer, chemical shifts are given in ppm relevant to a TMS standard. Spectra measured in deuterated solvents as indicated.

LC MS Method A: Standard:

Spectra were recorded on a Mass Spectrometer from Waters (SQD or ZQ Single quadrupole mass spectrometer) equipped with an electrospray source (Polarity: positive or negative ions, Capillary: 3.00 kV, Cone range: 30-60 V, Extractor: 2.00 V, Source Temperature: 150 °C, Desolvation Temperature: 350 °C, Cone Gas Flow: 0 L/Hr, Desolvation Gas Flow: 650 L/Hr, Mass range: 100 to 900 Da) and an Acquity UPLC from Waters: Binary pump, heated column compartment and diode-array detector. Solvent degasser, binary pump, heated column compartment and diode-array detector. Column: Waters UPLC HSS T3 , 1.8 Dm, 30 x 2.1 mm, Temp: 60 °C, DAD Wavelength range (nm): 210 to 500, Solvent Gradient: A = water + 5% MeOH + 0.05 % HCOOH, B= Acetonitrile + 0.05 % HCOOH:

gradient: gradient: 0 min 0% B, 100%A; 1 .2-1.5min 100% B; Flow (ml/min) 0.85.

LC MS Method B: Standard long: Spectra were recorded on a Mass Spectrometer from Waters (SQD or ZQ Single quadrupole mass spectrometer) equipped with an electrospray source (Polarity: positive or negative ions, Capillary: 3.00 kV, Cone range: 30-60 V, Extractor: 2.00 V, Source Temperature: 150 °C, Desolvation Temperature: 350 °C, Cone Gas Flow: 0 L/Hr, Desolvation Gas Flow: 650 L/Hr, Mass range: 100 to 900 Da) and an Acquity UPLC from Waters: Binary pump, heated column compartment and diode-array detector. Solvent degasser, binary pump, heated column compartment and diode-array detector. Column: Waters UPLC HSS T3, 1.8 Dm, 30 x 2.1 mm, Temp: 60 °C, DAD Wavelength range (nm): 210 to 500, Solvent Gradient: A = water + 5% MeOH + 0.05 % HCOOH, B= Acetonitrile + 0.05% HCOOH:

gradient: gradient: 0 min 0% B, 100% A; 2.7-3. Omin 100% B; Flow (ml/min) 0.85.

LC MS Method C: Unpolar:

Spectra were recorded on a Mass Spectrometer from Waters (SQD or ZQ Single quadrupole mass spectrometer) equipped with an electrospray source (Polarity: positive or negative ions, Capillary: 3.00 kV, Cone range: 30-60 V, Extractor: 2.00 V, Source Temperature: 150 °C, Desolvation Temperature: 350 °C, Cone Gas Flow: 0 L/Hr, Desolvation Gas Flow: 650 L/Hr, Mass range: 100 to 900 Da) and an Acquity UPLC from Waters: Binary pump, heated column compartment and diode-array detector. Solvent degasser, binary pump, heated column compartment and diode-array detector. Column: Waters UPLC HSS T3, 1.8 Dm, 30 x 2.1 mm, Temp: 60 °C, DAD Wavelength range (nm): 210 to 500, Solvent Gradient: A = water + 5% MeOH + 0.05% HCOOH, B= Acetonitrile + 0.05% HCOOH:

gradient: gradient: 0 min 40% B, 60% A; 1.2-1.5 min 100% B; Flow (ml/min) 0.85.

LC MS Method D

ACQUITY SQD Mass Spectrometer from Waters (Single quadrupole mass spectrometer) lonisation method: Electrospray

Polarity: positive ions

Capillary (kV) 3.00, Cone (V) 60.00, Extractor (V) 3.00, Source Temperature (°C) 150, Desolvation

Temperature (°C) 400, Cone Gas Flow (L/Hr) 60, Desolvation Gas Flow (L/Hr) 700

Mass range: 100 to 800 Da

DAD Wavelength range (nm): 210 to 400

Method Waters ACQUITY UPLC with the following HPLC gradient conditions

(Solvent A: Water/Methanol 9:1 ,0.1 % formic acid and Solvent B: Acetonitrile,0.1 % formic acid )

Time (minutes) A (%) B (%) Flow rate (ml/min)

0 100 0 0.75

2.5 0 100 0.75

2.8 0 100 0.75

3.0 100 0 0.75

Type of column: Waters ACQUITY UPLC HSS T3; Column length: 30 mm; Internal diameter of column: 2.1 mm; Particle Size: 1 .8 micron; Temperature: 60°C. Example 1 : 2-chloro-N-(1-cvanocvclopropyn-5-[5-[2-methyl-5-(1 , 1 ,2,2, 2-pentafluoroethvn-4- (trifluoromethvnpyrazol-3-yllisoxazol-3-yllbenzamide (compound 3)

Step 1 : methyl 2-chloro-5-(hvdroxyiminomethvDbenzoate

To a solution of 500 mg methyl 2-chloro-5-formyl-benzoate in 7.6 ml ethanol was added 220 mg pyridine followed by 175 mg hydroxylamine hydrochloride, and the resulting yellow solution was heated to 50°C for 1 hour. Then the reaction mixture was evaporated and the residue purified by chromatography on silica gel, using ethyl acetate/cyclohexane (gradient from 1 :19 to 1 :3) as a solvent. Thus, 482 mg of methyl 2-chloro-5-(hydroxyiminomethyl)benzoate was obtained as a solid, mp 98- 100 °C. H-NMR (CDCI ₃ , 400 MHz,□ in ppm): 8.1 1 (s, 1 H), 8.01 (d, 1 H), 7.66 (dd, 1 H), 7.47 (d, 1 H), 7.34 (s, broad, 1 H), 3.93 (s, 3H).

Step 2: 5-ethynyl-1-methyl-3-(1 , 1 ,2,2,2-pentafluoroethylH-(trifluoromethyl)pyrazole

A solution of 1.25 g trimethylsilylacetylene in 36 ml diethyl ether was cooled to 0 °C, then 8.4 ml of lithium diisopropylamide (1.5M in tetrahydrofurane) was added dropwise over 5 minutes at 0 °C. Then the mixture was stirred for 5 min at 0°C and a solutionof 3.0 g 5-fluoro-1-methyl-3-(1 , 1 ,2,2,2- pentafluoroethyl)-4-(trifluoromethyl)pyrazole in 5 ml of diethyl ether was added dropwise. The resulting brown solution was stirred at 0° C for 10 minutes. Then the mixture was warmed up slowly to ambient temperature and heated to 45 °C for 3 hours. Then the reaction mixture was evaporated and the residue was dissolved in 21 ml methanol and 1.45 g potassium carbonate was added. The mixture was stirred at ambient temperature for 1 hour. Then the mixture was evaporated and the residue purified by chromatography, using ethyl acetate/cyclohexane (gradient from pure cyclohextan to 1 :9) as a solvent. Thus, 430 mg of 5-ethynyl-1-methyl-3-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazole was obtained. H-NMR (CDCI ₃ , 400 MHz,□ in ppm): 4.02 (s, 3H), 3.80 (s, 1 H). ⁹ F-NMR (CDCI ₃ , 376 MHz,□ in ppm): -56.0 (m), -83.4 (m), -1 10.6 (m).

Step 3: methyl 2-chloro-5-[5-[2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethylH-(trifluoromethvQpyrazol-3- yll isoxazol-3-νΠ benzoate

To a solution of 360 mg methyl 2-chloro-5-(hydroxyiminomethyl)benzoate (Step 1 ) in 10 ml acetonitrile was added 333 mg N-bromosuccinimide at 0 °C, then the resulting solution was stirred at 0 °C for 10 minutes and at ambient temperature for 30 minutes. To this solution was added 492 mg 5-ethynyl-1- methyl-3-(1 , 1 ,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazole (Step 2), then 447 mg sodium carbonate. Gas evolution and an exothermic reaction were observed. The resulting orange suspension was stirred at 50°C for 3 hours. Then the solvent was evaporated and the residue was purified by chromatography on silica gel using ethyl acetate/cyclohexane (gradient from 1 : 9 to 1 :3) as a solvent. Thus 308 mg of impure methyl 2-chloro-5-[5-[2-methyl-5-(1 , 1 ,2,2, 2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-3-yl]benzoate was obtained, which was used for the next step without further purification. H-NMR (CDCI ₃ , 400 MHz,□ in ppm): 8.30 (d, 1 H), 7.95 (dd, 1 H), 7.62 (d, 1 H), 7.00 (s, 1 H), 4.09 (s, 3H), 4.00 (s, 3H).

Step 4: 2-chloro-5-[5-[2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethvn-4-(trifluoromethvnpyrazol-3-yllisoxa zol-3- yllbenzoic acid

To a solution of 330 mg methyl 2-chloro-5-[5-[2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-3-yl]benzoate (Step 3) in 2.6 ml tetrahydrofuran and 330 Dl water was added 32 mg lithium hxdroxide monohydrate. The mixture was heated to 50°C for 18 hours. Then 5 ml of aqueous hydrochloric acid (1 N solution) was added and the mixture was extracted with ethyl acetate and water. The organic layer was isolated, dried over anhydrous sodium sulfate, and evaporated to give 327 mg of crude 2-chloro-5-[5-[2-methyl-5-(1 , 1 ,2,2, 2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-3-yl]benzoic acid as a yellow solid, which was used for step 5 without further purification. H-NMR (CDCI ₃ , 400 MHz,□ in ppm): 8.47 (d, 1 H), 8.01 (dd, 1 H), 7.68 (d, 1 H), 7.02 (s, 1 H), 4.08 (s, 3H).

Step 5: 2<;hloro-N-(1-cvanocvclopropyl)-5-[5-[2-methyl-5-(1 , 1 ,2,2, 2-pentafluoroethyl)-4-

(trifluoromethvDpyrazol-3-vHisoxazol-3-vHbenzamide

To a suspension of 150 mg 2-chloro-5-[5-[2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4-

(trifluoromethyl)pyrazol-3-yl]isoxazol-3-yl]benzoic acid (Step 4) in 2.5 ml dichloromethane were added 41 mg 1-aminocyclopropanecarbonitrile hydrochloride, 108 D l , triethylamine, 66 mg 3- (ethyliminomethyleneamino)-N,N-dimethyl-propan-1-amine hydrochloride and 47 mg 3- hydroxytriazolo[4,5-b]pyridine at ambient temperature. The resulting yellow solution was stirred for 3 hours, then heated to 35°C for 18 hours. Then the solvent was evaporated and the residue purified by chromatography on silica gel using ethyl acetate/cyclcohexane (gradient from 1 :9 to 1 : 1 ) as a solvent. The product so obtained was further purified by chromatography on silica gel using

dichloromethane/methanol (gradient from 0% to 5 % methanol) as a solvent. Thus, 9 mg of : 2-chloro- N-(1-cyanocyclopropyl)-5-[5-[2-methyl-5-(1 , 1 ,2,2, 2-pentafluoroethyl)-4-(trifluoromethyl)pyrazol-3- yl]isoxazol-3-yl]benzamide were obtained as a solid, mp 174-178°C, H-NMR (CDCI ₃ , 400 MHz,□ in ppm): 8.20 (d, 1 H), 7.98 (dd, 1 H), 7.57 (d, 1 H), 7.02 (s, 1 H), 6.91 (s, broad, 1 H), 4.07 (s, 3H), 1.70 (m, 2H), 1 .42 (m, 2H).

Example 2: 2-chloro-N-(1-cvanocvclopropyl)-5-[3-[2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yllisoxazol-5-yllbenzamide (compound 4)

Step 1 : N-methoxy-N,2-dimethyl-5-(1 , 1 ,2,2,2-pentafluoroethylH-(trifluoromethyl)pyrazole-3- carboxamide

A solution of 10.3 g 2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazole-3-carbo nyl chloride in 50 ml dichloromethane was added dropwise over 15 minutes to a solution of 3.72 g Ν,Ο- dimethylhydroxylamine hydrochloride and 7.96 g triethylamine in 170 ml dichloromethane. Then the reaction mixture was stirred for 15 minutes at ambient temperature. Then aqueous ammonium chloride was added and the mixture was extracted twice with dichloromethane. The combined organic phases were washed with aqueous potassium carbonate, dried over anhydrous sodium sulfate, filtered and the solvent evaporated under reduced pressure. Thus, 10.1 g crude N-methoxy-N,2-dimethyl-5- (1 , 1 ,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazole-3-carbo xamide was obtained as a brown oil, which was used for the next step without further purification. H-NMR (CDCI ₃ , 400 MHz,□ in ppm): 3.90 (s, 3H), 3.54 (s, 3H), 3.40 (s, 1 H). ⁹ F-NMR (CDCI ₃ , 376 MHz,□ in ppm): -55.5 (m), -83.5 (m), - 1 10.6 (m). Step 2: 2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethylH-(trifluoromethyl)pyrazole-3-carbald ehyde

To a solution of 9.30 g N-methoxy-N,2-dimethyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazole-3-carboxamide (step 1 ) in 130 ml tetrahydrofurane was added dropwise 13 ml of a solution of lithium aluminium hydride (2.0 M) in THF at -78 °C under argon over 10 minutes. The solution was stirred for additional 10 minutes at -75 °C, then allowed to warm to 0 °C and stirred for at 0 °C for 30 minutes. The reaction mixture was again cooled to -78 °C and 30 ml of saturated aqueous potassium hydrogen sulfate was added. Then the mixture was allowed to warm up to ambient temperature, filtered over celite and extracted with ethyl acetate. The organic layer was washed with water, brine, dried over anhydrous sodium sulfate, filtered and the solvent evaporated to give 10.7 g of 2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazole-3-carba ldehyde as a yellow oil, which was used for the next step without further purification. H-NMR (CDCI ₃ , 400 MHz,□ in ppm): 10.12 (s, 1 H), 4.28 (s, 3H). Step 3: 2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazole-3-carba ldehyde oxime

To a solution of 10.5 g 2-methyl-5-(1 , 1 ,2,2, 2-pentafluoroethyl)-4-(trifluoromethyl)pyrazole-3- carbaldehyde (step 2) in 106 ml ethanol was added 2.60 ml pyridine, then 2.09 g hydroxylamine hydrochloride and the resulting solution was heated to 45 °C for 1 hour. Then the solvent was evaporated and the residue was purified by chromatography on silica gel, using ethyl

acetate/cyclohexane (gradient from 1 : 19 to 1 :4) as a solvent. Thus, 5.23 g 2-methyl-5-(1 , 1 ,2,2,2- pentafluoroethyl)-4-(trifluoromethyl)pyrazole-3-carbaldehyde oxime was obtained as an oil. H-NMR (CDCI ₃ , 400 MHz,□ in ppm): 8.52 (s, broad, 1 H), 8.30 (s, 1 H), 4.13 (s, 3H).

Step 4: methyl 2-chloro-5-[3-[2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazol-3- yll isoxazol-5-νΠ benzoate

To a solution of 100 mg 2-methyl-5-(1 , 1 ,2,2, 2-pentafluoroethyl)-4-(trifluoromethyl)pyrazole-3- carbaldehyde oxime (step 3) in 1.9 ml acetonitrile was added 64 mg N-bromosusscinimide at 0 °C. Then the resulting solution was stirred at 0 °C for 1 hour and at ambient temperature for 1 hour. Then 62 mg methyl 2-chloro-5-ethynyl-benzoate was added, followed by 85 mg sodium carbonate. The resulting brown solution was stirred at ambient temperature for 18 hours. Then the mixture was heated to 50 °C for 2 hours, then the solvent was evapoarted. The residue was purified by chromatography on silica gel, using ethyl acetate7cyclohexane (gradient from 1 : 9 to 1 :3) as a solvent. Thus, 80 mg of impure methyl 2-chloro-5-[3-[2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazol-3- yl]isoxazol-5-yl]benzoate was obtained, which was used for the next step without further purification. An analytical sample of methyl 2-chloro-5-[3-[2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4-

(trifluoromethyl)pyrazol-3-yl]isoxazol-5-yl]benzoate was obtained by preparative reversed phase HPLC as a solid, mp 122-126 °C. H-NMR (CDCI ₃ , 400 MHz,□ in ppm): 8.30 (d, 1 H), 7.90 (dd, 1 H), 7.63 (d, 1 H), 6.80 (s, 1 H), 4.06 (s, 3H), 4.00 (s, 3H). Step 5: 2-chloro-5-[3-[2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethvn-4-(trifluoromethvnpyrazol-3-yllisoxa zol-5- yllbenzoic acid

To a solution of 620 mg methyl 2-chloro-5-[3-[2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4-

(trifluoromethyl)pyrazol-3-yl]isoxazol-5-yl]benzoate (step 4) in 4.9 ml tetrahydrofuran and 0.62 ml water was added 59 mg lithium hxdroxide monohydrate, then the mixture was stirred at ambient temperature for 2 hours, then at 50 °C for additional 2 hours. Then the reaction mixture was allowed to cool to ambient temperature, 3 ml of aqueous HCI (1 N) was added, and the mixture was extracted with ethyl acetate and water. The organic layer was isolated, dried over anhydrous sodium sulfate, filtered, and the solvent evaporated. Thus, 0.63 g crude 2-chloro-5-[3-[2-methyl-5-(1 , 1 ,2,2, 2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5-yl]benzoic acid was obtained as a solid, which was used for the next step without further purification. H-NMR (CDCI ₃ , 400 MHz,□ in ppm): 8.46 (d, 1 H), 7.94 (dd, 1 H), 7.68 (d, 1 H), 6.83 (s, 1 H), 4.05 (s, 3H).

Step 6: 2-chloro-N-(1-cvanocvclopropy0-5-[3-[2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethylH-

(trifluoromethvDpyrazol-3-vHisoxazol-5-vHbenzamide

To a solution of 200 mg 2-chloro-5-[3-[2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yl]isoxazol-5-yl]benzoic acid (step 5) in 1 .63 ml dichloromethane was added a drop of Ν,Ν-dimethylformamide and 64 mg oxalyl chloride. The resulting solution was stirred at ambient temperature for 1 hour. Then the solvent was evaporated and the residue dissolved in 2 ml tetahydrofurane. This solution was added dropwise to a mixture of 53 mg 1-aminocyclopropane- carbonitrile hydrochloride and 138 D l triethylamine in 1.6 ml tetahydrofurane. The resulting reaction mixture was stirred at ambient temperature for 2 hours. Then the solvent was evaporated and the residue purified by chromatography on silica gel, using ethyl acetate/cyclohexane (gradient from 1 :9 to 1 : 1 ) as a solvent. From this procedure, 45 mg of a solid product was obtained, which was further purified by preparative reversed phase HPLC. Thus, 25 mg of pure 2-chloro-N-(1-cyanocyclopropyl)-5- [3-[2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazol-3-yl]iso xazol-5-yl]benzamide was obtained as a solid, mp 165-170 °C. H-NMR (CDCI ₃ , 400 MHz,□ in ppm):8.22 (d, 1 H), 7.91 (dd, 1 H), 7.60 (d, 1 H), 6.89 (s, broad, 1 H), 6.83 (s, 1 H), 4.06 (s, 3H), 1 .71 (m, 2H), 1 .43 (m, 2H). Example 3: 2-Chloro-N-(1-cvanocvclopropyn-5-[3-[2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethylH-

(trifluoromethvDpyrazol-3-νΠ-1 ,2,4-oxadiazol-5-yllbenzamide (compound 10)

Step 1 : Methyl 4-chloro-3-cvano-benzoate

A solution of 2.21 g sodium nitrite (32 mmol) in 10ml water was added over 10 min to a mixture of 5.0 g methyl 3-amino-4-chloro-benzoate (5.0 g, 26.9 mmol) in 40 ml water at 0°C. Concentrated HCI (10 ml) was added at -5°C and the solution was stirred at -5°C for 1 h. The suspension of the diazonium salt was then added portion-wise to a suspension of potassium cuprotetracyanide [K ₂ Cu(CN) ₄ , prepared by dropwise addition of a solution of KCN (10 g, 149 mmol) in 18 ml water to a solution of copper sulfate (7.0 g, 44 mmol) in 12 ml water at 70°C] at 50°C for 1 h. After 1 h further stirring at RT, TLC analysis showed complete conversion. The reaction mixture was carefully acidified with HCI 1.5N. After addition of ethyl acetate and water, the organic phase was separated, washed with water and dried over MgS0 ₄ . Evaporation of the solvent gave a solid which was crystallized in diisopropylether to yield 2.28 g of a white solid. H-NMR (CDCI ₃ , 400 MHz,□ in ppm): 8.43 (d, 1 H), 8.18 (dd, 1 H), 7.61 (dd, 1 H), 3.98 (s, 3H).

Step 2: 4-Chloro-3-cyano-benzoic acid

1.78 g methyl 4-chloro-3-cyano-benzoate (9.10 mmol, step 1 ) and 0.654 g lithium hydroxyde (27.3 mmol) were suspended in 15 ml water THF 1 : 1 and stirred at rt for 2h. After evaporation of the THF, the solution was diluted with water and washed with ethyl acetate. The aqueous solution was acidified with HCI 1 N and the precipitate formed was collected and dried under vacuum to give 300 mg of the title compound. LCMS: 180 (M-H) ^~ , Rt = 0.95 min (method B). H-NMR (CDCI ₃ , 400 MHz,□ in ppm): 8.59 (s, 1 H), 4.89 (s, b, 1 H), 3.99 (s, 3H).

Step 3: N-Hydroxy-2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazole-3-carbo xamidine

A solution of 2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazole-3-carbo nitrile (3.90g, 13.3 mmol) was dissolved in 80 ml MeOH. To this mixture 5.57 g K ₂ C0 ₃ (39.9 mmol), followed by 2.83 g hydroxylamine hydrochloride (39.9 mmol) were added in portions. The temperature of the solution rose to 45°C during the addition of the reagents. The reaction mixture was heated at reflux overnight. After cooling, the solvent was evaporated and the residue was dissolved in ethyl acetate. The organic phase was washed with brine and dried over MgS0 ₄ . After evaporation of the solvent, the residue was purified by flash-chromatography to give 3.44 g of the title compound as a colourless oil. LCMS: 327 (M+H) ⁺ , Rt = 1 .32 min (method B). H-NMR (CDCI ₃ , 400 MHz,□ in ppm): 8.59 (s, 1 H), 4.89 (s, b, 1 H), 3.99 (s, 3H).

Step 4: 2-Chloro-5-[3-[2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazol-3-yll-1 ,2,4- oxadiazol-5-yllbenzonitrile

To a suspension of 4-chloro-3-cyano-benzoic acid (1.5 g, 8.26 mmol, step 2) in 15 ml dry CH ₂ CI ₂ was added 5 ml oxalyl chloride (58.2 mmol) and a few drops DMF. The solution was heated at reflux until HCI evolution stopped. The volatiles were removed and the residue was dissolved in 50 ml DMF. To this solution, 2.70 g N-hydroxy-2-methyl-5-(1 , 1 ,2,2, 2-pentafluoroethyl)-4-(trifluoromethyl)pyrazole-3- carboxamidine (8.28 mmol, step 3) was added and the mixture was heated at 120°C for 2h. After evaporation of the solvent, the residue was dissolved in ethyl acetate. The organic phase was washed with water, dried over MgS0 ₄ and evaporated. The solid was crystallized from ethyl acetate / diisopropyl ether and cold methanol to give 2.25 g of the title compound as a white solid. Mp: 160-1 °C. LCMS: 472 (M-H) ^~ , Rt = 2.17 min (method B). H-NMR (CDCI ₃ , 400 MHz,□ in ppm): 8.51 (d, 1 H), 8.38 (dd, 1 H), 7.80 (d, 1 H), 4.11 (s, 3H).

Step 5: 2-Chloro-5-[3-[2-methyl-5-(1 ,1 ,2,2,2-pentafluoroethvn-4-(trifluoromethvnpyrazol-3-yll-1 ,2,4- oxadiazol-5-yllbenzamide

To a solution of 2-chloro-5-[3-[2-methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazol-3-yl]- 1 ,2,4-oxadiazol-5-yl]benzonitrile (100mg, 0.21 mmol, step 4) in DMSO was added 29.3 mg K ₂ C0 ₃ and dropwise a solution of 0.171 ml H ₂ 0 ₂ (5.58 mmol) at 0°C. The reaction mixture was stirred at RT for 2h. The solution was then diluted with ice water and the precipitate was collected to give 92 mg of the title compound as a white solid, which was further used without purification. LCMS: 490 (M+H) ⁺ , Rt = 1.82 min (method B). _. H-NMR (CDCI ₃ , 400 MHz,□ in ppm): 8.62 (d, 1 H), 8.21 (dd, 1 H), 7.79 (dd, 1 H), 6.35 (s, b, 1 H), 6.00 (s, b, 1 H), 4.10 (s, 3H).

Step 6: 2-Chloro-5-[3-[2-methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazol-3-yll-1 ,2,4- oxadiazol-5-νΠ benzoic acid

To a solution of 2-chloro-5-[3-[2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazol-3-yl]- 1 ,2,4-oxadiazol-5-yl]benzamide (step 5, 40 mg, 0.082 mmol) in dioxane was added 2 ml aqueous HCI 32% and the reaction mixture was heated at 100°C over 72h. After cooling, the solution was basified with NaOH 1 N and extracted with tertbutylmethylether. The aqueous phase was acidified with HCI 1 N and extracted with ethyl acetate. After drying over MgS04, the solution was evaporated to yield 50 mg of a gum. LCMS: 489 (M-H) ^~ , Rt = 1.96 min (method B). H-NMR (CDCI ₃ , 400 MHz,□ in ppm): 8.79 (d, 1 H), 8.27 (dd, 1 H), 7.73 (dd, 1 H), 4.1 1 (s, 3H). Step7: 2-Chloro-N-(1-cvanocvclopropyn-5-[3-[2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethylH- (trifluoromethvDpyrazol-3-νΠ-1 ,2,4-oxadiazol-5-yllbenzamide (compound 10)

To a suspension of 2-chloro-5-[3-[2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazol-3- yl]-1 ,2,4-oxadiazol-5-yl]benzoic acid (210 mg, 0.43 mmol, step 6) in 5 ml dry CH ₂ CI ₂ was added sequentially oxalyl chloride (2 ml, 23.4 mmol) and a few drops DMF under an argon atmosphere. The mixture was heated to reflux until HCI evolution stopped. The volatiles were removed under reduced pressure and the residue dissolved in 5 ml THF. To this solution was added at RT, 1- aminocyclopropanecarbonitrile hydrochloride (46 mg, 0.39 mmol) and pyridine (170 mg, 2.14 mmol). The reaction mixture was heated at 60°C overnight. After quenching with methanol, the solution was evaporated. The residue was taken in ethyl acetate and washed with water/brine. The organic layer was separated, dried over MgS0 ₄ and evaporated. The residue was purified by flash chromatography to give 96 mg of the title compound as a white solid. Mp: 193-4°C. LCMS: 555 (M+H) ⁺ , Rt = 1.96 min (method B). H-NMR (CDCI ₃ , 400 MHz,□ in ppm): 8.52 (d, 1 H), 8.22 (dd, 1 H), 7.66 (dd, 1 H), 6.87 (s, b, 1 H), 4.1 1 (s, 3H), 1.71 (m, 2H), 1.44 (m, 2H).

Example 4: 2-chloro-N-(1-cvanocvclopropyl)-5-[3-[2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-vH-1 ,2,4-triazol-1-yllbenzamide (compound 36)

Step 1 : N-amino-2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethvn-4-(trifluoromethyl)pyrazole-3-carbox amidine

Hydrazine hydrate (1.05 g) was added to a solution of 2-methyl-5-(1 , 1 ,2,2, 2-pentafluoroethyl)-4- (trifluoromethyl)pyrazole-3-carbonitrile (2.00 g) in ethanol (20.5 ml) at 20°C, under stirring. The solution was warmed at 40°C and kept at this temperature for four days. The reaction mixture was then concentrated under vacuum and the residue was partitioned between dichloromethane and water. The phases were separated and the aqueous phase was extracted twice with dichloromethane. The joined organic phases were washed with brine and dried over sodium sulfate. After evaporation at the rotary evaporator, the residue was submitted to flash chromatography over silica gel, eluting with a mixture of methanol and dichloromethane. The selected fractions were evaporated to yield the title compound as a colorless powder that was characterized by its H-NMR spectrum. LC-MS: 326

(M+H)+, Rt = 0.65 min (Method A). H-NMR (CDCI ₃ , 400 MHz,□ in ppm): 5.00 - 4.20 (br s, 4H), 4.00 (s, 3H).

Step 2: 3-[2-methyl-5-( 1 , 1 ,2,2,2-pentafluoroethylH-(trifluoromethvQpyrazol-3-vn-1 H-1 ,2,4-triazole

A solution of N-amino-2-methyl-5-(1 , 1 ,2,2, 2-pentafluoroethyl)-4-(trifluoromethyl)pyrazole-3- carboxamidine (0.500 g) in formic acid (10.7 g) was heated at 100°C for 105 minutes. Removal of the volatiles at the rotary evaporator leaved the title compounds as a colourless solid (mp. 227-229°C) that was pure enough to be used in the following step. LC-MS: 336 (M+H)+ , Rt. 0.96 (Method A). NMR (CD ₃ OD, 400 MHz,□ in ppm): 8.71 (s, 1 H), 3.95 (s, 3H).

Step 3: 2<;hloro-N-(1-cvanocvclopropyl)-5-[3-[2-methyl-5-(1 ,1 ,2,2,2-pentafluoroethylH- (trifluoromethvnpyrazol-3-yll-1 ,2,4-triazol-1-yllbenzamide

A solution light yellow solution of 3-[2-methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazol- 3-yl]-1 H-1 ,2,4-triazole (0.082 g) and 2-chloro-N-(1-cyanocyclopropyl)-5-iodo-benzamide (0.13 g) in dimethylformamide (3.00 ml) was flushed with argon for five minutes, then copper(l) iodide (0.0095 g) followed by N,N'-dimethylethylenediamine (0.0087 g) and potassium carbonate (0.014 g) were added. The dark blue reaction mixture was heated at 125°C and stirred for seventeen hours. The dark brown reaction mixture was then evaporated at the roraty evaporator (bath temp 80°C) and the residue was partitioned between dichloromethane and water. The aqueous phase was extracted with

dichloromethane and the joined organic phases were washed with brine and dried over sodium sulfate. After removal of the solvent under reduced pressure, the brown oily residue was submitted to chromatography over silica gel eluting with a mixture of ethyl acetate and cyclohexane. The title compound was obtained as a colorless powder. LC-MS: 554, 556 (M+H)+ , Rt. 1.06 (Method A)

Example 5: 2-chloro-N-(1-cvanocvclopropyl)-5-[4-[2-methyl-5-(1 ,1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yllthiazol-2-yllbenzamide (compound 52)

Step 1 : 2-bromo-1-[2-methyl-5-(1 ,1 ,2,2,2-pentafluoroethvl)-4-(trifluoromethyl)pvrazol-3-vlleth anone

A solution of 10 g of 1 2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazol-3-yl]eth anone (preparation described in WO 2015193218 (publ. 23 December 2015)) in a mixture of ethyl acetate (129 ml) and chloroform (129 ml) was stirred under inert atmosphere in a flask equipped with a reflux condenser. Copper(ll) bromide (14.6 g) was added and the yellow solution became a dark suspension, which turned into a pale green suspension within 10 minutes. . The mixture was stirred for 43 hours at 80°C. After cooling to 20°C, the suspension was filtered and the filtrate diluted with ethyl acetate, then washed with aqueous hydrochloric acid (1 N), then successively with water then brine and dried over sodium sulfate. After removal of the solvent under reduced pressure, the pale brown residue was chromatographed over silica gel eluting with ethyl acetate-cyclohexane mixture. The title compound was isolated as pale yellow oil. .

H-NMR (CDCI ₃ , 400 MHz,□ in ppm): 4.33 (s, 2H), 4.02 (s, 3H). Step 2: 5-carbamothioyl-2-chloro-benzoic acid

Water (2.5 g) was added to a solution of 4-chloro-3-cyano-benzoic acid (described above) in dioxane (12 ml), followed by Ο,Ο'-diethyl-dithiophosphate (1.13 ml) and the mixture was stirred for 20 hours at 100°C. The reaction mixture was cooled down to 20°C, diluted with water (100 ml) and extracted twice with ethyl acetate. The combined organic layers were washed with water and dried over sodium sulfate. After removal of the solvent under reduced pressure, the crude title product was obtained as a pale brown powder. LC-MS: 216, 218 (M+H)+ , Rt. 0.56 min (Method A)

Step 3: 2-chloro-5-[4-[2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazol-3-yllthi azol-2- yllbenzoic acid

To a solution of 0.4 g 5-carbamothioyl-2-chloro-benzoic acid (step 2) in 5 ml ethanol was added 2- bromo-1-[2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazol-3-yl]eth anone (step 1 ) (0.72 g) and the mixture was stirred for 20 hours at 20°C. After removal of the solvent under reduced pressure, the oily residue contained ethyl ester of the desired product. The whole amount was dissolved in tetrahydrofurane (10 ml) and treated with aqueous sodium hydroxide (2 N) and refluxed for 1 hour. The reaction mixture was cooled down to 20°C and poured onto diluted hydrochloric acid (75 ml). The compound was then extracted twice with ethyl acetate. The organic phases were washed with water, then brine and dried over sodium sulfate.

LC-MS: 506, 508 (M+H)+ , Rt. 1.13 min (Method A)

Step 4: 2-chloro-N-(1-cvanocvclopropyl)-5-[4-[2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4- (trifluoromethyl)pyrazol-3-yllthiazol-2-yllbenzamide

The title compound was obtained in a similar way as described in step 6 of example 2, by replacing 2- chloro-5-[3-[2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazol-3-yl]iso xazol-5-yl]benzoic acid with 2-chloro-5-[4-[2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazol-3-yl]thi azol-2- yl]benzoic acid (step 3).

The crude product was purified by flash chromatography over silica gel, eluting with a mixture of ethyl acetate and cyclohexane. Colorless crystals (mp: 175 - 179°C).

H-NMR (CD ₃ CN, 400 MHz,□ in ppm): 8.1 1-8.06 (m, 2H), 7.95 (s, 1 H), 7.70 (br. s, 1 H), 7.64 (d, 1 H), 3.93 (s, 3H), 1.65-1.48 (m, 2H), 1.43-1.36 (m, 2H).

Example 6: 2-chloro-N-(1-cvanocvclopropyl)-5-[2-[2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4-

(trifluoromethyl)pyrazol-3-yllthiazol-4-yllbenzamide (compound 54)

Step 1 : tert-butyl 5-acetyl-2-chloro-benzoate

To a solution of tert-butyl 5-bromo-2-chloro-benzoate (23.6 g) in dry dimethylsulfoxide (200 ml) under nitrogen atmosphere, was added butyl vinyl ether (16.5 g) and diisopropyl amine (20.6 g). The solution was degased by passing a stream of nitrogen through it for at least 5 minutes. 1 ,3- bis(diphenylphosphino)propane (3.3 g), 1-butyl-3-methylimidazolium tetrafluoroborate (1.8 g) and palladium (II) acetate (1.8 g) were added. The reaction mixture was heated at 1 10°C for 20 hours, cooled down to 20°C and treated with diluted aqueous hydrochloric acid (1 liter). The resulting mixture was extracted twice with ethyl acetate and the organic phase was rinsed with water, brine and dried over sodium sulfate. Removal of the solvent under reduced pressure left a red brown oil that was purified by chromatography over silica gel. The fractions containing the desired product were collected and evaporated. The title compound was isolated as yellow oil.

H-NMR (CDCI ₃ , 400 MHz,□ in ppm): 8.38 (d, 1 H), 7.96 (dd, 1 H), 7.52 (d, 1 H), 2.63 (s, 3H), 1.64 (s, 9H). Step 2: 5-(2-bromoacetyl)-2-chloro-benzoic acid

A solution of 1.00 g of tert-butyl 5-acetyl-2-chloro-benzoate (step 1 ) in a mixture of ethyl acetate (16 ml) and chloroform (16 ml) was stirred under inert atmosphere in a flask equipped with a reflux condenser. Copper(ll) bromide (1.77 g) was added under stirring. The dark suspension turned into a pale green suspension within 10 minutes. The mixture was stirred for 20 hours at 80°C. After cooling to 20°C, the suspension was filtered and the filtrate diluted with ethyl acetate, then washed with aqueous hydrochloric acid (1 N), then successively with water then brine and dried over sodium sulfate. After removal of the solvent under reduced pressure, the pale brown residue was chromatographed over silica gel eluting with methanol - dichloromethane mixture. The title compound was isolated as pale brown solid.. .

H-NMR (DMSO-d6), 400 MHz,□ in ppm): 13.8 (br. s, 1 H), 8.35 (d, 1 H), 8.12 (dd, 1 H), 7.78 (dd, 1 H), 4.99 (s, 2H). Step_^2-chloro-5-[2-[2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazol-3-yl]thi azol-4- yl]benzoic acid

To a solution of 0.2 g 2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazole-3- carbothioamide (described in WO 2015150442 A1 20151008) in 1 ml ethanol was added 5-(2- bromoacetyl)-2-chloro-benzoic acid (step 2) (0.170 g) and the mixture was stirred for 20 hours at 20°C. After removal of the solvent under reduced pressure, the residue was purified by

chromatography over silica gel, eluting with a mixture of methanol and dichloromethane. The title compound was obtained as a light yellow powder.

LC-MS: 506, 508 (M+H)+ , Rt. 1 .15 min (Method A)

H-NMR (DMSO-d6), 400 MHz,□ in ppm): 13.60 (s, 1 H), 8.80 (s, 1 H), 8.43 (d, 1 H), 8.18 (dd, 1 H), 7.68 (d, 1 H), 3.98 (s, 3H).

Step 4: 2-chloro-N-(1-cvanocvclopropyl)-5-[2-[2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4-

(trifluoromethyl)pyrazol-3-yllthiazol-4-yllbenzamide (compound 54)

The title compound was obtained in a similar way as described in step 5 of example 1 , by replacing 2- chloro-5-[5-[2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazol-3-yl]iso xazol-3-yl]benzoic acid with 2-chloro-5-[2-[2-methyl-5-(1 , 1 ,2,2,2-pentafluoroethyl)-4-(trifluoromethyl)pyrazol-3-yl]thi azol-4- yl]benzoic acid (step 3).

The crude product was purified by flash chromatography over silica gel, eluting with a mixture of ethyl acetate and cyclohexane. Colorless crystals (mp: 176 - 179°C).

H-NMR (CDCI ₃ , 400 MHz,□ in ppm): 8.32 (s, 1 H), 8.05 (d, 1 H), 7.95 (s, 1 H), 7.54 (d, 1 H), 6.95 (s, 1 H), 4.05 (s, 3H), 1.78 - 1.68 (m, 2H), 1.50-1.40 (m, 2H).

The following compounds may be prepared in analogy with Examples 1 to 6 or according to known literature methods or according to methods described in WO2014/122083, WO2012/107434, WO2015/067646, WO2015/067647, WO2015/067648 and WO2010/051926. Table 1

T

1

7 1

7

Formulation examples (% = percent by weight)

Example F1 : Emulsion concentrates a) b) c) Active ingredient 25 % 40 % 50 % Calcium dodecylbenzenesulfonate 5 % 8 % 6 % Castor oil polyethylene

glycol ether (36 mol of EO) 5 %

Tributylphenoxypolyethylene glycol

ether (30 mol of EO) 12 % Cyclohexanone 15% 20%

Xylene mixture 65 % 25 % 20 %

Emulsions of any desired concentration can be prepared from such concentrates by dilution with water.

Example F2: Solutions a) b) c) d)

Active ingredient 80% 10% 5% 95%

Ethylene glycol monomethyl

ether 20% -

Polyethylene glycol

MW 400 70% -

N-Methylpyrrolid-2-one 20% - Epoxidized coconut oil 1 % 5 %

Petroleum ether

(boiling range: 160-190°) 94% -

The solutions are suitable for use in the form of microdrops. Example F3: Granules a) b) c) d)

Active ingredient 5% 10% 8% 21 %

Kaolin 94% - 79% 54%

Highly disperse silica 1 % - 13% 7%

Attapulgite - 90% - 18%

The active ingredient is dissolved in dichloromethane, the solution is sprayed onto the carrier(s), and the solvent is subsequently evaporated in vacuo.

Example F4: Dusts a) b)

Active ingredient 2 % 5 %

Highly disperse silica 1 % 5%

Talc 97 % -

Kaolin - 90 %

Ready-to-use dusts are obtained by intimately mixing the carriers and the active ingredient. Example F5: Wettable powders a) b) c)

Active ingredient 25 % 50 % 75 %

Sodium lignosulfonate 5 % 5 %

Sodium lauryl sulfate 3 % - 5 % Sodium diisobutyl- naphthalenesulfonate - 6 % 10 %

Octylphenoxypolyethylene glycol

ether (7-8 mol of EO) - 2 %

Highly disperse silica 5 % 10 % 10 %

Kaolin 62 % 27 % -

The active ingredient is mixed with the additives and the mixture is ground thoroughly in a suitable mil This gives wettable powders, which can be diluted with water to give suspensions of any desired concentration.

Example F6: Extruder granules

Active ingredient 10 %

Sodium lignosulfonate 2 %

Carboxymethylcellulose 1 %

Kaolin 87 %

The active ingredient is mixed with the additives, and the mixture is ground, moistened with water, extruded, granulated and dried in a stream of air.

Example F7: Coated granules

Active ingredient 3 %

Polyethylene glycol (MW 200) 3 %

Kaolin 94 %

In a mixer, the finely ground active ingredient is applied uniformLy to the kaolin, which has been moistened with the polyethylene glycol. This gives dust-free coated granules.

Example F8: Suspension concentrate

Active ingredient 40 %

Ethylene glycol 10 %

Nonylphenoxypolyethylene glycol ether (15 mol of EO) 6 %

Sodium lignosulfonate 10 %

Carboxymethylcellulose 1 %

37 % agueous formaldehyde solution 0.2 %

Silicone oil (75 % agueous emulsion) 0.8 %

Water 32 %

The finely ground active ingredient is mixed intimately with the additives. Suspensions of any desired concentration can be prepared from the thus resulting suspension concentrate by dilution with water. Example F9: Powders for dry seed treatment a) b) c) active ingredient 25 % 50 % 75 %

light mineral oil 5 % 5 % 5 %

highly dispersed silicic acid 5 % 5 %

Kaolin 65 % 40 %

Talcum - - 20 %

The combination is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording powders that can be used directly for seed treatment.

Example F10: Emulsifiable concentrate

active ingredient 10 %

octylphenol polyethylene glycol ether 3 %

(4-5 mol of ethylene oxide)

calcium dodecylbenzenesulfonate 3 %

castor oil polyglycol ether (35 mol of ethylene oxide) 4 %

Cyclohexanone 30 %

xylene mixture 50 %

Emulsions of any required dilution, which can be used in plant protection, can be obtained from this concentrate by dilution with water.

Example F1 1 : Flowable concentrate for seed treatment

active ingredients 40 %

propylene glycol 5 %

copolymer butanol PO/EO 2 %

Tristyrenephenole with 10-20 moles EO 2 %

1 ,2-benzisothiazolin-3-one (in the form of a 20% solution in water) 0.5 %

monoazo-pigment calcium salt 5 %

Silicone oil (in the form of a 75 % emulsion in water) 0.2 %

Water 45.3 %

The finely ground combination is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion.

The activity of the compositions according to the invention can be broadened considerably, and adapted to prevailing circumstances, by adding other insecticidally, acaricidally and/or fungicidally active ingredients. The mixtures of the compounds according to any one of embodiments 1 to 24 with other insecticidally, acaricidally and/or fungicidally active ingredients may also have further surprising advantages which can also be described, in a wider sense, as synergistic activity. For example, better tolerance by plants, reduced phytotoxicity, insects can be controlled in their different development stages or better behaviour during their production, for example during grinding or mixing, during their storage or during their use.

Suitable additions to active ingredients here are, for example, representatives of the following classes of active ingredients: organophosphorus compounds, nitrophenol derivatives, thioureas, juvenile hormones, formamidines, benzophenone derivatives, ureas, pyrrole derivatives, carbamates, pyrethroids, chlorinated hydrocarbons, acylureas, pyridylmethyleneamino derivatives, macrolides, neonicotinoids and Bacillus thuringiensis preparations.

The following mixtures of the compounds according to any one of embodiments 1 to 24 with active ingredients are preferred (the abbreviation "TX" means "one compound selected from the compounds according to any one of embodiments 1 to 24, preferably embodiment 24): an adjuvant selected from the group of substances consisting of petroleum oils (alternative name) (628) + TX,

an acaricide selected from the group of substances consisting of 1 , 1-bis(4-chlorophenyl)-2- ethoxyethanol (lUPAC name) (910) + TX, 2,4-dichlorophenyl benzenesulfonate (lUPAC/Chemical Abstracts name) (1059) + TX, 2-fluoro-A/-methyl-A/-1-naphthylacetamide (lUPAC name) (1295) + TX, 4-chlorophenyl phenyl sulfone (lUPAC name) (981 ) + TX, abamectin (1 ) + TX, acequinocyl (3) + TX, acetoprole [CCN] + TX, acrinathrin (9) + TX, aldicarb (16) + TX, aldoxycarb (863) + TX, alpha- cypermethrin (202) + TX, amidithion (870) + TX, amidoflumet [CCN] + TX, amidothioate (872) + TX, amiton (875) + TX, amiton hydrogen oxalate (875) + TX, amitraz (24) + TX, aramite (881 ) + TX, arsenous oxide (882) + TX, AVI 382 (compound code) + TX, AZ 60541 (compound code) + TX, azinphos-ethyl (44) + TX, azinphos-methyl (45) + TX, azobenzene (lUPAC name) (888) + TX, azocyclotin (46) + TX, azothoate (889) + TX, benomyl (62) + TX, benoxafos (alternative name) [CCN] + TX, benzoximate (71 ) + TX, benzyl benzoate (lUPAC name) [CCN] + TX, bifenazate (74) + TX, bifenthrin (76) + TX, binapacryl (907) + TX, brofenvalerate (alternative name) + TX, bromo- cyclen (918) + TX, bromophos (920) + TX, bromophos-ethyl (921 ) + TX, bromopropylate (94) + TX, buprofezin (99) + TX, butocarboxim (103) + TX, butoxycarboxim (104) + TX, butylpyridaben (alternative name) + TX, calcium polysulfide (lUPAC name) (1 1 1 ) + TX, camphechlor (941 ) + TX, carbanolate (943) + TX, carbaryl (1 15) + TX, carbofuran (1 18) + TX, carbophenothion (947) + TX, CGA 50'439 (development code) (125) + TX, chinomethionat (126) + TX, chlorbenside (959) + TX, chlordimeform (964) + TX, chlordimeform hydrochloride (964) + TX, chlorfenapyr (130) + TX, chlorfenethol (968) + TX, chlorfenson (970) + TX, chlorfensulfide (971 ) + TX, chlorfenvinphos

(131 ) + TX, chlorobenzilate (975) + TX, chloromebuform (977) + TX, chloromethiuron (978) + TX, chloropropylate (983) + TX, chlorpyrifos (145) + TX, chlorpyrifos-methyl (146) + TX, chlorthiophos (994) + TX, cinerin I (696) + TX, cinerin II (696) + TX, cinerins (696) + TX, clofentezine (158) + TX, closantel (alternative name) [CCN] + TX, coumaphos (174) + TX, crotamiton (alternative name) [CCN] + TX, crotoxyphos (1010) + TX, cufraneb (1013) + TX, cyanthoate (1020) + TX, cyflumetofen (CAS Reg. No.: 400882-07-7) + TX, cyhalothrin (196) + TX, cyhexatin (199) + TX, cypermethrin (201 ) + TX, DCPM (1032) + TX, DDT (219) + TX, demephion (1037) + TX, demephion-0 (1037) + TX, demephion-S (1037) + TX, demeton (1038) + TX, demeton-methyl (224) + TX, demeton-O (1038) + TX, demeton-O-methyl (224) + TX, demeton-S (1038) + TX, demeton-S-methyl (224) + TX, demeton-S-methylsulfon (1039) + TX, diafenthiuron (226) + TX, dialifos (1042) + TX, diazinon (227) + TX, dichlofluanid (230) + TX, dichlorvos (236) + TX, dicliphos (alternative name) + TX, dicofol (242) + TX, dicrotophos (243) + TX, dienochlor (1071 ) + TX, dimefox (1081 ) + TX, dimethoate (262) + TX, dinactin (alternative name) (653) + TX, dinex (1089) + TX, dinex-diclexine (1089) + TX, dinobuton (269) + TX, dinocap (270) + TX, dinocap-4 [CCN] + TX, dinocap-6 [CCN] + TX, dinocton (1090) + TX, dinopenton (1092) + TX, dinosulfon (1097) + TX, dinoterbon (1098) + TX, dioxathion (1 102) + TX, diphenyl sulfone (lUPAC name) (1 103) + TX, disulfiram (alternative name) [CCN] + TX, disulfoton (278) + TX, DNOC (282) + TX, dofenapyn (1 1 13) + TX, doramectin (alternative name) [CCN] + TX, endosulfan (294) + TX, endothion (1 121 ) + TX, EPN (297) + TX, eprinomectin (alternative name) [CCN] + TX, ethion (309) + TX, ethoate-methyl (1 134) + TX, etoxazole (320) + TX, etrimfos (1 142) + TX, fenazaflor (1 147) + TX, fenazaquin (328) + TX, fenbutatin oxide (330) + TX, fenothiocarb (337) + TX, fenpropathrin (342) + TX, fenpyrad (alternative name) + TX, fenpyroximate (345) + TX, fenson (1 157) + TX, fentrifanil (1 161 ) + TX, fenvalerate (349) + TX, fipronil (354) + TX, fluacrypyrim (360) + TX, fluazuron (1 166) + TX, flubenzimine (1 167) + TX, flucycloxuron (366) + TX, flucythrinate (367) + TX, fluenetil (1 169) + TX, flufenoxuron (370) + TX, flumethrin (372) + TX, fluorbenside (1 174) + TX, fluvalinate (1 184) + TX, FMC 1 137 (development code) (1 185) + TX, formetanate (405) + TX, formetanate hydrochloride (405) + TX, formothion (1 192) + TX, formparanate (1 193) + TX, gamma-HCH (430) + TX, glyodin (1205) + TX, halfenprox (424) + TX, heptenophos (432) + TX, hexadecyl cyclopropanecarboxylate (lUPAC/Chemical Abstracts name) (1216) + TX, hexythiazox (441 ) + TX, iodomethane (lUPAC name) (542) + TX, isocarbophos (alternative name) (473) + TX, isopropyl 0-(methoxyaminothiophosphoryl)salicylate (lUPAC name) (473) + TX, ivermectin

(alternative name) [CCN] + TX, jasmolin I (696) + TX, jasmolin II (696) + TX, jodfenphos (1248) + TX, lindane (430) + TX, lufenuron (490) + TX, malathion (492) + TX, malonoben (1254) + TX, mecarbam (502) + TX, mephosfolan (1261 ) + TX, mesulfen (alternative name) [CCN] + TX, methacrifos (1266) + TX, methamidophos (527) + TX, methidathion (529) + TX, methiocarb (530) + TX, methomyl (531 ) + TX, methyl bromide (537) + TX, metolcarb (550) + TX, mevinphos (556) + TX, mexacarbate (1290) + TX, milbemectin (557) + TX, milbemycin oxime (alternative name) [CCN] + TX, mipafox (1293) + TX, monocrotophos (561 ) + TX, morphothion (1300) + TX, moxidectin (alternative name) [CCN] + TX, naled (567) + TX, NC-184 (compound code) + TX, NC- 512 (compound code) + TX, nifluridide (1309) + TX, nikkomycins (alternative name) [CCN] + TX, nitrilacarb (1313) + TX, nitrilacarb 1 :1 zinc chloride complex (1313) + TX, NNI-0101 (compound code) + TX, NNI-0250 (compound code) + TX, omethoate (594) + TX, oxamyl (602) + TX, oxydeprofos (1324) + TX, oxydisulfoton (1325) + TX, pp'-DDT (219) + TX, parathion (615) + TX, permethrin (626) + TX, petroleum oils (alternative name) (628) + TX, phenkapton (1330) + TX, phenthoate (631 ) + TX, phorate (636) + TX, phosalone (637) + TX, phosfolan (1338) + TX, phosmet (638) + TX, phosphamidon (639) + TX, phoxim (642) + TX, pirimiphos-methyl (652) + TX, polychloroterpenes (traditional name) (1347) + TX, polynactins (alternative name) (653) + TX, proclonol (1350) + TX, profenofos (662) + TX, promacyl (1354) + TX, propargite (671 ) + TX, propetamphos (673) + TX, propoxur (678) + TX, prothidathion (1360) + TX, prothoate (1362) + TX, pyrethrin I (696) + TX, pyrethrin II (696) + TX, pyrethrins (696) + TX, pyridaben (699) + TX, pyridaphenthion (701 ) + TX, pyrimidifen (706) + TX, pyrimitate (1370) + TX, quinalphos (71 1 ) + TX, quintiofos (1381 ) + TX, R-1492 (development code) (1382) + TX, RA-17 (development code) (1383) + TX, rotenone (722) + TX, schradan (1389) + TX, sebufos (alternative name) + TX, selamectin (alternative name) [CCN] + TX, SI-0009 (compound code) + TX, sophamide (1402) + TX, spirodiclofen (738) + TX, spiromesifen (739) + TX, SSI-121 (development code) (1404) + TX, sulfiram (alternative name) [CCN] + TX, sulfluramid (750) + TX, sulfotep (753) + TX, sulfur (754) + TX, SZI-121 (development code) (757) + TX, tau-fluvalinate (398) + TX, tebufenpyrad (763) + TX, TEPP (1417) + TX, terbam (alternative name) + TX, tetrachlorvinphos (777) + TX, tetrad ifon (786) + TX, tetranactin (alternative name) (653) + TX, tetrasul (1425) + TX, thiafenox (alternative name) + TX, thiocarboxime (1431 ) + TX, thiofanox (800) + TX, thiometon (801 ) + TX, thioquinox (1436) + TX, thuringiensin (alternative name) [CCN] + TX, triamiphos (1441 ) + TX, triarathene (1443) + TX, triazophos (820) + TX, triazuron (alternative name) + TX, trichlorfon (824) + TX, trifenofos (1455) + TX, trinactin (alternative name) (653) + TX, vamidothion (847) + TX, vaniliprole [CCN] and YI-5302 (compound code) + TX,

an algicide selected from the group of substances consisting of bethoxazin [CCN] + TX, copper dioctanoate (lUPAC name) (170) + TX, copper sulfate (172) + TX, cybutryne [CCN] + TX, dichlone (1052) + TX, dichlorophen (232) + TX, endothal (295) + TX, fentin (347) + TX, hyd rated lime [CCN] + TX, nabam (566) + TX, quinoclamine (714) + TX, quinonamid (1379) + TX, simazine (730) + TX, triphenyltin acetate (lUPAC name) (347) and triphenyltin hydroxide (lUPAC name) (347) + TX,

an anthelmintic selected from the group of substances consisting of abamectin (1 ) + TX, crufomate (101 1 ) + TX, doramectin (alternative name) [CCN] + TX, emamectin (291 ) + TX, emamectin benzoate (291 ) + TX, eprinomectin (alternative name) [CCN] + TX, ivermectin (alternative name) [CCN] + TX, milbemycin oxime (alternative name) [CCN] + TX, moxidectin (alternative name) [CCN] + TX, piperazine [CCN] + TX, selamectin (alternative name) [CCN] + TX, spinosad (737) and thiophanate (1435) + TX,

an avicide selected from the group of substances consisting of chloralose (127) + TX, endrin (1 122) + TX, fenthion (346) + TX, pyridin-4-amine (lUPAC name) (23) and strychnine (745) + TX, a bactericide selected from the group of substances consisting of 1-hydroxy-1 /- -pyridine-2-thione (lUPAC name) (1222) + TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide (lUPAC name) (748) + TX, 8-hydroxyquinoline sulfate (446) + TX, bronopol (97) + TX, copper dioctanoate (lUPAC name) (170) + TX, copper hydroxide (lUPAC name) (169) + TX, cresol [CCN] + TX, dichlorophen (232) + TX, dipyrithione (1 105) + TX, dodicin (1 1 12) + TX, fenaminosulf (1 144) + TX, formaldehyde (404) + TX, hydrargaphen (alternative name) [CCN] + TX, kasugamycin (483) + TX, kasugamycin hydrochloride hydrate (483) + TX, nickel bis(dimethyldithiocarbamate) (lUPAC name) (1308) + TX, nitrapyrin (580) + TX, octhilinone (590) + TX, oxolinic acid (606) + TX, oxytetracycline (61 1 ) + TX, potassium hydroxyquinoline sulfate (446) + TX, probenazole (658) + TX, streptomycin (744) + TX, streptomycin sesquisulfate (744) + TX, tecloftalam (766) + TX, and thiomersal (alternative name) [CCN] + TX,

a biological agent selected from the group of substances consisting of Adoxophyes orana GV

(alternative name) (12) + TX, Agrobacterium radiobacter (alternative name) (13) + TX, Amblyseius spp. (alternative name) (19) + TX, Anagrapha falcifera NPV (alternative name) (28) + TX, Anagrus atomus (alternative name) (29) + TX, Aphelinus abdominalis (alternative name) (33) + TX, Aphidius colemani (alternative name) (34) + TX, Aphidoletes aphidimyza (alternative name) (35) + TX, Autographa californica NPV (alternative name) (38) + TX, Bacillus firmus (alternative name) (48) + TX, Bacillus sphaericus Neide (scientific name) (49) + TX, Bacillus thuringiensis Berliner (scientific name) (51 ) + TX, Bacillus thuringiensis subsp. aizawai (scientific name) (51 ) + TX, Bacillus thuringiensis subsp. israelensis (scientific name) (51 ) + TX, Bacillus thuringiensis subsp. japonensis (scientific name) (51 ) + TX, Bacillus thuringiensis subsp. kurstaki (scientific name) (51 ) + TX, Bacillus thuringiensis subsp. tenebrionis (scientific name) (51 ) + TX, Beauveria bassiana (alternative name) (53) + TX, Beauveria brongniartii (alternative name) (54) + TX, Chrysoperla carnea

(alternative name) (151 ) + TX, Cryptolaemus montrouzieri (alternative name) (178) + TX, Cydia pomonella GV (alternative name) (191 ) + TX, Dacnusa sibirica (alternative name) (212) + TX, Diglyphus isaea (alternative name) (254) + TX, Encarsia formosa (scientific name) (293) + TX, Eretmocerus eremicus (alternative name) (300) + TX, Helicoverpa zea NPV (alternative name) (431 ) + TX, Heterorhabditis bacteriophora and H. megidis (alternative name) (433) + TX, Hippodamia convergens (alternative name) (442) + TX, Leptomastix dactylopii (alternative name) (488) + TX, Macrolophus caliginosus (alternative name) (491 ) + TX, Mamestra brassicae NPV (alternative name) (494) + TX, Metaphycus helvolus (alternative name) (522) + TX, Metarhizium anisopliae var.

acridum (scientific name) (523) + TX, Metarhizium anisopliae var. anisopliae (scientific name) (523) + TX, Neodiprion sertifer NPV and N. lecontei NPV (alternative name) (575) + TX, Orius spp.

(alternative name) (596) + TX, Paecilomyces fumosoroseus (alternative name) (613) + TX,

Phytoseiulus persimilis (alternative name) (644) + TX, Spodoptera exigua multicapsid nuclear polyhedrosis virus (scientific name) (741 ) + TX, Steinernema bibionis (alternative name) (742) + TX, Steinernema carpocapsae (alternative name) (742) + TX, Steinernema feltiae (alternative name) (742) + TX, Steinernema glaseri (alternative name) (742) + TX, Steinernema riobrave (alternative name) (742) + TX, Steinernema riobravis (alternative name) (742) + TX, Steinernema scapterisci (alternative name) (742) + TX, Steinernema spp. (alternative name) (742) + TX, Trichogramma spp. (alternative name) (826) + TX, Typhlodromus occidentalis (alternative name) (844) and Verticillium lecanii (alternative name) (848) + TX,

a soil sterilant selected from the group of substances consisting of iodomethane (lUPAC name) (542) and methyl bromide (537) + TX,

a chemosterilant selected from the group of substances consisting of apholate [CCN] + TX, bisazir (alternative name) [CCN] + TX, busulfan (alternative name) [CCN] + TX, diflubenzuron (250) + TX, dimatif (alternative name) [CCN] + TX, hemel [CCN] + TX, hempa [CCN] + TX, metepa [CCN] + TX, methiotepa [CCN] + TX, methyl apholate [CCN] + TX, morzid [CCN] + TX, penfluron

(alternative name) [CCN] + TX, tepa [CCN] + TX, thiohempa (alternative name) [CCN] + TX, thiotepa (alternative name) [CCN] + TX, tretamine (alternative name) [CCN] and uredepa (alternative name) [CCN] + TX,

an insect pheromone selected from the group of substances consisting of (E)-dec-5-en-1-yl acetate with (E)-dec-5-en-1-ol (lUPAC name) (222) + TX, (E)-tridec-4-en-1-yl acetate (lUPAC name) (829) + TX, (E)-6-methylhept-2-en-4-ol (lUPAC name) (541 ) + TX, (E,Z)-tetradeca-4, 10-dien-1-yl acetate (lUPAC name) (779) + TX, (Z)-dodec-7-en-1-yl acetate (lUPAC name) (285) + TX, (Z)-hexadec-l 1- enal (lUPAC name) (436) + TX, (Z)-hexadec-l 1-en-1-yl acetate (lUPAC name) (437) + TX, (Z)- hexadec-13-en-1 1-yn-1-yl acetate (lUPAC name) (438) + TX, (Z)-icos-13-en-10-one (lUPAC name) (448) + TX, (Z)-tetradec-7-en-1-al (lUPAC name) (782) + TX, (Z)-tetradec-9-en-1-ol (lUPAC name) (783) + TX, (Z)-tetradec-9-en-1-yl acetate (lUPAC name) (784) + TX, (7E,9Z)-dodeca-7,9-dien-1-yl acetate (lUPAC name) (283) + TX, (9Z, 1 1 E)-tetradeca-9, 1 1-dien-1-yl acetate (lUPAC name) (780) + TX, (9Z, 12E)-tetradeca-9, 12-dien-1-yl acetate (lUPAC name) (781 ) + TX, 14-methyloctadec-1-ene (lUPAC name) (545) + TX, 4-methylnonan-5-ol with 4-methylnonan-5-one (lUPAC name) (544) + TX, alpha-multistriatin (alternative name) [CCN] + TX, brevicomin (alternative name) [CCN] + TX, codlelure (alternative name) [CCN] + TX, codlemone (alternative name) (167) + TX, cuelure (alternative name) (179) + TX, disparlure (277) + TX, dodec-8-en-1-yl acetate (lUPAC name) (286) + TX, dodec-9-en-1-yl acetate (lUPAC name) (287) + TX, dodeca-8 + TX, 10-dien-1-yl acetate (lUPAC name) (284) + TX, dominicalure (alternative name) [CCN] + TX, ethyl 4-methyloctanoate (lUPAC name) (317) + TX, eugenol (alternative name) [CCN] + TX, frontalin (alternative name) [CCN] + TX, gossyplure (alternative name) (420) + TX, grandlure (421 ) + TX, grandlure I

(alternative name) (421 ) + TX, grandlure II (alternative name) (421 ) + TX, grandlure III (alternative name) (421 ) + TX, grandlure IV (alternative name) (421 ) + TX, hexalure [CCN] + TX, ipsdienol (alternative name) [CCN] + TX, ipsenol (alternative name) [CCN] + TX, japonilure (alternative name) (481 ) + TX, lineatin (alternative name) [CCN] + TX, litlure (alternative name) [CCN] + TX, looplure (alternative name) [CCN] + TX, medlure [CCN] + TX, megatomoic acid (alternative name) [CCN] + TX, methyl eugenol (alternative name) (540) + TX, muscalure (563) + TX, octadeca-2, 13-dien-1-yl acetate (lUPAC name) (588) + TX, octadeca-3, 13-dien-1-yl acetate (lUPAC name) (589) + TX, orfralure (alternative name) [CCN] + TX, oryctalure (alternative name) (317) + TX, ostramone (alternative name) [CCN] + TX, siglure [CCN] + TX, sordidin (alternative name) (736) + TX, sulcatol (alternative name) [CCN] + TX, tetradec-1 1-en-1-yl acetate (lUPAC name) (785) + TX, trimedlure (839) + TX, trimedlure A (alternative name) (839) + TX, trimedlure B-, (alternative name) (839) + TX, trimedlure B ₂ (alternative name) (839) + TX, trimedlure C (alternative name) (839) and trunc-call (alternative name) [CCN] + TX,

an insect repellent selected from the group of substances consisting of 2-(octylthio)ethanol (lUPAC name) (591 ) + TX, butopyronoxyl (933) + TX, butoxy(polypropylene glycol) (936) + TX, dibutyl adipate (lUPAC name) (1046) + TX, dibutyl phthalate (1047) + TX, dibutyl succinate (lUPAC name) (1048) + TX, diethyltoluamide [CCN] + TX, dimethyl carbate [CCN] + TX, dimethyl phthalate [CCN] + TX, ethyl hexanediol (1 137) + TX, hexamide [CCN] + TX, methoquin-butyl (1276) + TX, methylneodecanamide [CCN] + TX, oxamate [CCN] and picaridin [CCN] + TX,

an insecticide selected from the group of substances consisting of 1-dichloro-1-nitroethane

(lUPAC/Chemical Abstracts name) (1058) + TX, 1 , 1-dichloro-2,2-bis(4-ethylphenyl)ethane (lUPAC name) (1056), + TX, 1 ,2-dichloropropane (lUPAC/Chemical Abstracts name) (1062) + TX, 1 ,2- dichloropropane with 1 ,3-dichloropropene (lUPAC name) (1063) + TX, 1-bromo-2-chloroethane (lUPAC/Chemical Abstracts name) (916) + TX, 2,2,2-trichloro-1-(3,4-dichlorophenyl)ethyl acetate (lUPAC name) (1451 ) + TX, 2,2-dichlorovinyl 2-ethylsulfinylethyl methyl phosphate (lUPAC name) (1066) + TX, 2-(1 ,3-dithiolan-2-yl)phenyl dimethylcarbamate (lUPAC/ Chemical Abstracts name) (1 109) + TX, 2-(2-butoxyethoxy)ethyl thiocyanate (lUPAC/Chemical Abstracts name) (935) + TX, 2- (4,5-dimethyl-1 ,3-dioxolan-2-yl)phenyl methylcarbamate (lUPAC/ Chemical Abstracts name) (1084) + TX, 2-(4-chloro-3,5-xylyloxy)ethanol (lUPAC name) (986) + TX, 2-chlorovinyl diethyl phosphate (lUPAC name) (984) + TX, 2-imidazolidone (lUPAC name) (1225) + TX, 2-isovalerylindan-1 ,3-dione (lUPAC name) (1246) + TX, 2-methyl(prop-2-ynyl)aminophenyl methylcarbamate (lUPAC name) (1284) + TX, 2-thiocyanatoethyl laurate (lUPAC name) (1433) + TX, 3-bromo-1-chloroprop-1-ene

(lUPAC name) (917) + TX, 3-methyl-1-phenylpyrazol-5-yl dimethylcarbamate (lUPAC name) (1283) + TX, 4-methyl(prop-2-ynyl)amino-3,5-xylyl methylcarbamate (lUPAC name) (1285) + TX, 5,5-dimethyl- 3-oxocyclohex-1-enyl dimethylcarbamate (lUPAC name) (1085) + TX, abamectin (1 ) + TX, acephate (2) + TX, acetamiprid (4) + TX, acethion (alternative name) [CCN] + TX, acetoprole [CCN] + TX, acrinathrin (9) + TX, acrylonitrile (lUPAC name) (861 ) + TX, alanycarb (15) + TX, aldicarb (16) + TX, aldoxycarb (863) + TX, aldrin (864) + TX, allethrin (17) + TX, allosamidin (alternative name) [CCN] + TX, allyxycarb (866) + TX, alpha-cypermethrin (202) + TX, alpha- ecdysone (alternative name) [CCN] + TX, aluminium phosphide (640) + TX, amidithion (870) + TX, amidothioate (872) + TX, aminocarb (873) + TX, amiton (875) + TX, amiton hydrogen oxalate (875) + TX, amitraz (24) + TX, anabasine (877) + TX, athidathion (883) + TX, AVI 382 (compound code) + TX, AZ 60541 (compound code) + TX, azadirachtin (alternative name) (41 ) + TX, azamethiphos (42) + TX, azinphos-ethyl (44) + TX, azinphos-methyl (45) + TX, azothoate (889) + TX, Bacillus thuringiensis delta endotoxins (alternative name) (52) + TX, barium hexafluorosilicate (alternative name) [CCN] + TX, barium polysulfide (lUPAC/Chemical Abstracts name) (892) + TX, barthrin [CCN] + TX, Bayer 22/190 (development code) (893) + TX, Bayer 22408 (development code) (894) + TX, bendiocarb (58) + TX, benfuracarb (60) + TX, bensultap (66) + TX, beta- cyfluthrin (194) + TX, beta-cypermethrin (203) + TX, bifenthrin (76) + TX, bioallethrin (78) + TX, bioallethrin S-cyclopentenyl isomer (alternative name) (79) + TX, bioethanomethrin [CCN] + TX, biopermethrin (908) + TX, bioresmethrin (80) + TX, bis(2-chloroethyl) ether (lUPAC name) (909) + TX, bistrifluron (83) + TX, borax (86) + TX, brofenvalerate (alternative name) + TX, bromfenvinfos (914) + TX, bromocyclen (918) + TX, bromo-DDT (alternative name) [CCN] + TX, bromophos (920) + TX, bromophos-ethyl (921 ) + TX, bufencarb (924) + TX, buprofezin (99) + TX, butacarb (926) + TX, butathiofos (927) + TX, butocarboxim (103) + TX, butonate (932) + TX,

butoxycarboxim (104) + TX, butylpyridaben (alternative name) + TX, cadusafos (109) + TX, calcium arsenate [CCN] + TX, calcium cyanide (444) + TX, calcium polysulfide (lUPAC name) (1 1 1 ) + TX, camphechlor (941 ) + TX, carbanolate (943) + TX, carbaryl (1 15) + TX, carbofuran (1 18) + TX, carbon disulfide (lUPAC/Chemical Abstracts name) (945) + TX, carbon tetrachloride (lUPAC name) (946) + TX, carbophenothion (947) + TX, carbosulfan (1 19) + TX, cartap (123) + TX, cartap hydrochloride (123) + TX, cevadine (alternative name) (725) + TX, chlorbicyclen (960) + TX, chlordane (128) + TX, chlordecone (963) + TX, chlordimeform (964) + TX, chlordimeform hydrochloride (964) + TX, chlorethoxyfos (129) + TX, chlorfenapyr (130) + TX, chlorfenvinphos (131 ) + TX, chlorfluazuron (132) + TX, chlormephos (136) + TX, chloroform [CCN] + TX, chloropicrin (141 ) + TX, chlorphoxim (989) + TX, chlorprazophos (990) + TX, chlorpyrifos (145) + TX, chlorpyrifos-methyl (146) + TX, chlorthiophos (994) + TX, chromafenozide (150) + TX, cinerin l (696) + TX, cinerin II (696) + TX, cinerins (696) + TX, cis-resmethrin (alternative name) + TX, cismethrin (80) + TX, clocythrin (alternative name) + TX, cloethocarb (999) + TX, closantel (alternative name) [CCN] + TX, clothianidin (165) + TX, copper acetoarsenite [CCN] + TX, copper arsenate [CCN] + TX, copper oleate [CCN] + TX, coumaphos (174) + TX, coumithoate (1006) + TX, crotamiton (alternative name) [CCN] + TX, crotoxyphos (1010) + TX, crufomate (101 1 ) + TX, cryolite (alternative name) (177) + TX, CS 708 (development code) (1012) + TX, cyanofenphos (1019) + TX, cyanophos (184) + TX, cyanthoate (1020) + TX, cyclethrin [CCN] + TX,

cycloprothrin (188) + TX, cyfluthrin (193) + TX, cyhalothrin (196) + TX, cypermethrin (201 ) + TX, cyphenothrin (206) + TX, cyromazine (209) + TX, cythioate (alternative name) [CCN] + TX, d- limonene (alternative name) [CCN] + TX, cf-tetramethrin (alternative name) (788) + TX, DAEP (1031 ) + TX, dazomet (216) + TX, DDT (219) + TX, decarbofu ran (1034) + TX, deltamethrin (223) + TX, demephion (1037) + TX, demephion-0 (1037) + TX, demephion-S (1037) + TX, demeton (1038) + TX, demeton-methyl (224) + TX, demeton-0 (1038) + TX, demeton-O-methyl (224) + TX, demeton-S (1038) + TX, demeton-S-methyl (224) + TX, demeton-S-methylsulphon (1039) + TX, diafenthiuron (226) + TX, dialifos (1042) + TX, diamidafos (1044) + TX, diazinon (227) + TX, dicapthon (1050) + TX, dichlofenthion (1051 ) + TX, dichlorvos (236) + TX, dicliphos (alternative name) + TX, dicresyl (alternative name) [CCN] + TX, dicrotophos (243) + TX, dicyclanil (244) + TX, dieldrin (1070) + TX, diethyl 5-methylpyrazol-3-yl phosphate (lUPAC name) (1076) + TX, diflubenzuron (250) + TX, dilor (alternative name) [CCN] + TX, dimefluthrin [CCN] + TX, dimefox (1081 ) + TX, dimetan (1085) + TX, dimethoate (262) + TX, dimethrin (1083) + TX,

dimethylvinphos (265) + TX, dimetilan (1086) + TX, dinex (1089) + TX, dinex-diclexine (1089) + TX, dinoprop (1093) + TX, dinosam (1094) + TX, dinoseb (1095) + TX, dinotefuran (271 ) + TX, diofenolan (1099) + TX, dioxabenzofos (1 100) + TX, dioxacarb (1 101 ) + TX, dioxathion (1 102) + TX, disulfoton (278) + TX, dithicrofos (1 108) + TX, DNOC (282) + TX, doramectin (alternative name) [CCN] + TX, DSP (1 1 15) + TX, ecdysterone (alternative name) [CCN] + TX, El 1642 (development code) (1 1 18) + TX, emamectin (291 ) + TX, emamectin benzoate (291 ) + TX, EMPC (1 120) + TX, empenthrin (292) + TX, endosulfan (294) + TX, endothion (1 121 ) + TX, endrin (1 122) + TX, EPBP (1 123) + TX, EPN (297) + TX, epofenonane (1 124) + TX, eprinomectin (alternative name) [CCN] + TX, esfenvalerate (302) + TX, etaphos (alternative name) [CCN] + TX, ethiofencarb (308) + TX, ethion (309) + TX, ethiprole (310) + TX, ethoate-m ethyl (1 134) + TX, ethoprophos (312) + TX, ethyl formate (lUPAC name) [CCN] + TX, ethyl-DDD (alternative name) (1056) + TX, ethylene dibromide (316) + TX, ethylene dichloride (chemical name) (1 136) + TX, ethylene oxide [CCN] + TX, etofenprox (319) + TX, etrimfos (1 142) + TX, EXD (1 143) + TX, famphur (323) + TX, fenamiphos (326) + TX, fenazaflor (1 147) + TX, fenchlorphos (1 148) + TX, fenethacarb (1 149) + TX, fenfluthrin (1 150) + TX, fenitrothion (335) + TX, fenobucarb (336) + TX, fenoxacrim (1 153) + TX, fenoxycarb (340) + TX, fenpirithrin (1 155) + TX, fenpropathrin (342) + TX, fenpyrad (alternative name) + TX, fensulfothion (1 158) + TX, fenthion (346) + TX, fenthion-ethyl [CCN] + TX, fenvalerate (349) + TX, fipronil (354) + TX, flonicamid (358) + TX, flubendiamide (CAS. Reg. No.: 272451-65-7) + TX, flucofuron (1 168) + TX, flucycloxuron (366) + TX,

flucythrinate (367) + TX, fluenetil (1 169) + TX, flufenerim [CCN] + TX, flufenoxuron (370) + TX, flufenprox (1 171 ) + TX, flumethrin (372) + TX, fluvalinate (1 184) + TX, FMC 1 137 (development code) (1 185) + TX, fonofos (1 191 ) + TX, formetanate (405) + TX, formetanate hydrochloride (405) + TX, formothion (1 192) + TX, formparanate (1 193) + TX, fosmethilan (1 194) + TX, fospirate (1 195) + TX, fosthiazate (408) + TX, fosthietan (1 196) + TX, furathiocarb (412) + TX, furethrin (1200) + TX, gamma-cyhalothrin (197) + TX, gamma-HCH (430) + TX, guazatine (422) + TX, guazatine acetates (422) + TX, GY-81 (development code) (423) + TX, halfenprox (424) + TX, halofenozide (425) + TX, HCH (430) + TX, HEOD (1070) + TX, heptachlor (121 1 ) + TX, heptenophos (432) + TX, heterophos [CCN] + TX, hexaflumuron (439) + TX, HHDN (864) + TX, hydramethylnon (443) + TX, hydrogen cyanide (444) + TX, hydroprene (445) + TX, hyquincarb (1223) + TX, imidacloprid (458) + TX, imiprothrin (460) + TX, indoxacarb (465) + TX,

iodomethane (lUPAC name) (542) + TX, IPSP (1229) + TX, isazofos (1231 ) + TX, isobenzan (1232) + TX, isocarbophos (alternative name) (473) + TX, isodrin (1235) + TX, isofenphos (1236) + TX, isolane (1237) + TX, isoprocarb (472) + TX, isopropyl 0-(methoxy- aminothiophosphoryl)salicylate (lUPAC name) (473) + TX, isoprothiolane (474) + TX, isothioate (1244) + TX, isoxathion (480) + TX, ivermectin (alternative name) [CCN] + TX, jasmolin I (696) + TX, jasmolin II (696) + TX, jodfenphos (1248) + TX, juvenile hormone I (alternative name) [CCN] + TX, juvenile hormone II (alternative name) [CCN] + TX, juvenile hormone III (alternative name) [CCNj + TX, kelevan (1249) + TX, kinoprene (484) + TX, lambda-cyhalothrin (198) + TX, lead arsenate [CCN] + TX, lepimectin (CCN) + TX, leptophos (1250) + TX, lindane (430) + TX, lirimfos (1251 ) + TX, lufenuron (490) + TX, lythidathion (1253) + TX, m-cumenyl methylcarbamate (lUPAC name) (1014) + TX, magnesium phosphide (lUPAC name) (640) + TX, malathion (492) + TX, malonoben (1254) + TX, mazidox (1255) + TX, mecarbam (502) + TX, mecarphon (1258) + TX, menazon (1260) + TX, mephosfolan (1261 ) + TX, mercurous chloride (513) + TX, mesulfenfos (1263) + TX, metaflumizone (CCN) + TX, metam (519) + TX, metam-potassium (alternative name) (519) + TX, metam-sodium (519) + TX, methacrifos (1266) + TX, methamidophos (527) + TX, methanesulfonyl fluoride (lUPAC/Chemical Abstracts name) (1268) + TX, methidathion (529) + TX, methiocarb (530) + TX, methocrotophos (1273) + TX, methomyl (531 ) + TX, methoprene (532) + TX, methoquin-butyl (1276) + TX, methothrin (alternative name) (533) + TX, methoxychlor (534) + TX, methoxyfenozide (535) + TX, methyl bromide (537) + TX, methyl isothiocyanate (543) + TX, methylchloroform (alternative name) [CCN] + TX, methylene chloride [CCN] + TX, metofluthrin [CCN] + TX, metolcarb (550) + TX, metoxadiazone (1288) + TX, mevinphos (556) + TX, mexacarbate (1290) + TX, milbemectin (557) + TX, milbemycin oxime (alternative name) [CCN] + TX, mipafox (1293) + TX, mirex (1294) + TX, monocrotophos (561 ) + TX, morphothion (1300) + TX, moxidectin (alternative name) [CCN] + TX, naftalofos (alternative name) [CCN] + TX, naled (567) + TX, naphthalene (lUPAC/Chemical Abstracts name) (1303) + TX, NC-170 (development code) (1306) + TX, NC-184 (compound code) + TX, nicotine (578) + TX, nicotine sulfate (578) + TX, nifluridide (1309) + TX, nitenpyram (579) + TX, nithiazine (131 1 ) + TX, nitrilacarb (1313) + TX, nitrilacarb 1 :1 zinc chloride complex (1313) + TX, NNI-0101 (compound code) + TX, NNI-0250 (compound code) + TX, nornicotine (traditional name) (1319) + TX, novaluron (585) + TX, noviflumuron (586) + TX, 0-5-dichloro-4-iodophenyl O-ethyl ethylphosphonothioate (lUPAC name) (1057) + TX, 0,0-diethyl 0-4-methyl-2-oxo-2A -chromen-7-yl phosphorothioate (lUPAC name) (1074) + TX, Ο,Ο-diethyl 0-6-methyl-2-propylpyrimidin-4-yl phosphorothioate (lUPAC name) (1075) + TX, 0,0, 0',Ο'-tetrapropyl dithiopyrophosphate (lUPAC name) (1424) + TX, oleic acid (lUPAC name) (593) + TX, omethoate (594) + TX, oxamyl (602) + TX, oxydemeton-methyl (609) + TX, oxydeprofos (1324) + TX, oxydisulfoton (1325) + TX, pp'-DDT (219) + TX, para-dichlorobenzene [CCN] + TX, parathion (615) + TX, parathion-methyl (616) + TX, penfluron (alternative name) [CCN] + TX, pentachlorophenol (623) + TX, pentachlorophenyl laurate (lUPAC name) (623) + TX, permethrin (626) + TX, petroleum oils (alternative name) (628) + TX, PH 60-38 (development code) (1328) + TX, phenkapton (1330) + TX, phenothrin (630) + TX, phenthoate (631 ) + TX, phorate (636) + TX, phosalone (637) + TX, phosfolan (1338) + TX, phosmet (638) + TX, phosnichlor

(1339) + TX, phosphamidon (639) + TX, phosphine (lUPAC name) (640) + TX, phoxim (642) + TX, phoxim-methyl (1340) + TX, pirimetaphos (1344) + TX, pirimicarb (651 ) + TX, pirimiphos-ethyl (1345) + TX, pirimiphos-methyl (652) + TX, polychlorodicyclopentadiene isomers (lUPAC name) (1346) + TX, polychloroterpenes (traditional name) (1347) + TX, potassium arsenite [CCN] + TX, potassium thiocyanate [CCN] + TX, prallethrin (655) + TX, precocene I (alternative name) [CCN] + TX, precocene II (alternative name) [CCN] + TX, precocene III (alternative name) [CCN] + TX, primidophos (1349) + TX, profenofos (662) + TX, profluthrin [CCN] + TX, promacyl (1354) + TX, promecarb (1355) + TX, propaphos (1356) + TX, propetamphos (673) + TX, propoxur (678) + TX, prothidathion (1360) + TX, prothiofos (686) + TX, prothoate (1362) + TX, protrifenbute [CCN] + TX, pymetrozine (688) + TX, pyraclofos (689) + TX, pyrazophos (693) + TX, pyresmethrin (1367) + TX, pyrethrin I (696) + TX, pyrethrin II (696) + TX, pyrethrins (696) + TX, pyridaben (699) + TX, pyridalyl (700) + TX, pyridaphenthion (701 ) + TX, pyrimidifen (706) + TX, pyrimitate (1370) + TX, pyriproxyfen (708) + TX, quassia (alternative name) [CCN] + TX, quinalphos (71 1 ) + TX, quinalphos-methyl (1376) + TX, quinothion (1380) + TX, quintiofos (1381 ) + TX, R-1492

(development code) (1382) + TX, rafoxanide (alternative name) [CCN] + TX, resmethrin (719) + TX, rotenone (722) + TX, RU 15525 (development code) (723) + TX, RU 25475 (development code) (1386) + TX, ryania (alternative name) (1387) + TX, ryanodine (traditional name) (1387) + TX, sabad ilia (alternative name) (725) + TX, schradan (1389) + TX, sebufos (alternative name) + TX, selamectin (alternative name) [CCN] + TX, SI-0009 (compound code) + TX, SI-0205 (compound code) + TX, SI-0404 (compound code) + TX, SI-0405 (compound code) + TX, silafluofen (728) + TX, SN 72129 (development code) (1397) + TX, sodium arsenite [CCN] + TX, sodium cyanide (444) + TX, sodium fluoride (lUPAC/Chemical Abstracts name) (1399) + TX, sodium

hexafluorosilicate (1400) + TX, sodium pentachlorophenoxide (623) + TX, sodium selenate (lUPAC name) (1401 ) + TX, sodium thiocyanate [CCN] + TX, sophamide (1402) + TX, spinosad (737) + TX, spiromesifen (739) + TX, spirotetrmat (CCN) + TX, sulcofuron (746) + TX, sulcofuron-sodium (746) + TX, sulfluramid (750) + TX, sulfotep (753) + TX, sulfuryl fluoride (756) + TX, sulprofos (1408) + TX, tar oils (alternative name) (758) + TX, tau-fluvalinate (398) + TX, tazimcarb (1412) + TX, TDE (1414) + TX, tebufenozide (762) + TX, tebufenpyrad (763) + TX, tebupirimfos (764) + TX, teflubenzuron (768) + TX, tefluthrin (769) + TX, temephos (770) + TX, TEPP (1417) + TX, terallethrin (1418) + TX, terbam (alternative name) + TX, terbufos (773) + TX, tetrachloroethane [CCN] + TX, tetrachlorvinphos (777) + TX, tetramethrin (787) + TX, theta-cypermethrin (204) + TX, thiacloprid (791 ) + TX, thiafenox (alternative name) + TX, thiamethoxam (792) + TX, thicrofos (1428) + TX, thiocarboxime (1431 ) + TX, thiocyclam (798) + TX, thiocyclam hydrogen oxalate

(798) + TX, thiodicarb (799) + TX, thiofanox (800) + TX, thiometon (801 ) + TX, thionazin (1434) + TX, thiosultap (803) + TX, thiosultap-sodium (803) + TX, thuringiensin (alternative name) [CCN] + TX, tolfenpyrad (809) + TX, tralomethrin (812) + TX, transfluthrin (813) + TX, transpermethrin (1440) + TX, triamiphos (1441 ) + TX, triazamate (818) + TX, triazophos (820) + TX, triazuron (alternative name) + TX, trichlorfon (824) + TX, trichlormetaphos-3 (alternative name) [CCN] + TX, trichloronat (1452) + TX, trifenofos (1455) + TX, triflumuron (835) + TX, trimethacarb (840) + TX, triprene (1459) + TX, vamidothion (847) + TX, vaniliprole [CCN] + TX, veratridine (alternative name) (725) + TX, veratrine (alternative name) (725) + TX, XMC (853) + TX, xylylcarb (854) + TX, YI-5302 (compound code) + TX, zeta-cypermethrin (205) + TX, zetamethrin (alternative name) + TX, zinc phosphide (640) + TX, zolaprofos (1469) and ZXI 8901 (development code) (858) + TX, cyantraniliprole [736994-63-19 + TX, chlorantraniliprole [500008-45-7] + TX, cyenopyrafen [560121- 52-0] + TX, cyflumetofen [400882-07-7] + TX, pyrifluquinazon [337458-27-2] + TX, spinetoram

[187166-40-1 + 187166-15-0] + TX, spirotetramat [203313-25-1] + TX, sulfoxaflor [946578-00-3] + TX, flufiprole [704886-18-0] + TX, meperfluthrin [915288-13-0] + TX, tetramethylfluthrin [84937-88-2] + TX, triflumezopyrim (disclosed in WO 2012/0921 15) + TX,

a molluscicide selected from the group of substances consisting of bis(tributyltin) oxide (lUPAC name) (913) + TX, bromoacetamide [CCN] + TX, calcium arsenate [CCN] + TX, cloethocarb (999) + TX, copper acetoarsenite [CCN] + TX, copper sulfate (172) + TX, fentin (347) + TX, ferric phosphate (lUPAC name) (352) + TX, metaldehyde (518) + TX, methiocarb (530) + TX, niclosamide (576) + TX, niclosamide-olamine (576) + TX, pentachlorophenol (623) + TX, sodium pentachlorophenoxide (623) + TX, tazimcarb (1412) + TX, thiodicarb (799) + TX, tributyltin oxide (913) + TX, trifenmorph (1454) + TX, trimethacarb (840) + TX, triphenyltin acetate (lUPAC name) (347) and triphenyltin hydroxide (lUPAC name) (347) + TX, pyriprole [394730-71-3] + TX,

a nematicide selected from the group of substances consisting of AKD-3088 (compound code) + TX, 1 ,2-dibromo-3-chloropropane (lUPAC/Chemical Abstracts name) (1045) + TX, 1 ,2-dichloropropane (lUPAC/ Chemical Abstracts name) (1062) + TX, 1 ,2-dichloropropane with 1 ,3-dichloropropene (lUPAC name) (1063) + TX, 1 ,3-dichloropropene (233) + TX, 3,4-dichlorotetrahydrothiophene 1 ,1- dioxide (lUPAC/Chemical Abstracts name) (1065) + TX, 3-(4-chlorophenyl)-5-methylrhodanine

(lUPAC name) (980) + TX, 5-methyl-6-thioxo-1 ,3,5-thiadiazinan-3-ylacetic acid (lUPAC name) (1286) + TX, 6-isopentenylaminopurine (alternative name) (210) + TX, abamectin (1 ) + TX, acetoprole [CCN] + TX, alanycarb (15) + TX, aldicarb (16) + TX, aldoxycarb (863) + TX, AZ 60541

(compound code) + TX, benclothiaz [CCN] + TX, benomyl (62) + TX, butylpyridaben (alternative name) + TX, cadusafos (109) + TX, carbofuran (1 18) + TX, carbon disulfide (945) + TX, carbosulfan (1 19) + TX, chloropicrin (141 ) + TX, chlorpyrifos (145) + TX, cloethocarb (999) + TX, cytokinins (alternative name) (210) + TX, dazomet (216) + TX, DBCP (1045) + TX, DCIP (218) + TX, diamidafos (1044) + TX, dichlofenthion (1051 ) + TX, dicliphos (alternative name) + TX, dimethoate (262) + TX, doramectin (alternative name) [CCN] + TX, emamectin (291 ) + TX, emamectin benzoate (291 ) + TX, eprinomectin (alternative name) [CCN] + TX, ethoprophos (312) + TX, ethylene dibromide (316) + TX, fenamiphos (326) + TX, fenpyrad (alternative name) + TX, fensulfothion (1 158) + TX, fosthiazate (408) + TX, fosthietan (1 196) + TX, furfural (alternative name) [CCN] + TX, GY-81 (development code) (423) + TX, heterophos [CCN] + TX, iodomethane (lUPAC name) (542) + TX, isamidofos (1230) + TX, isazofos (1231 ) + TX, ivermectin (alternative name) [CCN] + TX, kinetin (alternative name) (210) + TX, mecarphon (1258) + TX, metam (519) + TX, metam-potassium (alternative name) (519) + TX, metam-sodium (519) + TX, methyl bromide (537) + TX, methyl isothiocyanate (543) + TX, milbemycin oxime (alternative name) [CCN] + TX, moxidectin (alternative name) [CCN] + TX, Myrothecium verrucaria composition (alternative name) (565) + TX, NC-184 (compound code) + TX, oxamyl (602) + TX, phorate (636) + TX,

phosphamidon (639) + TX, phosphocarb [CCN] + TX, sebufos (alternative name) + TX, selamectin (alternative name) [CCN] + TX, spinosad (737) + TX, terbam (alternative name) + TX, terbufos (773) + TX, tetrachlorothiophene (lUPAC/ Chemical Abstracts name) (1422) + TX, thiafenox (alternative name) + TX, thionazin (1434) + TX, triazophos (820) + TX, triazuron (alternative name) + TX, xylenols [CCN] + TX, YI-5302 (compound code) and zeatin (alternative name) (210) + TX, fluensulfone [318290-98-1] + TX,

a nitrification inhibitor selected from the group of substances consisting of potassium ethylxanthate [CCN] and nitrapyrin (580) + TX,

a plant activator selected from the group of substances consisting of acibenzolar (6) + TX, acibenzolar-S-methyl (6) + TX, probenazole (658) and Reynoutria sachalinensis extract (alternative name) (720) + TX,

a rodenticide selected from the group of substances consisting of 2-isovalerylindan-1 ,3-dione (lUPAC name) (1246) + TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide (lUPAC name) (748) + TX, alpha- chlorohydrin [CCN] + TX, aluminium phosphide (640) + TX, antu (880) + TX, arsenous oxide (882) + TX, barium carbonate (891 ) + TX, bisthiosemi (912) + TX, brodifacoum (89) + TX,

bromadiolone (91 ) + TX, bromethalin (92) + TX, calcium cyanide (444) + TX, chloralose (127) + TX, chlorophacinone (140) + TX, cholecalciferol (alternative name) (850) + TX, coumachlor (1004) + TX, coumafuryl (1005) + TX, coumatetralyl (175) + TX, crimidine (1009) + TX, difenacoum (246) + TX, difethialone (249) + TX, diphacinone (273) + TX, ergocalciferol (301 ) + TX, flocoumafen (357) + TX, fluoroacetamide (379) + TX, flupropadine (1 183) + TX, flupropadine hydrochloride (1 183) + TX, gamma-HCH (430) + TX, HCH (430) + TX, hydrogen cyanide (444) + TX, iodomethane (lUPAC name) (542) + TX, lindane (430) + TX, magnesium phosphide (lUPAC name) (640) + TX, methyl bromide (537) + TX, norbormide (1318) + TX, phosacetim (1336) + TX, phosphine (lUPAC name) (640) + TX, phosphorus [CCN] + TX, pindone (1341 ) + TX, potassium arsenite [CCN] + TX, pyrinuron (1371 ) + TX, scilliroside (1390) + TX, sodium arsenite [CCN] + TX, sodium cyanide (444) + TX, sodium fluoroacetate (735) + TX, strychnine (745) + TX, thallium sulfate [CCN] + TX, warfarin (851 ) and zinc phosphide (640) + TX,

a synergist selected from the group of substances consisting of 2-(2-butoxyethoxy)ethyl piperonylate (lUPAC name) (934) + TX, 5-(1 ,3-benzodioxol-5-yl)-3-hexylcyclohex-2-enone (lUPAC name) (903) + TX, farnesol with nerolidol (alternative name) (324) + TX, MB-599 (development code) (498) + TX, MGK 264 (development code) (296) + TX, piperonyl butoxide (649) + TX, piprotal (1343) + TX, propyl isomer (1358) + TX, S421 (development code) (724) + TX, sesamex (1393) + TX, sesasmolin (1394) and sulfoxide (1406) + TX,

an animal repellent selected from the group of substances consisting of anthraquinone (32) + TX, chloralose (127) + TX, copper naphthenate [CCN] + TX, copper oxychloride (171 ) + TX, diazinon (227) + TX, dicyclopentadiene (chemical name) (1069) + TX, guazatine (422) + TX, guazatine acetates (422) + TX, methiocarb (530) + TX, pyridin-4-amine (lUPAC name) (23) + TX, thiram (804) + TX, trimethacarb (840) + TX, zinc naphthenate [CCN] and ziram (856) + TX,

a virucide selected from the group of substances consisting of imanin (alternative name) [CCN] and ribavirin (alternative name) [CCN] + TX,

a wound protectant selected from the group of substances consisting of mercuric oxide (512) + TX, octhilinone (590) and thiophanate-methyl (802) + TX, and biologically active compounds selected from the group consisting of azaconazole (60207-31-0] + TX, bitertanol [70585-36-3] + TX, bromuconazole [1 16255-48-2] + TX, cyproconazole [94361-06-5] + TX, difenoconazole [1 19446-68-3] + TX, diniconazole [83657-24-3] + TX, epoxiconazole

[106325-08-0] + TX, fenbuconazole [1 14369-43-6] + TX, fluquinconazole [136426-54-5] + TX, flusilazole [85509-19-9] + TX, flutriafol [76674-21-0] + TX, hexaconazole [79983-71-4] + TX, imazalil [35554-44-0] + TX, imibenconazole [86598-92-7] + TX, ipconazole [125225-28-7] + TX, metconazole [1251 16-23-6] + TX, myclobutanil [88671-89-0] + TX, pefurazoate [101903-30-4] + TX, penconazole [66246-88-6] + TX, prothioconazole [178928-70-6] + TX, pyrifenox [88283-41-4] + TX, prochloraz [67747-09-5] + TX, propiconazole [60207-90-1] + TX, simeconazole [149508-90-7] + TX, tebuconazole [107534-96-3] + TX, tetraconazole [1 12281-77-3] + TX, triadimefon [43121-43-3] + TX, triad imenol [55219-65-3] + TX, triflumizole [99387-89-0] + TX, triticonazole [131983-72-7] + TX, ancymidol [12771-68-5] + TX, fenarimol [60168-88-9] + TX, nuarimol [63284-71-9] + TX, bupirimate [41483-43-6] + TX, dimethirimol [5221-53-4] + TX, ethirimol [23947-60-6] + TX, dodemorph [1593-77-7] + TX, fenpropidine [67306-00-7] + TX, fenpropimorph [67564-91-4] + TX, spiroxamine [1 18134-30-8] + TX, tridemorph [81412-43-3] + TX, cyprodinil [121552-61-2] + TX, mepanipyrim [1 10235-47-7] + TX, pyrimethanil [531 12-28-0] + TX, fenpiclonil [74738-17-3] + TX, fludioxonil [131341-86-1] + TX, benalaxyl [71626-1 1-4] + TX, furalaxyl [57646-30-7] + TX, meta- laxyl [57837-19-1] + TX, R-metalaxyl [70630-17-0] + TX, ofurace [58810-48-3] + TX, oxadixyl [77732-09-3] + TX, benomyl [17804-35-2] + TX, carbendazim [10605-21-7] + TX, debacarb

[62732-91-6] + TX, fuberidazole [3878-19-1] + TX, thiabendazole [148-79-8] + TX, chlozolinate [84332-86-5] + TX, dichlozoline [24201-58-9] + TX, iprodione [36734-19-7] + TX, myclozoline [54864-61-8] + TX, procymidone [32809-16-8] + TX, vinclozoline [50471-44-8] + TX, boscalid [188425-85-6] + TX, carboxin [5234-68-4] + TX, fenfuram [24691-80-3] + TX, flutolanil [66332-96- 5] + TX, mepronil [55814-41-0] + TX, oxycarboxin [5259-88-1] + TX, penthiopyrad [183675-82-3] + TX, thifluzamide [130000-40-7] + TX, guazatine [108173-90-6] + TX, dodine [2439-10-3] [1 12-65- 2] (free base) + TX, iminoctadine [13516-27-3] + TX, azoxystrobin [131860-33-8] + TX, dimoxystrobin [149961-52-4] + TX, enestroburin {Proc. BCPC, Int. Congr., Glasgow, 2003, 1 , 93} + TX, fluoxastrobin [361377-29-9] + TX, kresoxim-methyl [143390-89-0] + TX, metominostrobin [133408-50-1] + TX, trifloxystrobin [141517-21-7] + TX, orysastrobin [248593-16-0] + TX, picoxystrobin [1 17428-22-5] + TX, pyraclostrobin [175013-18-0] + TX, ferbam [14484-64-1] + TX, mancozeb [8018-01-7] + TX, maneb [12427-38-2] + TX, metiram [9006-42-2] + TX, propineb [12071-83-9] + TX, thiram [137-26-8] + TX, zineb [12122-67-7] + TX, ziram [137-30-4] + TX, captafol [2425-06-1] + TX, captan [133-06-2] + TX, dichlofluanid [1085-98-9] + TX, fluoroimide [41205-21-4] + TX, folpet [133-07-3 ] + TX, tolylfluanid [731-27-1] + TX, bordeaux mixture [801 1- 63-0] + TX, copperhydroxid [20427-59-2] + TX, copperoxychlorid [1332-40-7] + TX, coppersulfat [7758-98-7] + TX, copperoxid [1317-39-1] + TX, mancopper [53988-93-5] + TX, oxine-copper [10380-28-6] + TX, dinocap [131-72-6] + TX, nitrothal-isopropyl [10552-74-6] + TX, edifenphos [17109-49-8] + TX, iprobenphos [26087-47-8] + TX, isoprothiolane [50512-35-1] + TX, phosdiphen [36519-00-3] + TX, pyrazophos [13457-18-6] + TX, tolclofos-methyl [57018-04-9] + TX, acibenzo- lar-S-methyl [135158-54-2] + TX, anilazine [101-05-3] + TX, benthiavalicarb [413615-35-7] + TX, blasticidin-S [2079-00-7] + TX, chinomethionat [2439-01-2] + TX, chloroneb [2675-77-6] + TX, chlorothalonil [1897-45-6] + TX, cyflufenamid [180409-60-3] + TX, cymoxanil [57966-95-7] + TX, dichlone [117-80-6] + TX, diclocymet [139920-32-4] + TX, diclomezine [62865-36-5] + TX, dicloran [99-30-9] + TX, diethofencarb [87130-20-9] + TX, dimethomorph [110488-70-5] + TX, SYP-LI90 (Flumorph) [211867-47-9] + TX, dithianon [3347-22-6] + TX, ethaboxam [162650-77-3] + TX, etridiazole [2593-15-9] + TX, famoxadone [131807-57-3] + TX, fenamidone [161326-34-7] + TX, fenoxanil [115852-48-7] + TX, fentin [668-34-8] + TX, ferimzone [89269-64-7] + TX, fluazinam [79622-59-6] + TX, fluopicolide [2391 10-15-7] + TX, flusulfamide [106917-52-6] + TX, fenhexamid [126833-17-8] + TX, fosetyl-aluminium [39148-24-8] + TX, hymexazol [10004-44-1] + TX, iprovalicarb [140923-17-7] + TX, IKF-916 (Cyazofamid) [120116-88-3] + TX, kasugamycin [6980-18- 3] + TX, methasulfocarb [66952-49-6] + TX, metrafenone [220899-03-6] + TX, pencycuron [66063- 05-6] + TX, phthalide [27355-22-2] + TX, polyoxins [1 1 1 13-80-7] + TX, probenazole [27605-76-1] + TX, propamocarb [25606-41-1] + TX, proquinazid [189278-12-4] + TX, pyroquilon [57369-32-1] + TX, quinoxyfen [124495-18-7] + TX, quintozene [82-68-8] + TX, sulfur [7704-34-9] + TX, tiadinil [223580-51-6] + TX, triazoxide [72459-58-6] + TX, tricyclazole [41814-78-2] + TX, triforine [26644- 46-2] + TX, validamycin [37248-47-8] + TX, zoxamide (RH7281 ) [156052-68-5] + TX,

mandipropamid [374726-62-2] + TX, isopyrazam [881685-58-1] + TX, sedaxane [874967-67-6] + TX, 3-difluoromethyl-1-methyl-1 H-pyrazole-4-carboxylic acid (9-dichloromethylene-1 ,2,3,4-tetrahydro-1 ,4- methano-naphthalen-5-yl)-amide (dislosed in WO 2007/048556) + TX, 3-difluoromethyl-1-methyl-1 H- pyrazole-4-carboxylic acid (3',4',5'-trifluoro-biphenyl-2-yl)-amide (disclosed in WO 2006/087343) + TX, [(3S,4R,4aR,6S,6aS, 12R, 12aS, 12bS)-3-[(cyclopropylcarbonyl)oxy]- 1 _I 3,4,4a _I 5 _> 6,6a, 12,12a _> 12b- decahydro-6, 12-dihydroxy-4,6a,12b-trimethyl-^

e]pyran-4-yl]methyl- cyclopropanecarboxylate [915972-17-7] + TX and 1 ,3,5-trimethyl-N-(2-methyl-1-oxopropyl)-N-[3-(2- methylpropyl)-4-[2,2,2-trifluoro-1-methoxy-1-(trifluoromethy l)ethyl]phenyl]-1 H-pyrazole-4-carboxam [926914-55-8] + TX.

The references in brackets behind the active ingredients, e.g. [3878-19-1] refer to the Chemical Abstracts Registry number. The above described mixing partners are known. Where the active ingredients are included in "The Pesticide Manual" [The Pesticide Manual - A World Compendium; Thirteenth Edition; Editor: C. D. S. TomLin; The British Crop Protection Council], they are described therein under the entry number given in round brackets hereinabove for the particular compound; for example, the compound "abamectin" is described under entry number (1 ). Where "[CCN]" is added hereinabove to the particular compound, the compound in question is included in the "Compendium of Pesticide Common Names", which is accessible on the internet [A. Wood; Compendium of Pesticide Common Names, Copyright © 1995-2004]; for example, the compound "acetoprole" is described under the internet address http://www.alanwood.net/pesticides/acetoprole.html. Most of the active ingredients described above are referred to hereinabove by a so-called "common name", the relevant "ISO common name" or another "common name" being used in individual cases. If the designation is not a "common name", the nature of the designation used instead is given in round brackets for the particular compound; in that case, the lUPAC name, the lUPAC/Chemical Abstracts name, a "chemical name", a "traditional name", a "compound name" or a "develoment code" is used or, if neither one of those designations nor a "common name" is used, an "alternative name" is employed. "CAS Reg. No" means the Chemical Abstracts Registry Number.

The active ingredient mixture of the compounds according to any one of embodiments 1 to 24 with active ingredients described above comprises a compound according to any one of embodiments 1 to 24 and an active ingredient as described above preferably in a mixing ratio of from 100:1 to 1 :6000, especially from 50:1 to 1 :50, more especially in a ratio of from 20: 1 to 1 :20, even more especially from 10: 1 to 1 : 10, very especially from 5:1 and 1 :5, special preference being given to a ratio of from 2: 1 to 1 :2, and a ratio of from 4:1 to 2: 1 being likewise preferred, above all in a ratio of 1 :1 , or 5: 1 , or 5:2, or 5:3, or 5:4, or 4: 1 , or 4:2, or 4:3, or 3:1 , or 3:2, or 2: 1 , or 1 :5, or 2:5, or 3:5, or 4:5, or 1 :4, or 2:4, or 3:4, or 1 :3, or 2:3, or 1 :2, or 1 :600, or 1 :300, or 1 :150, or 1 :35, or 2:35, or 4:35, or 1 :75, or 2:75, or 4:75, or 1 :6000, or 1 :3000, or 1 :1500, or 1 :350, or 2:350, or 4:350, or 1 :750, or 2:750, or 4:750. Those mixing ratios are by weight.

The mixtures as described above can be used in a method for controlling pests, which comprises applying a composition comprising a mixture as described above to the pests or their environment, with the exception of a method for treatment of the human or animal body by surgery or therapy and diagnostic methods practised on the human or animal body.

The mixtures comprising a compound of according to any one of embodiments 1 to 24 and one or more active ingredients as described above can be applied, for example, in a single "ready-mix" form, in a combined spray mixture composed from separate formulations of the single active ingredient components, such as a "tank-mix", and in a combined use of the single active ingredients when applied in a sequential manner, i.e. one after the other with a reasonably short period, such as a few hours or days. The order of applying the compounds according to any one of embodiments 1 to 24 and the active ingredients as described above is not essential for working the present invention.

The compositions according to the invention can also comprise further solid or liquid auxiliaries, such as stabilizers, for example unepoxidized or epoxidized vegetable oils (for example epoxidized coconut oil, rapeseed oil or soya oil), antifoams, for example silicone oil, preservatives, viscosity regulators, binders and/or tackifiers, fertilizers or other active ingredients for achieving specific effects, for example bactericides, fungicides, nematocides, plant activators, molluscicides or herbicides. The compositions according to the invention are prepared in a manner known per se, in the absence of auxiliaries for example by grinding, screening and/or compressing a solid active ingredient and in the presence of at least one auxiliary for example by intimately mixing and/or grinding the active ingredient with the auxiliary (auxiliaries). These processes for the preparation of the compositions and the use of the compounds I for the preparation of these compositions are also a subject of the invention.

The application methods for the compositions, that is the methods of controlling pests of the abovementioned type, such as spraying, atomizing, dusting, brushing on, dressing, scattering or pouring - which are to be selected to suit the intended aims of the prevailing circumstances - and the use of the compositions for controlling pests of the abovementioned type are other subjects of the invention. Typical rates of concentration are between 0.1 and 1000 ppm, preferably between 0.1 and 500 ppm, of active ingredient. The rate of application per hectare is generally 1 to 2000 g of active ingredient per hectare, in particular 10 to 1000 g/ha, preferably 10 to 600 g/ha. A preferred method of application in the field of crop protection is application to the foliage of the plants (foliar application), it being possible to select frequency and rate of application to match the danger of infestation with the pest in question. Alternatively, the active ingredient can reach the plants via the root system (systemic action), by drenching the locus of the plants with a liquid composition or by incorporating the active ingredient in solid form into the locus of the plants, for example into the soil, for example in the form of granules (soil application). In the case of paddy rice crops, such granules can be metered into the flooded paddy-field.

The compounds of the invention and compositions thereof are also be suitable for the protection of plant propagation material, for example seeds, such as fruit, tubers or kernels, or nursery plants, against pests of the abovementioned type. The propagation material can be treated with the compound prior to planting, for example seed can be treated prior to sowing. Alternatively, the compound can be applied to seed kernels (coating), either by soaking the kernels in a liquid composition or by applying a layer of a solid composition. It is also possible to apply the compositions when the propagation material is planted to the site of application, for example into the seed furrow during drilling. These treatment methods for plant propagation material and the plant propagation material thus treated are further subjects of the invention. Typical treatment rates would depend on the plant and pest/fungi to be controlled and are generally between 1 to 200 grams per 100 kg of seeds, preferably between 5 to 150 grams per 100 kg of seeds, such as between 10 to 100 grams per 100 kg of seeds.

The term seed embraces seeds and plant propagules of all kinds including but not limited to true seeds, seed pieces, suckers, corns, bulbs, fruit, tubers, grains, rhizomes, cuttings, cut shoots and the like and means in a preferred embodiment true seeds.

The present invention also comprises seeds coated or treated with or containing a compound according to any one of embodiments 1 to 24. The term "coated or treated with and/or containing" generally signifies that the active ingredient is for the most part on the surface of the seed at the time of application, although a greater or lesser part of the ingredient may penetrate into the seed material, depending on the method of application. When the said seed product is (re)planted, it may absorb the active ingredient. In an embodiment, the present invention makes available a plant propagation material adhered thereto with according to any one of embodiments 1 to 24. Further, it is hereby made available, a composition comprising a plant propagation material treated with a compound according to any one of embodiments 1 to 24.

Seed treatment comprises all suitable seed treatment techniques known in the art, such as seed dressing, seed coating, seed dusting, seed soaking and seed pelleting. The seed treatment application of the compound according to any one of embodiments 1 to 24 can be carried out by any known methods, such as spraying or by dusting the seeds before sowing or during the sowing/planting of the seeds.

The pesticidal/insecticidal properties of the compounds according to any one of embodiments 1 to 24 can be illustrated via the following tests:

Spodoptera littoral is (Egyptian cotton leaf worm)

Cotton leaf discs were placed onto agar in 24-well microtiter plates and sprayed with aqueous test solutions prepared from 10Ό00 ppm DMSO stock solutions. After drying the leaf discs were infested with five L1 larvae. The samples were assessed for mortality 3 days after infestation.

The following compounds resulted in at least 80% mortality at an application rate of 200 ppm:

Compounds 3 , 4 , 8 , 10 , 29 , 35 , 39 , 41 , 43 , 44 , 46 , 47 , 48 , 49 , 54 , 72 , 73 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 86 , 87 , 88 , 89 , 90 , 92 , 93 , 94 , 95 , 96 , 97 and 98. Plutella xylostella (Diamond back moth):

24-well microtiter plates with artificial diet were treated with aqueous test solutions prepared from 10Ό00 ppm DMSO stock solutions by pipetting. After drying, the plates were infested with L2 larvae (10 to 15 per well). The samples were assessed for mortality and growth inhibition in comparison to untreated samples 5 days after infestation. The following compounds resulted in at least 80% control at an application rate of 200 ppm: Compounds 3 , 4 , 8 , 10 , 21 , 29 , 35 ,39 , 41 , 43 , 44 , 47 , 48 ,49 , 53 , 54 , 70 , 72 , 76 , 77 , 79 , 80 , 81 , 82 , 83 , 84 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 and 98 . Diabrotica balteata, (Corn root worm)

Maize sprouts placed onto an agar layer in 24-well microtiter plates were treated with aqueous test solutions prepared from 10Ό00 ppm DMSO stock solutions by spraying. After drying, the plates were infested with L2 larvae (6 to 10 per well). The samples were assessed for mortality 4 days after infestation.

The following compounds resulted in at least 80% mortality at an application rate of 200 ppm:

Compounds 3 , 4 , 8 , 9 , 10 , 29 , 39 , 41 , 43, 44 , 47 , 48 , 49 , 54 , 72, 75, 76 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 86 , 87 , 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 , 97 and 98 .

Thrips tabaci (Onion thrips):

Sunflower leaf discs were placed on agar in 24-well microtiter plates and sprayed with aqueous test solutions prepared from 10Ό00 ppm DMSO stock solutions. After drying the leaf discs were infested with a thrips population of mixed ages. The samples were assessed for mortality 6 days after infestation. The following compounds resulted in at least 80% control at an application rate of 200 ppm: Compounds 3 , 4 , 8 , 10 , 39 , 41 , 43 , 44 , 48 ,54 , 79 , 75 , 76 , 77 , 78 , 80 , 81 , 82 , 83 , 84 , 86 , 87, 88 , 89 , 90 , 91 , 92 , 93 , 94 , 95 , 96 and 98 .

Tetranychus urticae (Two-spotted spider mite):

Bean leaf discs on agar in 24-well microtiter plates were sprayed with aqueous test solutions prepared from 10Ό00 ppm DMSO stock solutions. After drying the leaf discs were infested with a mite population of mixed ages. The samples were assessed for mortality on mixed population (mobile stages) 8 days after infestation. The following compounds resulted in at least 80% control at an application rate of 200 ppm: Compounds 3 , 4 , 8 , 29 , 39 , 41 , 43 , 44 , 48 , 54 , 73 , 76 , 77 , 78 , 79 , 80, 81 , 84 , 85 , 86 , 87 , 89 , 90 , 91 , 92 , 93 , 94 and 98 . Euschistus heros (Neotropical Brown Stink Bug):

Two weeks old soybean plants were sprayed in a turn table spray chamber with the diluted spray solutions. After drying 2 soybean seeds were added and plants were infested with 10 N2 nymphs of the neotropical brown stink bug Euschistus heros in plastic test boxes. The samples were assessed for mortality in comparison to untreated samples 5 days after infestation.

The following compounds gave at least 80% mortality of Euschistus heros at an application rate of 12.5 ppm: Compounds 3 , 4 , 8 , 39 , 43 , 44 , 46 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 88 , 90 , 93 and 95 .

Myzus persicae (Green peach aphid):

Sunflower leaf discs were placed on agar in a 24-well microtiter plate and sprayed with test solutions at an application rate of 200 ppm. After drying, the leaf discs were infested with an aphid population of mixed ages. After an incubation period of 6 DAT, samples were checked for mortality. The following compounds gave at least 50% mortality of Myzus persicae: Compounds 3 , 4 , 8 , 43 , 44 , 75 , 76 , 77 , 80 , 81 , 90 and 92 .

Myzus persicae (Green peach aphid):

Test compounds were applied by pipette into 24 well plates and mixed with Sucrose solution.

Application rate: 12.5ppm. The plates were closed with a stretched parafilm. A plastic stencil with 24 holes is placed onto the plate and infested pea seedlings were placed directly on the Parafilm. The infested plate is closed with a gel blotting paper and another plastic stencil and then turned upside down. 5 days after infestation the samples were checked on mortality.

The following compounds gave at least 80% mortality of Myzus persicae: Compound 4 , 10 , 29 , 38 , 39 , 43 , 44 , 72 , 75 , 76 , 77 , 81 , 92 , 93 , 96 and 97 .

The following compounds gave at least 50% mortality of Myzus persicae: Compound 3.

The compounds of the invention can be distinguished from known compounds by virtue of greater efficacy at low application rates, which can be verified by the person skilled in the art using the experimental procedures outlined in the Examples, using lower application rates if necessary, for example 50 ppm, 12.5 ppm, 6 ppm, 3 ppm, 1.5 ppm or 0.8 ppm.

The compounds according to any one of embodiments 1 to 24 also have a better bee safety profile compared with compounds of the prior art.

Biological comparison data:

Compound A is disclosed in WO2012/107434 as example A103 (Table A) and compound B is disclosed in WO 2014/122083 as compound lc-2 (p. 82, Tabelle 3). The activities of compounds A and B to treat different pests are compared with the activities of compound 4 and 44 according to the present invention. The tests are carried out at different concentrations (ppm). It can be seen that compounds 4 and 44 of the present invention have surprisingly improved activity in comparison with compounds A and B. a) Insecticidal activity against Diabrotica balteata (Corn root worm):

Maize sprouts, placed on an agar layer in 24-well microtiter plates were treated with aqueous test solutions prepared from 10Ό00 ppm DMSO stock solutions by spraying. After drying, the plates were infested with L2 larvae (6 to 10 per well). The samples were assessed for mortality and growth inhibition in comparison to untreated samples 4 days after infestation.

b) Insecticidal activity against Thrips tabaci (Onion thrips):

Sunflower leaf discs were placed on agar in 24-well microtiter plates and sprayed with agueous test solutions prepared from 10Ό00 ppm DMSO stock solutions. After drying the leaf discs were infested with a thrips population of mixed ages. The samples were assessed for mortality 6 days after infestation.

c) Insecticidal activity against Spodoptera littoralis (Egyptian cotton leaf worm):

(larvicide L-3, feeding/contact)

Soybean plants are sprayed with diluted test solutions in an application chamber. The plants (2 replicates) are infested with 10 L ₃ larvae 1 day after treatment. Samples are checked 5 days after infestation for mortality, feeding behavior, and growth regulation.